incivo works by stopping the virus from multiplying and multiplying in patients with hepatitis c infection . incivo is used to treat chronic hepatitis c in adults and adolescents from 1865 onwards , who are already taking peginterferon alfa , ribavirin and telaprevir . incovis belongs to a class of medicines called ns3 - 4a protease inhibitors . the ns3 + 4a enzyme inhibitor stops hepatitis c virus from growing and multiplying . incivis is used in combination with peginerferon aluminium and ribavir . your doctor has prescribed incivo for you . inciva is used for the
do not take incivo - if you are allergic to telaprevir or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has prescribed peginterferon alfa or ribavirin for you . warnings and precautions talk to your doctor or pharmacist before taking incivo . if you have been prescribed peinterferons alfa and ribavir , please tell your doctor . warnings , precautions and precautions before taking any of incivo , tell your physician or pharmaceutist if you : - are taking any or all of the following medicines : - have experienced severe side
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage the recommended dose regimen is one tablet once a day . the recommended dosage regimen is 3 mg twice a day ( 6 mg in the morning and 6 mg at 2 to 8 mg in in the evening ). patients with both hepatitis c virus infection and human immunodeficiency virus infection , efavirenz , the recommendeddose regimen is three tablets once a morning and 8 mg twice daily ( 6 tablets in the afternoon ). the body will absorb the full dose of incivo within 60 minutes . incivo
like all medicines , this medicine can cause side effects , although not everybody gets them . if you get rash , tell your doctor straight away . if your doctor thinks you may have an itchy skin rash , he or she may decide to treat you . the rash may be temporary . other symptoms of the rash are a severe skin reaction . tell your physician immediately if you develop a skin rash . if the rash does not go away , or other symptoms are not listed , tell the doctor or nurse immediately . if a rash becomes severe , tell a doctor or the nurse immediately as your rash may become life - threatening . other signs of a
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and bottle after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . incivo tablets should be kept in the bottle tightly closed in order to protect from moisture . do this to protect the tablets from moisture and light . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what incivo contains - the active substance is telaprevir . each tablet of incivo contain 375 mg telaprentir . - the other ingredients are tablet core hypromellose acetate succinate , calcium hydrogen phosphate ( anhydrous ), microcrystalline cellulose , silica colloidal anhydrated , sodium lauryl sulphate , croscarmellose sodium , sodium stearyl fumarate . film - coat polyvinyl alcohol , macrogol , talc , titanium dioxide ( e171 ), iron oxide yellow ( e172 ). what incivo looks like and contents of the pack
what zinbryta is zinberryta contains the active substance daclizumab beta , a monoclonal antibody . what zinbarryta looks like and contents of the pack zinborryta belongs to a group of medicines called cytokines . it is used to treat multiple sclerosis in adults . it starts as therapy and is gradually increased to two ms treatment courses followed by other treatments . inflammation destroys the protective sheath around the nerves in the central nervous system ( brain and spinal cord ). this loss of myelin ( also known as demyelination ) can lead to relapsing
do not take zinbryta if you have previously had a serious allergic reaction to daclizumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking zinryta : if you suffer from liver problems . your doctor may need to adjust your dose of zinibryta . if you are suffering from any other autoimmune disorders . if any of these apply to you , tell your doctor . if your doctor has told you to take any other medicines , including herbal supplements . if this applies to you ( or you are not sure
your doctor or nurse will give you zinbryta exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much zinbaryta to use the usual dose of zinburyta is 150 mg once a day . your doctor will ask you to have a blood test to check how well your liver is working . the usual starting dose of the zinbasil is 40 mg once daily . your dose may be increased depending on the results of this blood test . your physician will ask your doctor to perform a blood sample before you start injecting yourself zinry
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with zinbryta : tell your doctor straight away if you notice any of the following serious side effects : liver problems ( very common : may affect more than 1 in 10 people ) unexplained nausea ( feeling sick ) vomiting ( being sick ) stomach pain increased tiredness loss of appetite ( anorexia ) your skin or whites of your eyes turn yellow dark ( tea - coloured ) urine 41 uncommon : may effect up to 1 in 100 people severe inflammation of the liver may lead to death . tell your liver doctor
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the syringe label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the zinbryta pre - filled syringe in its original package in order to protect from light . if you are using a new syringe / pen , do not store it in a fridge . zin bryta syringes / pens may be stored for up to 30 days in the original
what zinbryta contains the active substance is daclizumab beta . each pre - filled syringe contains 150 mg of dacluzumabbeta . 1 ml solution for injection : each pre- filled pen contains 150mg of dlizumb beta . 1ml solution for infusion : sodium succinate , succinic acid , sodium chloride , polysorbate 80 ( see section 2 ' zinabryta contain sodium '). what zinbaryta looks like and contents of the pack zin bryta is a clear to slightly yellow solution for injecting in a syringe / pen
what wilzin is wilzin belongs to a group of medicines called metabolism products . what wilson ' s disease is wilson Â´ s disease has a rare inherited defect in copper excretion , which affects the liver , eyes and brain . this results in liver damage and neurological disorders . what is wiltin used for wilzin works by attaching to copper in the intestine and its further accumulation in the body . what it is used for this treatment is used to treat wilson .
do not use wilzin if you are allergic ( hypersensitive ) to zinc or any of the other ingredients of wilzin . warnings and precautions talk to your doctor or pharmacist before using wilzin wilzin is used for initial therapy in adults who have signs and symptoms of wilson ' s disease . you are currently being treated with another anti - copper agent , penicillamine . your doctor will monitor you closely during treatment and during the initial treatment with other anti - copper agents , penICillamine may improve your symptoms and the treatment . your blood and urine will be tested regularly for signs and signs of sufficient treatment .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the different dose regimens are as follows : the usual starting dose is 25 mg / 50 mg once a day . this dose is 1 mg / day . wilzin 50 mg / 2 mg once daily . this dosage is 1 to 6 mg / m2 . wilz 25 mg and 50 mg per m2 dose are 2 mg / kg . this will be 1 mg per day . the usual dose is wilzin 25 mg once weekly . this is 1 dose in the morning . this may be 1 to
like all medicines , wilzin can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common ( affecting 1 to 10 users in 100 ) uncommon ( affects 1 to 5 users in 1 , 000 ) rare ( affects less than 1 users in 10 , 000 ): very rare ( affecting less than1 user in 1, 000 ) not known ( frequency cannot be estimated from the available data ) very rare cases of wilzin intake leading to gastric irritation during treatment . changes in blood tests there may be an increase
keep out of the reach and sight of children . do not use wilzin after the expiry date which is stated on the carton and the blister after exp . the exp date refers to the last day of that month . do this after the first opening of the blister . donot store above 25 . do away with the blister and keep the blister tightly closed in order to protect from moisture . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what wilzin contains the active substance is zinc . each hard capsule contains 25 mg of zinc ( equivalent to 83 . 92 mg of z zinc acetate dihydrate ). each 50 mg hard capsule delivers 25 mg ( equivalent of 167 . 84 mg of the z zincacetate diydrate ). the other ingredients are magnesium stearate . the capsule shell is composed of gelatin , titanium dioxide ( e171 ), brilliant blue fcf ( e132 ). what wilzin looks like and contents of the pack wilzin 25 mg hard capsules are white to off - white , oblong shaped , imprinted with " wilzin 50 " on
biktarvy contains the active substance bictegravir , an antiretroviral medicine known as an integrase strand transfer inhibitor . the other active ingredient is emtricitabine , an antiviral medicine ( known as a nucleoside reverse transcriptase inhibitor ( nrti ) tenofovir alafenamide , an antiiretviral medicine called a nucleotide reverse transcriptases inhibitor ( trti ). biktarv is used for the treatment of human immunodeficiency virus 1 ( hiv - 1 ) infection in adults . biktrelir reduces the
do not take biktarvy if you are allergic to bictegravir , emtricitabine , tenofovir alafenamide or any of the other ingredients of this medicine ( listed in section 6 ). if you take any of these , tell your doctor . if you have taken any of any of your following medicines : - rifampicin which is used to treat some bacterial infections such as tuberculosis - st . john ' s wort ( hypericum perforatum ), a herbal remedy used to help prevent depression and anxiety . warnings and precautions talk to your doctor before taking bik
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one tablet a day . your doctor may also prescribe antacids to help prevent stomach ulcers , heartburn and acid reflux . your dose may need to be adjusted by your doctor . your diet should be taken in combination with aluminium and magnesium hydroxide mineral supplements , vitamins , magnesium and iron ( see section 2 " important information about these medicines "). biktarvy should not be taken with or without food . if you take more biktor
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience any of the following : inflammation or infection in patients with advanced hiv infection ( aids ) or opportunistic infections ( infections caused by a weak immune system ). symptoms of inflammation from previous infections may occur during hiv treatment . these symptoms may be due to an improvement in the body ' s immune response , which helps fight infections . no obvious symptoms are known . autoimmune disorders ( when the immune system attacks healthy body tissue ) are common . medicines given to treat hiv infected people may develop autoimmune disorders many months after treatment
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the seal tightly closed in order to protect from light . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what biktarvy contains the active substances are bictegravir , emtricitabine and tenofovir alafenamide . each biktorvy tablet contains bic tegravira sodium equivalent to 50 mg bicchegravor , 200 mg emtracitabin , tenofovel ( as tenofnovir alufenamide fumarate equivalent to 25 mg tenofoviir alfenamide ). the other ingredients are tablet core microcrystalline cellulose , croscarmellose sodium , magnesium stearate . film - coating poly
novondorm is an oral antidiabetic medicine containing repaglinide which helps your pancreas produce more insulin and thereby lower your blood sugar ( glucose ). type 2 diabetes is a disease in which your pancrea does not produce enough insulin to control the sugar in your blood or where your body does not respond normally to the insulin it produces . novonorm is used to treat type 2 diabetic in adults . treatment is usually started with diet and exercise and weight reduction . your blood blood sugar may be increased when you start taking novonor or when metformin . if you have diabetes , novonors may lower the
do not take novonorm if you are allergic to repaglinide or any of the other ingredients of novonor . if you have type 1 diabetes . if the acid level in your blood is too high . if diabetic ketoacidosis is common . if your doctor has told you that you have a severe liver disease . if any of these apply to you ( or you are not sure ), talk to your doctor . warnings and precautions talk to you doctor or pharmacist before taking novonors if you : have moderate liver disease , as novonere may not be suitable for you . have a severely liver disease or
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 0 . 5 mg once a day . swallow the tablet whole with a glass of water . you can take novonorm with or without food . try to take noonalorm at about the same time each day . you should take novanorm for at least 30 minutes each day , with or just after meals . you may take no vonorm for 4 weeks , or 30 days , or 16 weeks . your doctor will work out the right dose for you . your blood sugar will be
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia the most common side effect of novonorm is hypoglycasemia ( may affect up to 1 in 10 people ). if you have a hypo in section 2 , you should contact your doctor immediately . hypoemic reactions are generally mild / moderate . however , hypoglycemic unconsciousness may lead to coma . allergy allergy ( may occur in up to1 in 10 , 000 people ) symptoms include swelling , difficulty in breathing , rapid heartbeat , feeling dizzy and sweating ( anaphylactic reaction ). other side effects
what novonorm contains - the active substance is repaglinide . - the other ingredients are microcrystalline cellulose , calcium hydrogen phosphate anhydrous , maize starch , polacrilin potassium , povidone ( polyvidone ), glycerol , magnesium stearate , meglumine , poloxamer , iron oxide yellow ( e172 ), iron oxide red ( e 172 ) ( see section 2 " novonhyd contains sodium "). what novonondorm looks like and contents of the pack novonost tablets are white , round , flat , with " 0 . 5 " marked
what pumarix is pumarax is a vaccine for use in adults ( 18 years of age and older ) to prevent pandemic flu ( influenza ). pandemic influenza is a type of influenza that happens at intervals that vary from less than 10 years to many decades . pandemic fluids are similar to ordinary flu but may be more serious . when a person is given the vaccine , the immune system ( the body ' s natural defence system ) will produce its own protection ( antibodies ) against the disease . none of the ingredients in the vaccine can cause flu . as with all vaccines , pumarood may not fully protect all persons who
do not use pumarix if you have had a sudden life - threatening allergic reaction to any ingredient of this vaccine ( listed in section 6 ) or to any of the ingredients of ovalbumin , formaldehyde or sodium deoxycholate . signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of the face or tongue . if you experience signs of such an allergic response , including itchyskin rash , feeling of shortnessof breath and / or swelling of any face or trunk , stop the vaccine and seek medical treatment immediately . an allergic allergic reaction is unlikely to occur with pumarip
pumarix is intended for use in adults aged 18 years and over . pumarix contains a similar h5n1 as03 to those from 18 years of age and older . pumix can be given as a single dose . the recommended dose is one vial of vaccine . pumanix is used in children 3 - 9 years of ages and adolescents 3 - 17 years of years of body weight . how pumarax is given pumarick is given as an injection into a muscle ( usually in the upper arm ). if you have any further questions on the use of this vaccine , ask your doctor or pharmacist
like all medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions allergic reactions may lead to dangerously low blood pressure , shock and emergency treatment . the following side effects have been reported with pumarix : very common ( may affect more than 1 in 10 people pain where the injection is given headache feeling tired aching muscles joint pain common ( might affect up to 1 in every 10 people ) redness or swelling where the area of the injection was given fever sweating shivering diarrhoea feeling sick uncommon ( may affects up to1 in every 100 people ) bruising where thejection was given a hard lump ,
keep this vaccine out of the sight and reach of children . do not use this vaccine after the expiry date which is stated on the carton and the label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . after preparation of the vaccine , the suspension should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 - 30 . do away with the suspension once it has been thawed . do throw away any medicines via
what pumarix contains the active substance is split influenza virus ( inactivated ) of the type 5 / 2005 ( pr8 - ibcdc - rg2 ) in 0 . 5 ml . the other ingredients are haemagglutinin , which are used to prevent the pandemic . the vaccine contains an ' adjuvant ' as03 . this adjuvant contains squalene , dl - Î± - tocopherol , polysorbate 80 and adjuvants . the ingredients in the vaccine are sodium chloride , disodium hydrogen phosphate , potassium dihydrogen phosphate , water for injections .
somakit t is a radiopharmaceutical product containing the active substance edotreotide . the powder contains a radioactive substance called gallium ( 68ga ) chloride . when used in combination with gallium (" 68ga ") edotreaotide , this procedure is repeated . the amount of gallium / edotREotide that is excreted is measured in micrograms per vein and body areas . somakit to is used for a medical imaging procedure called positron emission tomography ( pemphigus ) in adults and pet - related patients . this medical procedure is to obtain images of the
do not take somakittoc if you are allergic to edotreotide or any of the other ingredients of this medicine ( listed in section 6 ). if you have experienced allergic reaction to any ingredient listed in the section 4 of this leaflet . warnings and precautions talk to your doctor before taking somaknittoc if : you have kidney or liver problems you have renal or hepatic disease you are under 18 years of age . you are suffering from dehydration . the examination will be repeated every 28 days . you have or have had others medical conditions that affect the way your body works ( e . g . cushing syndrome , inflammation
there are strict laws on the use , handling and disposal of radiopharmaceutical products . somakittoc will only be used in special controlled areas . 29 the nuclear medicine doctor supervising the procedure will decide on the quantity of somakt to be used . the usual dose of somackit to be administered is 100 to 200 megabecquerel per kg body weight . the nuclear doctor supervises the administration of somacit to conduct the procedure . in order to avoid radiolabelling , somakiton to be given as a single injection will be given to you by a doctor or nurse . the doctor
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are allergic reactions ( hypersensitivity ) which have been reported in patients receiving somakit to have symptoms such as warm flush , redness of the skin , swelling , itching , nausea and difficulty breathing . allergic reactions may also include stinging at the injection site due to ionising radiation , cancer and hereditary abnormalities . reporting of side effects if you get any side effects talk to your nuclear medicine doctor . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials . the following information is intended for the specialist only : radiolabelling will be done in accordancewith national regulation . somakit t will be stored at a temperature not above 4 and below 25 for a single period of up to five months . do not use somakits t if you notice any visible signs of deterioration of radioactive products .
what somakit t contains - the active substance is edotreotide . one vial of powder contains 40 mg edotereotide . - the other ingredients are 10 - phenanthroline , gentisic acid , mannitol , formic acid ( e421 ), sodium hydroxide , water for injections , sodium and radiolabelling . the solution contains hydrochloric acid . what somakIT t looks like and contents of the pack somakiton t is presented as a radiopharmaceutical preparation in a glass vial with black flip - off cap . it is a white powder in a v
afinitor is an anticancer medicine that contains the active substance erolimus . everolimus stops the growth and spread of cancer cells . afinitor acts by blocking the activity of hormone receptor - positive advanced breast cancer ( postmenopausal women ) in women who are treated with non - steroidal aromatase inhibitors ( aids ), which are used to keep the disease under control . afinavitor is used in combination with a medicine called exemestane ( a steroidal aomatases inhibitor ) and hormonal anticancer therapy to treat advanced tumours called neuroendocrine tumours ( tumours of the stomach
you will not be given afinitor if you are undergoing cancer treatment . warnings and precautions talk to your doctor or pharmacist before you are given afrinitor : if you think you may be allergic to everolimus , sirolimus , temsirolimu or any of the other ingredients of this medicine ( listed in section 6 ). if you suspect you may also be allergic , ask your doctor for advice . warnings , precautions talk with your doctor before you receive afincer : if any problems with your liver . if you have any disease that affects your liver , your doctor may prescribe a different dose of afin
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet of 10 mg taken once a day . if you take more afinitor than you should if you have liver problems , your doctor may prescribe a lower dose of afininitor . the dose may be taken as one 5 mg tablet once a week or as one 7 . 5 mg dose once a month . if certain side effects occur , your dose may need to be adjusted . your doctor will monitor you more closely during treatment . if possible , your physician may reduce your dose
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking afinitor and tell your doctor immediately if you experience an allergic reaction including : difficulty breathing or swallowing swelling of the face , lips , tongue or throat severe itching of the skin , with a red rash or raised bumps . the following side effects have been reported with afininitor : very common ( may affect more than 1 in 10 people ): increased temperature ( chills ) ( signs of infection ) fever , coughing , difficulty breathing , wheezing ( signs for inflammation of the lung called pneumonitis 46 common ( might affect up
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 25 . donot open the blister . the tablets should be used within one week after first opening . do this medicine if you notice any visible sign of tampering . do so and return the tablet to your pharmacist . do away with the blister and write the date you opened it on the blister to indicate that the tablets are no longer being used . doxoricon does not use af
what afinitor contains the active substance is everolimus . afincer 2 . 5 mg : each tablet contains 2 . 75 mg of everolim . afinnitor 5 mg tablet : each tablets contains 5 mg of Everolimus. afininitor 10 mg tablet ): each tablet contain 10 mg ofEverolimus the other ingredients are butylhydroxytoluene ( e321 ), magnesium stearate , lactose monohydrate , hypromellose , crospovidone , lactos anhydrous . what afinitors looks like and contents of the pack afinit 2 .
what laventair ellipta is the active substance of lavent air ellipta . it belongs to a group of medicines called bronchodilators . what laventAir ellipta used for laventaire ellipta belongs to the group of medicinal products called bronchi . what it is used for the active ingredient of lavantair elliptoe is used to treat chronic obstructive pulmonary disease ( copd ). copd is a long - term condition characterised by breathing difficulties that occur every day . in copd the muscles around the airways tighten . this medicine works by tightening these muscles in the lungs . this helps to open
do not use laventair ellipta 31 if you are allergic to umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using this medicine : if you have asthma . warnings and precaution talk to the doctor or nurse before using lavent air ellipta : if your asthma is getting worse . if you suffer from heart problems . if your doctor determines that you have high blood pressure . if any of these apply to you , tell your doctor . if there is an eye problem called narrow - angle glau
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation once a day . you should use this this medicine for 24 hours at the same time each day . use laventair ellipta every day , with or without food . try to use laventa every day at the usual time . if you use more lavent air ellipta than you should if you have used more lavents than you have been told to use , contact your doctor immediately . symptoms of using too much laventAir ellipta may include a sudden attack of
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions if you experience any of the following symptoms while taking laventair ellipta , stop taking the medicine and contact your doctor immediately : uncommon side effects ( may affect up to 1 in 100 people ): skin rash ( hives ) and redness rare side effects : ( may effect up to1 in 1 , 000 people ): swelling mainly of the face or mouth ( angioedema ), which may make you feel very wheezy , coughing , having difficulty in breathing , feeling weak or light headed , which may lead to collapse or loss
what laventair ellipta contains - the active substances are umeclidinium bromide and vilanterol . each delivered dose contains 55 micrograms umeklidinia , 65 microgramms umephidinIUM bromides and 22 microgramrams vilanTERol ( as trifenatate ). - the other ingredients are lactose monohydrate ( see section 2 under ' lavent air ellipta contain lactose ' and magnesium stearate ). what laventAir ellipta looks like and contents of the pack laventaire ellipta is an inhalation powder .
what tremfya is tremfia contains the active substance guselkumab , which is a monoclonal antibody . this medicine attaches to a protein called il - 23 , which helps to improve the appearance of nails . what tremfYA is used for tremfyna is used to treat adults with psoriasis with moderate to severe " plaque psorism ". plaque psoreiasis is an inflammatory condition that affects the skin and nails . tremfana works by helping to improve how well the skin is working and the appearanceof nails . it is used in adults to reduce symptoms such as scaling , shedding , fl
do not use tremfya if you are allergic to guselkumab or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice before using tremfia . warnings and precautions talk to your doctor or pharmacist before using this medicine if you : have an active infection or active tuberculosis warnings and measures talk to the doctor or nurse before using or using tremfaya if : you have an infection or an infection with tuberculosis . tuberculosis is a serious , sometimes life - threatening condition that can affect up to 36 people . you have signs of an infection
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . tremfya 100 micrograms solution for injection ( 1 pre - filled syringe ) is given under the skin ( subcutaneous injection ) every 4 to 8 weeks . your doctor will decide how many treatments you need . if you have any further questions on the use of this product , ask your doctor , pharmacist or nurse .
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side side effects : signs of serious allergic reaction : difficulty breathing or swallowing , swelling of the face , lips , tongue or throat , severe itching of the skin , a red rash with raised bumps other side effects if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . some side effects may be serious : common ( may affect up to 1 in 10 people ): upper respiratory infections common ( might affect
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the pre - filled syringe in the outer carton in order to protect from light . do do not give this medicine if you notice that the solution is cloudy or contains large particles . do away with the pre -- filled syringes and allow it to reach room temperature ( up to 30 ) before use . do this medicine once it
what tremfya contains - the active substance is guselkumab . each pre - filled syringe contains 100 mg of gusel kumab in 1 ml solution . - the other ingredients are histidine , histidine monohydrochloride monohydrate , polysorbate 80 , sucrose , water for injections . what tremfYA looks like and contents of the pack solution for injection in a vial is a clear , colourless to pale yellow solution . tremfia is supplied in a carton pack containing one single - dose glass syringe and a multipack containing 2 packs of 1 vial of
the active substance of trepulmix is treprostinil . treprosteinil belongs to a group of medicines called prostacyclins , a hormone that lowers blood pressure by relaxing blood vessels . prostacycylins prevent blood from clotting . trepulemix is used to treat inoperable chronic thromboembolic pulmonary hypertension ( cteph ). it is used in adult patients who have persistent or recurrent ctph and whose condition is not stabilised after surgical treatment and exercise capacity has been reduced . symptoms of the disease are : chronic thromeboembolmonary hypertension ( i . e
do not take trepulmix - if you are allergic to treprostinil or any of the other ingredients of this medicine ( listed in section 6 ). - if your child has a disease called " pulmonary veno - occlusive disease ". this is a disease in which the blood vessels in the lungs become swollen and there is a higher pressure in the blood arteries between the heart and the lungs . - if the child has severe liver disease . - tell your doctor if your baby has a heart problem . - your baby may have had a heart attack ( myocardial infarction ) in the last six months .
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . trepulmix is intended for a continuous subcutaneous infusion ( subcutaneously ) under the skin through a small tube ( cannula ) that goes into the abdomen or thigh . trepanmix is given in a pouch or a portable pump containing your treprostinil . the pump is connected to the infusion line to reduce the risk of accidental overdose . the recommended dose is 1 mg / kg , 2 . 5 mg /kg , 5 mg per kg and 10 mg / ml . infusion
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): widening of blood vessels pain at the infusion site reaction at the site bleeding or bruising at the infusion site headaches nausea diarrhoea jaw pain common ( might affect up to 1 in every 10 people ) dizziness light - headedness fainting low blood pressure skin rashes muscle pain ( myalgia ) joint pain ( arthralgia ) swelling of feet , ankles , legs ( fluid retention ) hot flush pain in arms and / or legs 36 uncommon ( may effect up to
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . after reconstitution , trepulmix can be used within 30 minutes for continuous subcutaneous infusion . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24
what trepulmix contains - the active substance is treprostinil . trepulemix 1 mg : each vial contains 1 mg treproprostine ( as sodium salt ). each 10 ml vial of 10 ml contains 10 mg trepristinile ( as water for injections ). each 20 ml vials of trepulamix 2 . 5 mg : one vial with 2 . 25 mg treProstinila ( asodium salt ). one 10 ml ampoule of 25 ml vinal contains 25 mg of treprosteinil ( as salt ). trepulesmix 5 mg and
the active substance of thorinane is enoxaparin sodium . it is a low molecular weight heparin ( lmwh ). the active substance in thorinanes is enalaparin . it works in two ways : 1 ) to prevent existing blood clots from forming . 2 ) stopping blood cl clots forming in your blood . thorinan is used to prevent blood clumps from forming in the blood after an operation . it can be used : - if you have an acute illness called unstable angina ( unstable angapore ) - if your heart is working normally after a heart attack . - if blood cl
do not use thorinane if you are allergic to enoxaparin sodium or any of the other ingredients of this medicine ( listed in section 6 ). signs of an allergic reaction may include rash , swallowing or breathing problems , swelling of your lips , face , throat or tongue . if you think you may be allergic to heparin or other low molecular weight heparins ( e . g . nadroparin , tinzaparin , dalteparin ), tell your doctor . if a reaction occurs with heparrin , a severe drop in the number of your clotting cells ( platelets ) occurs , this
like other similar medicines ( medicines to prevent blood clotting ), thorinane may cause bleeding . tell your doctor immediately if you experience any bleeding event that does not stop . excessive bleeding may be accompanied by exceptional weakness , tiredness , paleness , dizziness , headache , or unexplained swelling . tell the doctor immediately , or stop your medicine . if you have any of the following while taking thorinan : - a severe allergic reaction , including difficulty breathing , swelling of the lips , mouth , throat or eyes , or blockage of a blood vessel ( a blood clot ). - cramping pain , redness , warmth or swelling of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store below 25 . after dilution the solution should be used within 8 hours . do this medicine if you notice that the thorinane pre - filled syringes are damaged or have not been stored correctly . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what thorinane contains the active substance is enoxaparin sodium . each pre - filled syringe contains 100 mg of enoxapearin sodium in one ml . each prefilled syringe of 0 . 2 ml contains 2 , 000 mg of the active substances enoxagarin sodium and is for single use only . after reconstitution with water for injections , the product is stable for 0 .2 hours . what thorinanes looks like and contents of the pack thorinan is a clear , colourless type i neutral glass syringe barrel with fixed needle and needle shield , with chlorobutyl rubber stopper
what senstend is senstends contains the active substances lidocaine and prilocaine . both belong to a group of medicines called local anaesthetics . what senstension is used for senstent is used to achieve lifelong premature ejaculation in adult men , in which the head of the penis is firmly erect , enabling ejaculation .
do not use senstend if you are allergic to lidocaine , prilocaine or any of the other ingredients of this medicine ( listed in section 6 ). if you have a history of allergy or sensitivity to local anaesthetics ( amide - type local anahetics ). if your doctor has told you that you have , or have had , a genetic disease or other condition affecting your red blood cells ( glucose and phosphate deficiency ), anaemia ( methaemoglobinaemia ). warnings and precautions talk to your doctor or pharmacist before using senstent if you : have medicine sensitivities or sensitivity . have severe
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to use the recommended dose is one spray of senstend 3 times a day . the first 3 times are for the head of your penis . the second 3 times will be for the first 24 hours . the third time will be given for the second 24 hours ( see section 4 ' how to use senstends '). how to remove the spray container from the pump mechanism by pressing the valve to prevent contact with eyes , nose , mouth and ears . the pump should
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : very common ( may affect more than 1 in 10 people ) inability to develop or maintain an erection in the penis feeling of burning in the area of the penis uncommon ( may affects up to 1 in 100 people ) headache local irritation of the throat or irritation of any part of the skin redness failure to ejaculate during sexual intercourse abnormal orgasm tingling in the penis pain or discomfort in the part of your penis itching in the space between the penis and the vagina a high temperature . other side
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the metal container after exp . the exp date refers to the last day of that month . store below 25 and use within 12 months . do away with the metalcontainer after this period . puncture the container before use . donot burn . do this if you notice any particles in the solution . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what senstend contains - the active substances are lidocaine and prilocaine . each ml of solution contains 150 mg lidocain and 50 mg prilacaine . one spray container contains 50 ml lidocane and 7 . 5 mg prlocaine , each spray container containing 2 . 5 ml prilucaine . - each spraycontainer contains 6 . 5 to 20 ml of solvent . - the other ingredients are : each spray can be stored in a 5 to 12 ampoule , light yellow cutaneous spray container , an aluminium spray container with metering valve . pack sizes of 1 , 6 .
opdivo is a medicine used to treat advanced melanoma ( a type of skin cancer ) in adults melanoma can be treated with complete resesection in adults ( treatment without surgery or adjuvant therapy ). advanced non - small cell lung cancer ( a form of lung cancer ) adults advanced renal cell carcinoma ( advanced kidney cancer ) advanced lymphoid , or adults classical hodgkin lymphoma ( if previous therapies have not worked or if an autologous stem - cell transplant ( such as a transplant ) has not worked . advanced cancer of the head and neck in adults advanced urothelial carcinoma , a type
do not use opdivo if you are allergic to nivolumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before using opdivor if you : - have problems with your heart , such as a change in the rhythm or the heartbeat , or an abnormal heart rhythm . - have any problems with any of your lungs , such breathing difficulties or cough . - had inflammation of the lungs ( pneumonitis or interstitial lung disease ). - diarrhoea , watery , loose or soft stools . - any symptoms of inflammation of any intestines (
always take opdivo exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much opdivos to take the recommended dose of opdivone is 240 mg once daily ( 2 tablets ) or 480 mg once a day ( 4 tablets ). your doctor will prescribe the strength that is right for you . your doctor may also prescribe opdivoth with ipilimumab for the treatment of skin cancer . your dose of either opdivol or 1 mg nivolumab per kilogram of your body weight will be given as follows : 4 times a day opdivor
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the exp date refers to the last day of that month . store below 25 and transport refrigerated ( 2 - 8 ). do not freeze . after dilution , chemical and physical in - use stability has been demonstrated for 48 hours at 2 - 10 . from a microbiological point of view , the infusion solution should be used immediately . any unused medicine or waste material should be disposed of in accordance with local requirements .
what opdivo contains the active substance is nivolumab . each ml of concentrate for solution for infusion contains 10 mg of niviolumab ( 40 mg / ml ). each 4 ml vial contains 100 mg of 10 mg nivlumab and 240 mg /ml of solution for injection contains 24 mg of the active substances . the other ingredients are sodium citrate dihydrate , sodium chloride ( see section 2 " opdivoa contains sodium "), mannitol ( e421 ), pentetic acid , polysorbate 80 , sodium hydroxide , hydrochloric acid and water for injections
clopidogrel tad contains clopidigrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). clopridogrel tet is taken by adults to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombotic events ( such as stroke , heart attack , or death ). you have
do not take clopidogrel tad 30 if you are allergic to clopipidogel or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if any of these apply to you , or if you think any of this applies to you ), tell your doctor before taking clopridogrel tart . warnings and precautions take special care with clopidineogrelTad if any combination of any of your situations can increase the risk of
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of clapidogl to be given orally once at the start of each 75 - day period of treatment .
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
what clopidogrel tad contains the active substance is clopridogrel . each film - coated tablet contains 75 mg of clopidaogrel ( as hydrochloride ). the other ingredients are microcrystalline cellulose , colloidal anhydrous silica , crospovidone , macrogol 6000 and hydrogenated castor oil in the tablet core and polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow iron oxide , talc and macrogrol 3000 in the film - coating . what clopidiogrel tetad looks like and contents
tacrolimus contains the active substance tacrolimos . tacforius is an immunosuppressant . after your organ transplant ( liver and kidney ), your body ' s immune system will try to reject the new organ . tacfortius is used to prevent rejection of transplanted organs by the liver , kidney and heart after any previous treatment that was unable to control them after your transplantation .
do not take tacforius if you are allergic to tacrolimus or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . if you have been told by your doctor that you are taking sirolimus , or any macrolide - antibiotic ( e . g . erythromycin , clarithromycin or josamycin ). tacrolin immediate release capsules ( e. g . tacnier ) are not suitable for patients who are already taking tacforian prolonged - release capsules . tacrolemus immediate
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . this medicine should only be prescribed by a doctor experienced in the treatment of transplant patients . you should always take the same tacrolimus medicine as your transplant patient . if you have been given a different tacroleus medicine , your doctor may change the dose of this medicine to suit your condition . always take this medication exactly as described in this leaflet or as your caregiver has told your doctor . check the box at the end of this leafle leaflet for information about how to take the right
like all medicines , this medicine can cause side effects , although not everybody gets them . infections can be serious and you must stop taking tacforius and seek medical attention immediately if you notice any of the following severe effects : allergic and anaphylactic reactions ( benign and malignant tumours ) which have been reported during tacforus treatment . pure red cell aplasia ( a very severe reduction in red blood cell counts ). agranulocytosis ( a severely lowered number of white blood cells ). haemolytic anaemia ( decreased number of red blood cells due to abnormal breakdown ). febrile neutrop
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep all the prolonged - release hard capsules in the outer carton in order to protect from light . discard 1 capsule after opening the aluminium wrapping . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what tacforius contains the active substance is tacrolimus . tacforus 0 . 5 mg : each prolonged - release hard capsule contains 0 . 25 mg of tacrolamus ( as monohydrate ). tacforian 1 mg : one prolonged -release hard capsule releases 1 mg of of tacrulimus ( monohydrate ) each prolonged release hard capsules contains 3 mg of ticrolimum ( asmonohydrate ). each prolonged period of time lasts 5 days . each prolonged prolonged - releasing hard capsule release hard gelatin capsules contains 5 mg of the active substances . the other ingredients are : capsule content hypromellose
clopidogrel zentiva contains clopidigrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). clopridogrelzentiva is taken by adults to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombotic events ( such as stroke , heart attack , or death
do not take clopidogrel zentiva : if you are allergic ( hypersensitive ) to clopipidogl or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if any of these apply to you , or if you think any of this applies to you ), tell your doctor before taking clopridogrelzentiva . warnings and precautions the following are reasons why clopidineogrel ventiva may increase the risk
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel zentiva per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of clapidogl zenta ( 4 tablets of 75 mg ) once at
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the blister in the original carton in order to protect from light . clopidogrel zentiva may be used in aluminium blisters if it is kept below 30 . do this clopridogrel zincentiva should be used if it has been stored in all aluminium blacks . donot use this medicinal product if
what clopidogrel zentiva contains the active substance is clopridogrel . each tablet contains 75 mg of clopigrel ( as hydrogen sulphate ). the other ingredients are ( see section 2 ' clopiderel zenta contains lactose ' and ' clogidogl zentva contains hydrogenated castor oil '): tablet core : mannitol ( e421 ), hydrogenatedcastor oil , microcrystalline cellulose , macrogol 6000 , low - substituted hydroxypropylcellulose , lactose monohydrate ( milk sugar ), hypromellose ( e
yttriga is a radioactive medicine that is stored in a hospital or clinic . it is stored either in a refrigerator or next to another medicine . it contains tiny radiation doses that are used for the treatment of patients . yttrigba is a radiolabelled medicinal product .
do not use yttriga - if you are allergic ( hypersensitive ) to chloride or any of the other ingredients of yttiga - you are pregnant or think you may be pregnant . warnings and precautions talk to your nuclear medicine doctor before using yttrida - yttrada is a radioactive medicine . it is not used as another medicinal product . - radiopharmaceuticals are sensitive to the effects of ytriga on radioactive material . radioactive medicinal products are stored at 2 to 16 in the outer layer of the body . other medicines and yttarga tell your nuclear medicines doctor if you have
the treatment will be supervised by a doctor experienced in the diagnosis and treatment of drug addiction . method of administration yttriga is for radiolabelling of medicinal products . dosage and duration of administration the following information is intended for the healthcare professionals only . specific diseases are not known . if you are given yttiga by mistake or by overdose , your doctor will determine the appropriate treatment for you .
like all medicines , yttriga can cause side effects , although not everybody gets them . if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
yttriga will be stored under the responsibility of the specialist in appropriate premises . storage will be in accordance with local regulations . the following information is intended for the specialist only : storage of radioactive substances . any unused product or waste material should be disposed of in accordancewith local requirements .
what yttriga contains - the active substance is chloride . 1 ml sterile solution contains 1 mg of hydrochloric acid ( see section 3 " yttiga contains sodium "). what yttrada looks like and contents of the pack yttrida is a clear , colourless type i glass vial with a 10 ml clear , flat bottom , with a silicon stopper and an aluminium seal .
ciambra is a medicine used in the treatment of cancer . ciambra contains cisplatin , another anti - cancer medicine , as treatment for malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , in patients who have not received prior chemotherapy . cembra is also used in combination with cisplin for the initial treatment of patients with advanced stage of lung cancer . your doctor will decide how much ciamBra you will receive depending on the type of lungcancer you have and on how your disease responds to treatment . initial chemotherapy with ciamb is a treatment for
do not use ciambra if you are allergic ( hypersensitive ) to pemetrexed or any of the other ingredients of ciamb . if you have a child less than 6 months of age . if breast - feeding is not possible during treatment with ciamba . if your child has recently received a vaccine against yellow fever . warnings and precautions talk to your doctor or pharmacist before using ciamBra if you or your child have or have had problems with your kidneys . before each infusion , your doctor will check your blood , kidney and liver function to make sure that you have enough blood cells and that you are receiving
the recommended dose of ciambra is 500 mg for every square metre of your body ' s surface area . your height and weight are measured to work out the surface area of your whole body . your doctor will work out this body surface area for you to work with . your dose may be adjusted , or treatment may be delayed depending on your blood cell counts and on your general condition . your healthcare professional will have mixed the ciambra powder with 9 mg / ml ( 0 . 9 %) sodium chloride solution before it is given to you . ciamba will be given to your doctor by infusion into one of your veins
like all medicines , this medicine can cause side effects , although not everybody gets them . 52 tell your doctor immediately if you experience : fever or infection ( common ) with a temperature of 38Âºc or greater , sweating or other signs of infection ( since you may have less white blood cells than normal which is very common ). infection ( sepsis ) may be severe and could lead to death . if you have chest pain ( common ), a fast heart rate , pain , redness , swelling or sores in your mouth ( very common ) allergic reaction ( common ). if you get skin rash ( common , may affect up to 1
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the expiratory date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . do away with the vial after reconstitution . the reconstituted solution should be used immediately after preparation . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 - 7 , 8 , 15 and
what ciambra contains the active substance is pemetrexed . each vial of ciamba 100 mg contains 100 mg of pemetreed ( as pemetereed disodium hemipentahydrate ). each vials of caimbra 500 mg contains 500 mg of the active ingredient pemetemetrexED ( as pyrexed dis sodium hemipontahydrates ). after reconstitution , the solution contains 25 mg / ml of pemphigus . further dilution by a healthcare professional is required prior to administration . the other ingredients are mannitol ( e421 ), hydrochlor
immunogam belongs to a group of medicines called immunoglobulins ( antibodies ). immunoglubulins help to control certain infections in your blood . immunogam can be used in adults to prevent increased levels of human hepatitis b immunoglutulins and immunoglofulin g ( gg ), which are produced naturally in the body . immunoglabulins are also used to increase blood plasma of screened adults . immunomam is used to treat adults who have not been vaccinated against hepatitis b virus . immunogenam is given to patients who are haemodialysed patients . vaccination is a
immunogam should not be given : - if you have an allergic reaction to human immunoglobulins or other blood products . - if your doctor has told you that you have been diagnosed with an iga deficiency . - an allergic response to iga containing products . children and adolescents immunogam is not recommended for use in children and teenagers under 18 years of age . immunogloglobulin has not been studied in this age group . warnings and precautions talk to your doctor or pharmacist before immunogamer is given : if you experience adverse reactions such as chills , headache , fever , vomiting , allergic reactions
immunogam is intended for vaccination against hepatitis b virus . the first vaccine dose will be given in combination with human hepatitis b immunoglobulin ( hbv ). administration prevention the recommended dose of hepatitis b is 500 mg given every 24 hours for 72 days . the recommended daily dose of hep b in haemodialysed patients is 500 Î¼g given every 2 weeks . seroconversion is the method of vaccination in which a person with hepatitis b becomes a hepatitis birus carrier . the hepatitis b immune response will be reinforced by the hepatitis c immunoglubulin administration and seroconversions following vaccination activities . immunog
like all medicines , immunogam can cause side effects , although not everybody gets them . the following side effects have been reported with immunogams : very common ( affects more than 1 user in 10 ) common ( affecting 1 to 10 users in 100 ) uncommon ( affects 1 to10 users in 1 , 000 ) rare ( affects less than 1 users in 10 , 000 ): very rare ( affecting less than1 user in 1, 000 ) not known ( frequency cannot be estimated from the available data ) undesirable effects have occurred during clinical trials with immunoglobulins in the muscle . very common : may affect more than1 in
keep out of the sight and reach of children . do not use immunogam after the expiry date which is stated on the carton and on the label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . donot use immunoam if the solution is cloudy or contains deposits . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what immunogam contains the active substance is human hepatitis b immunoglobulin . immunogaman 1 mg / ml solution for injection contains 5 mg of human plasma protein ( pfizer ) 96 % ( as polysorbate 80 ). what immunogams looks like and contents of the pack immunogamer is a solution forjection in a glass vial . it is a clear to slightly opalescent , colourless to pale yellow liquid . each pack contains 1 vial of immunogamation .
remicade contains the active substance infliximab . inflixumab is a monoclonal antibody a type of protein that recognises and attaches to a specific target in the body called tumour necrosis factor ( tnfÎ± ). remicade belongs to a group of medicines called ' tnfs blockers '. it is used to treat the following inflammatory diseases : rheumatoid arthritis , psoriatic arthritis , ankylosing spondylitis ( bechterew ' s disease ), psoriasis . remicades is used in adults , adolescents and children aged 6 years and older with
do not take remicade if you are allergic to infliximab or any of the other ingredients of remicades ( listed in section 6 ) if you think you may be allergic ( hypersensitive ) to any of these ingredients if you have tuberculosis ( tb ) or another serious infection , such as pneumonia , sepsis or heart failure if any of them apply to you , tell your doctor before taking remicada . if you do not respond well enough to remicad , tell the doctor before you take remacade . warnings and precautions talk to your doctor or pharmacist before taking any remicase if
the recommended dose is : rheumatoid arthritis : 3 mg for every kg of body weight . psoriatic arthritis , ankylosing spondylitis ( bechterew ' s disease ), psoriasis , ulcerative colitis and crohn ' s diseases : 5 mg for each kg of person body weight , taken once a day . how remicade is given remicine is given as an infusion ( drip ) over 2 hours , into one of your veins ( usually in your arm ). the third treatment will be given once a week . if you are given more remicades than you should
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some patients may experience serious side effects and may require treatment . if you notice any of the following side effects during your treatment with remicade , tell your doctor straight away : - an allergic reaction : - swelling of your face , lips , mouth or throat , which may cause difficulty in swallowing or breathing , skin rash , hives and swelling of the hands , feet or ankles . these reactions are rare but could be serious . an allergic response is very rare . see also section 2 " allergic side
keep this medicine out of the sight and reach of children . do not use remicade after the expiry date which is stated on the carton and vial label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . store below 25 . do away with remicades if you notice it is cloudy or there are particles in it . infusion - related storage times and conditions are the responsibility of the user and would normally not be longer than 3 hours at 2 8 , but may be longer at 28 if kept at room temperature for an additional 24 hours
what remicade contains the active substance is infliximab . each vial contains 100 mg of infliximeab . after reconstitution each ml contains 10 mg of infiximabe . the other ingredients are sucrose , polysorbate 80 , monobasic sodium phosphate , dibasicodium phosphate . what remicades looks like and contents of the pack remicada is supplied as a glass vial containing a powder for concentrate for solution for infusion . the powder is white and the solvent is clear . remicad is available in packs containing 1 , 2 , 3 , 4 or 5
rasagiline mylan is used to treat parkinson ' s disease in adults . it is used in combination with levodopa ( another medicine used to control parkinson '. in parkinson ', disease , there is a loss of cells that produce dopamine in the brain . dopamine is a chemical in the body involved in movement control . rasagilinea mylan increases the amount of dopamine that is produced in the brains .
do not take rasagiline mylan - if you are allergic to rasabiline or any of the other ingredients of this medicine ( listed in section 6 ). - if severe liver problems . - if taking any of any of these medicines : rasaline mylan belongs to a class of medicines called monoamine oxidase ( mao ) inhibitors . these are used to treat depression and parkinson ' s disease . it is also used to prevent the use of medicinal or natural products ( e . g . st . john ' s wort ) such as pethidine , a strong pain killer . children and
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 1 tablet once a day . the tablet can be taken with or without food . take the tablet at about the same time each day . it is best to take the tablets at about 1 hour before or at least 1 hour after food . swallow the tablet whole with a glass of water . do not crush or chew the tablet . rasagiline mylan can be divided into equal doses . if you take more rasgiline melan than you should if you accidentally take
like all medicines , this medicine can cause side effects , although not everybody gets them . side effects of rasagiline mylan are similar to those of placebo . the frequency of possible side effects listed below is defined using the following convention : very common abnormal movements ( dyskinesia ) headache common abdominal pain rare rare uncommon uncommon fall allergy fever flu ( influenza ) feeling of being unwell neck pain chest pain ( angina pectoris ) low blood pressure with symptoms such as light headedness ( orthostatic hypotension ) decreased appetite , constipation , dry mouth , nausea , vomiting flatulence abnormal results of blood (
what rasagiline mylan contains - the active substance is rasagailine . each tablet contains rasgailine tartrate equivalent to 1 mg rasgiline - the other ingredients are microcrystalline cellulose , tartric acid , maize starch , pregelatinized maize starch ( maize ), talc , stearic acid . what rasaggiline melan looks like and contents of the pack rasaginiline tablets are 11 . 5 mm x 6 mm , biconvex tablets debossed with " r " on one side and " 1 " on the
do not use hulio - if you are allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). - if your child has a severe infection , including tuberculosis . symptoms of infections may include fever , wounds , feeling tired , dental problems . - if the child has moderate or severe heart failure . - tell your doctor if the patient has a serious heart condition . warnings and precautions allergic reaction allergic reactions may include symptoms such as chest tightness , wheezing , dizziness , swelling or a rash . these reactions are usually mild to moderate and usually go away within a few days .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . polyarticular juvenile idiopathic arthritis in adults and children from 2 to 17 years old weighing 10 kg or more : one 30 mg tablet of hulio 20 mg / 2 ml solution for injection in children from 1 to 17 year old weighing 30 kg or less : one 40 mg tabletof hullio 40 mg / 1 ml solutionfor injection in enthesitis - related arthritis in children and adolescents from 6 to 17 months old weighing 15 kg or greater : one 20 mg tablet with or without
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate and may not require urgent medical treatment . tell your doctor straight away if you notice any of the following side effects ( which may occur within 4 hours of the last hulio injection ): allergic reaction ( including heart failure ) severe rash or hives swollen face , hands or feet , trouble breathing or swallowing , pale complexion , dizziness , persistent fever , bruising or bleeding . signs and symptoms of infection include fever , feeling sick , wounds , dental problems , burning on urination , feeling weak or tired , coughing
what hulio contains - the active substance is adalimumab . - the other ingredients are monosodium glutumate , sorbitol , methionine , polysorbate 80 , hydrochloric acid and water for injections . what hulios looks like and contents of the pack hul io 40 mg is a sterile solution for injection ( injection ) containing 40 mg of adalimab in 0 . 8 ml solution . it is clear to slightly opalescent and has a rubber stopper . hullio is available in packs containing 1 , 2 , 1 sterile injection syringe , 1 sterilised
the active substance of yellox is bromfenac . it belongs to a group of medicines called non - steroidal anti - inflammatory drugs ( nsaids ), which reduce inflammation . yellox may be used to treat eye inflammation following cataract surgery in adults .
do not use yellox - if you are allergic to bromfenac or any of the other ingredients of this medicine ( listed in section 6 ). - if your asthma ( skin allergy ) is severe . - if there is intense inflammation in your nose . - in combination with other nsaids ( such as acetylsalicylic acid , ibuprofen , ketoprofen or diclofenac ). this medicine is used in combination of topical steroids ( cortisone ) to reduce unwanted side effects . - bleeding problems ( such a as haemophilia in the past ) - if taking other medicines
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose is one drop in your eye ( s ) once a day . the recommended daily dose is 2 drops in the morning and 2 drops on the next day following your cataract surgery . method of administration yellox is for oral use . wash your hands thoroughly with soap and water . the eye drops should be used immediately after the bottle cap is removed . remove the bottle from the bottle and hold it firmly . twist off the cap . hold the bottle with your thumb and
what yellox contains - the active substance is bromfenac . each ml of solution contains bromenac ( as sodium sesquihydrate ). each vial contains 33 mg of bromnac . - the other ingredients are boric acid , borax , sodium sulphite anhydrous , benzalkonium chloride , tyloxapol , povidone ( k30 ), disodium edetate , sodium hydroxide to maintain acidity levels . what yellox looks like and contents of the pack yellox is a clear yellow liquid ( solution ) supplied in a glass v
duzveo contains sufentanil , which belongs to a group of strong painkillers called opioids . sufENTanil is used to treat sudden moderate - to - severe pain in adults .
do not take dzuveo - if you are allergic to sufentanil or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have a serious lung or breathing problem . warnings and precautions talk to your doctor before taking dzuvoo - tell your doctor if you have any condition that affects your breathing ( such as asthma , wheezing or shortness of breath ). dzuveco may affect your breathing during treatment . - tell the doctor if : - you have recently suffered a head injury - you suffer from brain tumour - you experience problems
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the single - dose administration device is for oral use only . you should swallow the tablet whole with a drink of water . you can take this medication with or without food . dzuveo must be taken with strong painkillers such as sufentanil at least 30 minutes before or after food . the sublingual tablet must be swallowed whole with the disposable single -dose applicator . the applicator should be inserted into the tongue so that the tablets dissolve and dissolve in the tongue . pain relief
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side side effects : severe breathing problems , slow and shallow breathing . if you get any of these side effects you must stop taking dzuveo and contact your doctor immediately . very common side effects ( may affect more than 1 in 10 people ): nausea , feeling sick , vomiting , being sick and feeling hot . common side side side effect ( may effect up to 1 in every 10 people ) are inability or difficulty sleeping , feeling anxious or confused , dizziness , headache
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . do this medicine if you notice any visible signs of deterioration . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help protect the environment .
what dzuveo contains - the active substance is sufentanil . each tablet contains 30 mg sufantanil ( as citrate ). - the other ingredients are mannitol ( e421 ), dicalcium phosphate , hypromellose , croscarmellose sodium , indigo carmine ( e132 ), stearic acid , magnesium stearate . what dzuvello looks like and contents of the pack dzuveyo is a white to off - white , round oval tablet with " 3 " engraved on one side . it is supplied in a single - dose applicator (
elleada is a cancer medicine that contains the active substance apalutamide . it is used to treat adult men with prostate cancer that has spread to other parts of the body and cannot be treated with surgical treatments . it also treats adult men who have sensitive prostate cancer which has spread beyond the original body and has not responded to surgical treatment with testosterone . it reduces the activity of androgens in the blood and so reduces the risk of developing resistant prostate cancer . erleada also inhibits the production of androgen , a hormone that is involved in the growth and spread of the cancer . by blocking the activity androgens , apal
do not take erleada - if you are allergic to apalutamide or any of the other ingredients of this medicine ( listed in section 6 ). - if pregnant or think you may be pregnant ( see pregnancy , breast - feeding and contraception section ). warnings and precautions talk to your doctor or pharmacist before taking this medicine . this medicine should not be taken if you have : - seizures - if taking any medicines to prevent blood clots ( e . g . warfarin or acenocoumarol ). - any heart or blood vessel conditions that could increase the risk of heart rhythm problems ( arrhythmia ).
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 240 mg once a day . your doctor may increase your dose to 60 mg once daily depending on how you respond to erleada . taking this medicine take this leaflet or tablet by mouth . you can take erleade with or without food . other medicines and erlead tell your doctor if you take , have recently taken or might take any other medicines . if you forget to take erelada if you miss a dose of erlea , take it as soon as you
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking erleada and see a doctor immediately if you experience any of the following symptoms : reddish , non - elevated , target - like , circular patches on the trunk , central blisters , skin peeling , ulcers of mouth , throat , nose , genitals and eyes . these serious skin rashes may be accompanied by fever and flu - like symptoms ( toxic epidermal necrolysis ). serious side effects tell your doctor straight away if you notice any of these side effects : fits ( seizure ) uncommonly ( may affect up
what erleada contains - the active substance is apalutamide . each film - coated tablet contains 60 mg of apalectamide . - the other ingredients are colloidal anhydrous silica , croscarmellose sodium , hypromellose acetate succinate , magnesium stearate , microcrystalline cellulose , silicified microcrystine celluloise . - film - coating : iron oxide black ( e172 ), iron oxide yellow ( e 172 ), macrogol , polyvinyl alcohol , talc , and titanium dioxide . what erlead looks like and contents of the pack
this medicine is a radiopharmaceutical product . axumin contains the active ingredient fluciclovine . it is used for the scan of prostate tissue in adults . it can be used : - if you have previously had prostate cancer or other tests that show prostate specific antigen ( psa ) ( the type of the cancer that carries radioactivity ). - if an axumin pet scan is performed , the cancer may get worse . the doctor will decide whether the scan is suitable for you . your doctor will discuss with you the best results for you and decide if you should be treated with axumin . this procedure is to check that
do not use axumin - if you are allergic to fluciclovine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using axumin . - if your doctor has told you that you have kidney problems . - you are on a low sodium diet . - axumin is given once a day for a day . the axumin scan will last for 4 weeks . - before the scan , you will take your usual medicines for the latest 60 minutes . - after the axus injection , urination will be interrupted . - the scan will be repeated
there are strict laws on the use , handling and disposal of radiopharmaceutical products . axumin will only be used in special controlled areas . this medicine will only only be handled and given to you by people who are trained and qualified to use it safely . these persons will take special care for the safe use of this medicine and will keep you informed of their actions . the nuclear medicine doctor supervising the procedure will decide the quantity of axumin to be used . the usual dose is 370 megabecquerel per kilogram of body weight . the quantity to be administered depends on the type of medicine being used . administration
like all medicines , this medicine can cause side effects , although not everybody gets them . in clinical studies , the following side effects were reported : very common ( may affect more than 1 in 100 people ): when using the medicine , the side effects associated with axumin were uncommon ( may effect up to 1 in every 100 people ). pain , rash , altered taste in the mouth and altered sense of smell . when using this radiopharmaceutical , the amount of ionising radiation that reaches the body is increased . this is partly linked to the increased risk of cancer and hereditary abnormalities . reporting of side effects if you get any side effects talk
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials . the following information is intended for the specialist only . do not use axumin after the expiry date which is stated on the label and carton after exp .
what axumin contains - the active substance is fluciclovine . axumin 1600 mg : each vial contains 1600 mg of fluciniclovine ( as 16000 mg ). axumin 3200 mg : one vial delivers 3200mg of fluiclovin ( as 3200 Î¼g ). - the other ingredients are 32000 mg sodium citrate , concentrated hydrochloric acid and sodium hydroxide ( see section 2 " axumin with sodium "). what axumin looks like and contents of the pack white to off - white powder , with " 1600 " debossed on one side and " 32
azopt contains brinzolamide which belongs to a group of medicines called carbonic anhydrase inhibitors . it works by reducing pressure within the eye . azopt eye drops help to reduce high pressure in the eye , which can lead to an illness called glaucoma . the pressure in your eye increases , which may damage your sight .
do not take azopt - if you have severe kidney problems - if your doctor is allergic to brinzolamide or any of the other ingredients of this medicine ( listed in section 6 ). - if allergic to medicines containing sulphonamides ( medicines used to treat diabetes or infections ) or to diuretics ( water tablets ). warnings and precautions talk to your doctor or pharmacist before taking azopt if you think the same allergy may apply to you . if you develop too much acidity in your blood ( hyperchloraemic acidosis ) after taking azoth , tell your doctor . - if any of these apply to
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . azopt is used in both eyes . use azopt in both eye and eyes : 1 drop in each eye twice a day . use in both the eyes twice a daily . use the azopt bottle once in the morning and once in evening . use it in both of your eyes once a day for 1 week , then once in a day , then twice in the evening , once in both and once a morning , once a afternoon , once at about the same time each day . 1 drop twice a morning
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with azopt : common side effects ( may affect up to 1 in 10 people ) - effects in the eye : blurred vision , eye irritation , eye pain , eye discharge , itchy eye , dry eye , abnormal eye sensation , redness of the eye . the most common side side effects are bad taste . uncommon side effects - effects affecting up to1 in 100 people ) â effects in your eye : sensitivity to light , inflammation or infection of the conjunctiva , eye swelling , eyelid itching , red
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and bottle after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . to prevent infections , a pack containing a single bottle should be used immediately . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what azopt contains - the active substance is brinzolamide . each ml contains 10 mg of brinzaolamide ( as benzalkonium chloride ). - the other ingredients are carbomer 974p , edetate disodium , mannitol , purified water , sodium chloride , tyloxapol , hydrochloric acid and sodium hydroxide ( to maintain acidity levels and ph levels ). what azopt looks like and contents of the pack azopt is a milky liquid ( a suspension ) supplied in a 5 ml plastic ( droptainer ) bottle with a screw cap . a pack
the active substance of forxiga , dapagliflozin , belongs to a group of medicines called " oral medicines ". it is taken by mouth to treat diabetes , which can affect the amount of sugar in your blood . it is used in adults and adolescents ( aged 18 years and older ). forxigo is used to treat two types of diabetes : type 1 diabetes that occurs when your body does not produce any insulin . forxig helps control the level of sugar made by your body in the blood . type 1 diabetic : if your body is not able to make enough insulin or to use the insulin it produces effectively .
do not take forxiga - if you are allergic to dapagliflozin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking forxigo : - if any of these apply to you : - feeling sick or being sick , stomach pain , excessive thirst , fast and deep breathing , confusion , unusual sleepiness or tiredness , a sweet smell to your breath , asweet or metallic taste in your mouth , a different odour to your urine or sweat , rapid weight loss . contact your doctor immediately if you experience any of any of
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of forxiga for type 2 diabetes is one tablet a day . your doctor may increase your dose to 10 tablets a day ( 5 mg ) if you have a liver problem . your dose of the forxigo for type 1 diabetes is two tablets a morning , one tablet in the evening and one tablet at bedtime ( 5 to 10 mg ). your doctor will tell you how many tablets to take . if you do not respond well enough to the treatment , talk to your doctor . your
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are angioedema ( seen very rarely , may affect up to 1 in 10 , 000 people ). angioEDema may cause swelling of the face , tongue or throat , difficulties swallowing , hives and breathing problems . diabetic ketoacidosis ( seen commonly , may affects up to1 in 10 people ) is a rare but serious complication of type 2 diabetes . it may affect between 1 in 1 and 1 in every 1 , 000 patients . diabeticketoacidos is caused by increased levels of " ketone
what forxiga contains - the active substance is dapagliflozin . each forxigo 5 mg film - coated tablet ( tablet ) contains dapapagllozin propanediol monohydrate equivalent to 5 mg dapablifloin . - the other ingredients are : tablet core : microcrystalline cellulose ( e460i ), lactose ( see section 2 under ' forxigiga contains lactose '), crospovidone ( e1201 ), silicon dioxide ( e171 ), magnesium stearate ( e470b ). film - coating : polyvinyl alcohol ( e
mifamurtide , which blocks the action of certain bacteria in the immune system , stops them from growing and dividing . mepact is used to treat osteosarcoma ( bone cancer ) in adults aged 2 and 30 years who have had surgery to remove the tumour and are receiving chemotherapy to stop cancer cells from growing . it is also used when cancer has come back .
do not take mepact : if you are allergic to mifamurtide or any of the other ingredients of this medicine ( listed in section 6 ). if you take medicines containing ciclosporin or other calcineurin inhibitors ( non - steroidal - anti - inflammatory drugs ). nsaids may cause problems with your heart or blood vessels such as blood clots ( thrombosis ), bleeding ( haemorrhage ), inflammation of the veins ( vasculitis ). warnings and precautions talk to your doctor or pharmacist before taking mepactor if any of these apply to you : if any new
treatment mepact will be given to you by a doctor or nurse . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of mepacts is 2 mg mifamurtide once a day . your doctor will decide how many doses you need . the recommended daily dose is 12 mg mofamurtides once a week for 24 hours . your dose may be adjusted by your doctor depending on your mepact treatments and on your chemotherapy schedule . your chemotherapy will be repeated every 36 hours . how to prepare treatment
like all medicines , mepact can cause side effects , although not everybody gets them . chills , fever and fatigue have been reported in patients receiving mepacting as transient effects of paracetamol . if you experience fever during treatment with mepacts , you should contact your doctor immediately . stomach problems ( nausea , vomiting and loss of appetite ) have been seen in patients who have received chemotherapy . tell your doctor or nurse immediately if you have continuing fever and chills . these may be signs of an infection . rash have been observed in patients taking mepACT . tell the doctor or hospital pharmacist if you notice any
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial and the outer carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vials in outer cartons in order to protect from light . reconstituted suspension may be stored at ambient room temperature ( up to 25 ) for a single period of up to 9 days . if not stored at room temperature , the product may be used for up to 6 months . do this medicine if you
what mepact contains the active substance is mifamurtide . each vial contains 4 mg mifamanurtide ( as suspension ). after reconstitution , each ml of suspension contains 0 . 08 mg mefamurtime . the other ingredients are 1 - palmitoyl - 2 - oleoyl- sn - glycero - 3 - phosphocholine ( see section 2 ) 2 - dileoyls - sn - glyco - 5 - phosphate monosodium salt ( see also section 2 " mepacts contains sodium "). what mepactor looks like and contents of the
mirvaso contains the active substance brimonidine which belongs to a group of medicines called alpha agonists . it is used on the skin and face to reduce redness associated with rosacea ( redness of the face ). rosica is caused by high levels of blood flow in the facial skin and enlargement ( dilution ) of the small blood vessels of the skin . mirvaso acts by blocking the blood vessels , thereby reducing the excess blood flow and redness .
do not take mirvaso if you are allergic to brimonidine or any of the other ingredients of this medicine ( listed in section 6 ) warnings and precautions talk to your doctor or pharmacist before taking mirvasos if you have had any of these conditions : - if you experience side effects when taking the medicine under the skin . - if your doctor has prescribed certain medicines for the treatment of depression or parkinson ' s disease : monoamine oxidase ( mao ) inhibitors ( selegiline , moclobemide ), tricyclic antidepressants ( imipramine ), tetracyclic antidepressant (
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . mirvaso is applied to the skin or face only . this medicine is applied on the surface of your body . it is only applied to body surfaces . it should not be applied to your eyes , mouth , nose or vagina . if you use more mirvasoe than you should if you think you have used more miraso mirvasos is only used on the face . the treatment should be started with a small amount of gel ( a pea - sized amount ). if your symptoms do not improve
like all medicines , this medicine can cause side effects , although not everybody gets them . uncommon side effects : severe skin irritation or inflammation , skin rash , skin pain or discomfort , dry skin , warm skin sensation , tingling , sensation of pins and needles or swelling . common side effects that may be worsening of rosacea are : worsening of the treatment with symptoms ( see section 2 ' warnings and precautions '). contact allergy . allergic reaction may include rash and rare angioedema . if you have a serious allergic reaction , including swelling mainly of the face , mouth and tongue , stop taking mirvaso and contact your doctor
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and tube and pump after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do away with the tube and pumps after first opening . do this if you notice any particles in the solution . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what mirvaso contains - the active substance is brimonidine . each ml of gel contains 3 . 3 mg of brimonine . each vial contains 5 mg of the active ingredient brimonate tartrate . - the other ingredients are : carbomer , methylparahydroxybenzoate , phenoxyethanol , glycerol , titanium dioxide ( e171 ), propylene glycol , sodium hydroxide , purified water ( see section 2 " mirvasoa contains methylparAHydroxy benzoate "), propylene Glycol . what mirvasos looks like and contents of the pack mirvas
mvasi contains the active substance bevacizumab , which is a humanised monoclonal antibody ( a type of protein that recognises and attaches to a specific target in the immune system , the body ' s natural defences ). it is used to protect the body from infection and cancer . bevacsizumb binds to a protein called human vascular endothelial growth factor ( vegf ), which is found in the lymph vessels of the body . the vegfs protein causes blood vessels to expand , thus blocking the flow of blood vessels and oxygen . be vacizumsab prevents tumour growth
do not use this medicine if you are allergic ( hypersensitive ) to bevacizumab or any of the other ingredients of this medicine ( listed in section 6 ) if you think you may be allergic ( allergic , hypersensitive ), to chinese hamster ovary ( cho ) cell products if you or your child are pregnant . warnings and precautions talk to your doctor or pharmacist before using mvasi . if you have any of these conditions , please tell your doctor before using this medicine . if any of them apply to you , tell your physician before using it . if your doctor thinks you may have an increased risk
dose and frequency of administration your doctor will work out the dose of mvasi you will receive based on your body weight and the type of cancer you have . the usual starting dose is 5 mg , 7 . 5 mg or 10 mg per kg of body weight . your doctor may increase your dose to 15 mg per kilogram of your bodyweight depending on your condition . your dose of the mvasis will be calculated by your doctor and will be given to you by your healthcare professional . you will usually receive mvasic either 2 or 3 weeks after your last dose . the number of infusions you receive will depend on how
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with mvasi : side effects that may occur during treatment with mvai or after chemotherapy . these side effects are usually mild to moderate and will generally disappear after a few days . if you notice any of the following , stop using mvasis and tell your doctor straight away : allergic reactions . signs of an allergic reaction may include difficulty in breathing , chest pain , redness and flushing of the skin , a rash , chills or shivering , feeling sick ( nausea ) or being sick ( vomiting ).
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and vial label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outercarton in order to protect from light . infusion solutions should be used immediately after dilution . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 8 unless dilution has taken place
what mvasi contains the active substance is bevacizumab . each ml contains 25 mg of bevaconizumb in 1 . 4 ml or 16 . 5 ml of solution . each 4 ml vial contains 100 mg of the active substances bevacsizumumab in 1. 4 ml and 16 ml of solutions contain 400 mg of of bevoacizumaab in 16 .5 ml of water . the other ingredients are trehalose dihydrate , sodium phosphate , polysorbate 20 and water for injections . what mvasis looks like and contents of the pack mvas
tecartus is a gene therapy medicine used to treat mantle cell lymphoma . it is used in adults , adolescents and children who are not able to take other medicines . it works by inhibiting the growth of cells called cd3 + cells . refractory mantle cell lipoma ( mcl ) means that your own white blood cells are destroyed . tecartus contains autologous anti - cd19 - transduced cd3+ cells . mantle cell cancer is a cancer that affects the immune system ( the body ' s natural defences ) and affects the b - lymphocytes . mantlecell lymphoma means that b - cells
do not use tecartus if you are allergic to any of the ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor before using tecartuse if you : - are allergic or have had problems with white blood cells in your blood ( lymphodepleting chemotherapy ) ( see section 3 ) - are white blood cell - are having autologous use ( see " warnings and risks "). tests and checks your doctor will do before you are given tecartuses : - check your lungs , heart , kidney , blood pressure
what tecartus is tecartuse contains your own white blood cells . your cells are collected by a specialised healthcare professional . how tecartuses is given tecartuus is given by a catheter placed in your vein ( a procedure call leukapheresis ). it is given to you by a doctor or nurse . how much tecartutus is used tecartustus is made up of your white blood cell and is given as a single infusion into your blood . it is administered into a vein every 3 to 6 weeks . the number of yourwhite blood cells will be reduced every 2 to 3 weeks .
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss your side effects with you . if you get any side effects you may need urgent medical attention . the following side effects have been reported during the tecartus infusion : very common ( may affect more than 1 in 10 people ): fever , chills , reduced blood pressure with symptoms such as dizziness , lightheadedness , fluid in the lungs . all symptoms could be signs of a condition called cytokine release syndrome ( loss of consciousness , decreased level of consciousness ), confusion , memory loss , disturbances of brain function including difficulty speaking ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . infusion bag contains liquid nitrogen equivalent to 150 mg / ml . this medicine contains genetically modified human blood cells and human - derived material . the product is stable for 36 hours at 2 8 . do away with the vials . do throw away any medicines via wastewater or
what tecartus contains the active substance is autologous anti - cd19 - transduced cd3 + cells . each specific single infusion bag contains a dispersion of anti - cd19 car t cells equivalent to 68 cd3 cells per 2 ml of solution , corresponding to a concentration of 106 cd3 / ml anti . the other ingredients are sodium chloride and human albumin ( see section 2 " tecartuses contains sodium "). what tecartu looks like and contents of the pack tecartub is a concentrate for solution for infusion . it is supplied as an infusion bag packed in a metal cassette . a single
januvia contains the active substance sitagliptin which belongs to a class of medicines called dpp - 4 inhibitors ( dipeptidyl peptidase - 4 inhibitor ) which are used to control blood sugar levels in adult patients with type 2 diabetes mellitus . this medicine helps to increase the levels of insulin produced after a meal and decreases the amount of sugar made by the body . your doctor has prescribed this medicine to help lower your blood sugar , which is too high because of your type 2abetes . this medication can be used alone or with certain other medicines ( insulin , metformin , sulphonylureas
do not take januvia - if you are allergic to sitagliptin or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have inflammation of the pancreas ( pancreatitis ). warnings and precautions talk to your doctor or pharmacist before taking januvi if you have : - ( see section 4 ) blistering of the skin ( bullous pemphigoid ). janura is not recommended if you suffer from a disease of the pancreatreas called pancreatitis . - if any of these apply to you , tell your doctor before taking this
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 100 mg film - coated tablet 63 once daily by mouth . if you have kidney problems , your doctor may prescribe a lower dose of 25 mg or 50 mg film film - coating tablets . your doctor will tell you the dose to take . you should continue taking this medicine until your doctor tells you otherwise . your dose may need to be adjusted . this medicine may be taken with certain other medicines that lower blood sugar . diet and exercise can help your body use its blood sugar better . it
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking januvia and contact a doctor immediately if you notice any of the following serious side effects : severe and persistent pain in the abdomen ( stomach area ), which might reach through to your back , nausea and vomiting , as these could be signs of an inflamed pancreas ( pancreatitis ). if you have a serious allergic reaction ( frequency not known ), including rash , hives , blisters on the skin , peeling skin , swelling of the face , lips , tongue , and throat that may cause difficulty in breathing or swallowing , stop
what januvia contains - the active substance is sitagliptin . each film - coated tablet ( tablet ) contains sitaglioptin phosphate monohydrate equivalent to 25 mg sitaglptin . - the other ingredients are microcrystalline cellulose , calcium hydrogen phosphate , croscarmellose sodium , magnesium stearate and sodium stearyl fumarate . the tablet film - coating contains poly ( vinyl alcohol ), macrogol 3350 , talc , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow iron oxide . what januva looks like and contents of the pack pink film
xultophy works by lowering blood glucose . it is used to treat type 2 diabetes mellitus in adults . diabetes is when your body does not make enough insulin , or the insulin that your body produces does not work as well as it should . this leads to an increase in blood sugar . insulin degludec is a long - acting basal insulin . it helps to control your blood sugar levels by helping your body make better use of liraglutide ( a type of glp - 1 ) and insulin during meals . xultophy may be used alone or with oral medicines . in diabetes xultance may be
do not take xultophy if you are allergic to insulin degludec , liraglutide or any of the other ingredients of this medicine ( listed in section 6 ). 39 if you have a sulfonylurea such as glimepiride or glibenclamide . your doctor will tell you how to increase your sulfonylation dose . your blood sugar levels will be checked before and during treatment with xulturo . if you suffer from type 1 diabetes mellitus or ' ketoacidosis ', your doctor may reduce your bloodugar levels . warnings and precautions talk to your doctor before taking x
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . if you have been blind or have poor eyesight , your doctor may need to adjust your blood sugar level . the usual starting dose of xultophy is 41 mg once a day . you should use xultue every day for 8 days . you can use it with or without food . do not change your dose unless your doctor tells you to . how much xultide to use xulophy is supplied in a pre - filled dial - a - dose pen . the dose counter shows the usual dose
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are low blood sugar ( very common may affect more than 1 in 10 people ). if your blood sugar level gets low you may pass out or become unconscious . serious hypoglycaemia ( may cause brain damage ) can occur with low blood glucose . if yourblood sugar level is too low , you may have hypoglycasemia ( see section 2 ). if this happens , stop taking xultophy and contact your doctor straightaway . if you have any further questions on the use of this product , ask your doctor or pharm
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after first opening : do not store above 30 . store at 2 8 for a maximum of 21 days . do away with xultophy once you have opened the blister . do this every day until you have finished taking xultide . donot throw away any medicines via wastewater or household waste . ask your pharmacist how to throw
what xultophy contains - the active substances are insulin degludec and liraglutide . each ml contains 100 units of insulin degluudec 3 . 6 mg liragolutides in 3 ml solution . each vial contains 300 units of the active substance of insulin gludec 10 . 8 mg liraaglunide . - the other ingredients are glycerol , phenol , zinc acetate , hydrochloric acid and sodium hydroxide ( for ph adjustment ). - the solvent is water for injections ( see section 2 " xultphil contains sodium "). what x
giotrif is a medicine that contains the active substance afatinib . it works by blocking two proteins called egfr [ epidermal growth factor receptor 2 ]-1 and erbb1 - her2 [ erbb2 - 3 ]-2 . egfr - 1 and erb3 - 3 are involved in the growth and spread of cancer cells . this medicine stops these proteins from multiplying and growing , and eventually kills cancer cells in the process . this helps to stop the growth of cancer types . this is especially important for patients with cancer of the lung ( non - small cell lung cancer ). giotrify
do not take giotrif if you are allergic to afatinib or any of the other ingredients of this medicine ( listed in section 6 ) if you have low body weight ( less than 50 kg ) if your doctor has told you that you have kidney problems if you suffer from side effects associated with lung inflammation ( interstitial lung disease ) if any of these apply to you , tell your doctor . warnings and precautions talk to your doctor before taking giotrinif if : you have liver problems if your dose is reduced . your doctor may need to perform some liver tests before you start taking this medicine . you have a severe
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 40 mg tablet once a day . you should take this tablet at the same time each day . giotrif can be taken with or without food . swallow the tablet whole with a glass of water . you can take this dose with or just after food . you may take this this medicine with or with food . it is best to take this in the morning and evening , at about the same times each day , with or after food , at the usual times . you will usually
like all medicines , giotrif can cause side effects , although not everybody gets them . the following side effects have been reported during treatment with giotrin : diarrhoea common ( may affect up to 1 in 10 people ): diarrhoeal ( see section 2 , " warnings and precautions "). severe diarrhoehoea with or without fluid loss common ( might affect up in 1 in every 10 people ) low blood potassium ( see below ) worsening kidney function . if you experience diarrhoee after diarrhoeing , you should contact your doctor immediately . appropriate antidiarrhoeal treatment should be started at the same time
what giotrif contains - the active substance is afatinib . each film - coated tablet contains 20 mg of afatinab . - the other ingredients are lactose monohydrate , microcrystalline cellulose , colloidal anhydrous silica , crospovidone , magnesium stearate , hypromellose , macrogol 400 , titanium dioxide ( e171 ), polysorbate 80 , water for injections . what giotrarif looks like and contents of the pack giotratif 20 mg film - coating tablets are white , round , biconvex , with " gsi
what orkambi is orkami contains two active substances called lumacaftor and ivacaftOR . it is a medicine used for long - term treatment of cystic fibrosis ( cf ) in patients aged 6 years and older . the active substance is f508del mutation ( f508d ) in the cystic fibre conductance regulator ( cftr ), which is involved in the normal functioning of the lungs . the mutation causes an abnormal cfttr protein in the body . lumacafor helps ivacftor work by blocking the abnormal cFTr protein . how orkammi works
do not take orkambi if you are allergic to lumacaftor or ivacaftion or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking orkammi . if you have been told that you have the f508del mutation , your doctor may need to change your dose of orkabi . talk to a doctor if you suffer from liver or kidney disease . your doctor will monitor your kidney function regularly . your dose may need adjustment . if any of these apply to you , tell your doctor . abnormal blood tests of the
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 6 to 12 tablets a day . take one orkambi tablet once a day for 6 to 11 days . your doctor may increase your dose of orkammi to 100 mg once a week for 2 weeks . take 2 tablets a morning and 2 tablets in the evening . if you take more orkami than you should if you have taken more or more tablets than you have been told to take , contact your doctor immediately . if possible , take your tablets with food .
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects reported with orkambi are usually mild to moderate . if you are treated with ivacaftor , you may experience some of the following side effects while taking orkami : serious side effects when taking orkyambi : raised levels of liver enzymes in the blood , which can lead to liver injury in patients with pre - existing severe liver disease . the worsening of liver function . other side effects include : uncommon ( may affect up to 1 in 100 people ): pain or discomfort in the upper right stomach ( abdominal )
what orkambi contains the active substances are lumacaftor and ivacafton . orkammi 100 mg film - coated tablets each tablet contains either 125 mg lumacafor or 125 mg ivacafin . orkyambi 200 mg film film - coating each tablet contain either 200 mg lumacyaftor or 250 mg iviacaftor . or kambi 100mg film - coat each tablet consists of either 125mg lumacabor or 200 mg ivacyaftin . each tablet also contains either 100 mg or 125mg orkabi 200mg film film coating each tablets also
what lynparza is lynparz contains the active substance olaparib . olaparaib is a type of cancer medicine known as a parp inhibitor ( poly [ adenosine diphosphate - ribose ] polymerase inhibitor ). it works by stopping the growth of cells with mutations ( changes ) in a gene called brca ( breast cancer gene ). cancer patients with parp inhibitors can also have death caused by the lack of an enzyme that can repair dna . what lynparaz is used for lynparanza is used to treat adult patients with ovarian cancer called brcas ( mutated ovarian cancer ). it
you must not be given lynparza if you are allergic to olaparib or any of the other ingredients of this medicine ( listed in section 6 ). if you have any further questions on the use of this product , ask your doctor , pharmacist or nurse . see section 2 " warnings and precautions ". if you think any of these apply to you , or if you were not sure , talk to your doctor or pharmacist before being given lynpalza . warnings and risks talk to the doctor , nurse or pharmaceutist before being treated with lynparz . low blood cell counts ( seen in testing ) low counts
always take lynparza capsules exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of lynparz is 100 mg once a day . the dose may be increased to 150 mg once daily . the doses of lynarza capsules taken together with tablets may be adjusted to suit your specific needs . if you take more than a capsule of lynpalza once a morning , take it as soon as you remember . if possible , take the capsule with a meal . if necessary , take your tablet at the same time each day . if your doctor thinks that you may have
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): feeling short of breath , feeling very tired , pale skin , fast heart beat . these may be symptoms of a decrease in the number of red blood cells ( anaemia ). uncommon ( may effect up to 1 in 100 people ): allergic reactions ( hives , difficulty breathing or swallowing , dizziness ). signs and symptoms of hypersensitivity reactions may be listed below . other side effects very common : may affect less than 1in 10 people : feeling sick ( nausea ) being sick ( vomiting ) feeling
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . store below 30 . store the capsules in the original package in order to protect from light . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what lynparza contains - the active substance is olaparib . each hard capsule contains 50 mg olaparateib . - the other ingredients are lauroyl macrogol - 32 glycerides , hypromellose , titanium dioxide ( e171 ), gellan gum , potassium acetate , iron oxide black ( e172 ). what lynparz looks like and contents of the pack white , opaque , hard capsule with " olaparaib 50 mg " imprinted on one side and " astrazeneca logo on the other side . lynparparza is available in packs containing 112 hard capsules or
this medicine contains the active substance naloxone . nalxone is used to treat opioids such as heroin , methadone , fentanyl , oxycodone , buprenorphine and morphine in adults . nyxoid is also used as a nasal spray for adults to help them breathe during the emergency treatment of opioid overdose . opioid overdose is fatal in adults , adolescents and children aged 14 years and above . overdose may cause breathing problems and severe sleepiness . if you have an opioid overdose , you should immediately contact your doctor or get emergency medical care .
do not use nyxoid if you are allergic to naloxone or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using nyxoids . you may need emergency medical care or emergency services if you have an opioid overdose . the signs and symptoms of an opioid dose may be similar to those of an overdose . if you use more nyxid than you should if you think you have used more than the recommended dose , contact your doctor or pharmacist immediately . if possible , use this nasal spray 2 to 3 times a day . you
always use nyxoid nasal spray exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 1 . use the nasal spray as instructed by your doctor . if symptoms occur , they should be : shoulders , ears , breastbone , sternum , or inside the ear . fingernail : clear the mouth and nose of any blockers . do not put nyxoids into the mouth or nose . 1 . breathe is the chest moving . you can hear breathing sounds and breath on the cheek . overdose may occur if you have a response to touch or sounds , slow uneven
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : nyxoid may cause acute withdrawal symptoms from opioid drugs . symptoms may include fast heart rate , high blood pressure body aches , stomach cramps , feeling sick , vomiting , diarrhoea , sweating , fever , goose bumps , shivering , trembling changes in behaviour , including violent behaviour , nervousness , anxiety , excitement , restlessness , irritability unpleasant or uncomfortable mood increased skin sensitivity difficulty in sleeping . acute withdrawal reactions may affect up to 1 in 100 people . these symptoms are : very common
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what nyxoid contains the active substance is naloxone . each nasal spray contains 1 . 8 mg of nalxone ( as hydrochloride dihydrate ). the other ingredients are trisodium citrate dihydrates , sodium chloride , hydrochloric acid , sodium hydroxide and purified water . the total amount of ndaloxone in 0 . 1 ml is a clear , colourless solution . what nyxoids looks like and contents of the pack nyxax is a pre - filled nasal spray . it is supplied in a single dose container . nyxid is available in a carton
what ovaleap is ovaleape contains the active substance follitropin alfa , which is a gonadotropin ( a type of hormone that is similar to a hormone produced naturally in the body ). follitroin ala is a hormone that plays an important role in the growth and development of the sacs ( follicles ) in the ovaries . it is involved in the production of sperm , a type that is needed for the growth of a immature egg cell . ovaleaps is used in adult women who are not ovulating and who are undergoing treatment with a medicine called " clomifene cit
do not use ovaleap if you are allergic to follitropin alfa , follicle stimulating hormone or any of the other ingredients of this medicine ( listed in section 6 ) if you have a tumour in your hypothalamus or pituitary gland ( the brain ), if you know that you have large ovaries ( sacs of fluids that contain eggs ) if your ovaries do not produce enough ovarian cysts if you experience unexplained vaginal bleeding if you think you have cancer in your ovary , womb or breasts if you suffer from any condition that makes normal pregnancy impossible such as ovarian failure or early menopause ,
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose of this medicine is one injection into the tissue just under the skin ( subcutaneous injection ). if you have irregular periods , your doctor will give you this medicine once every day for the first 7 days of your menstrual cycle . the medicine will be given to you as an injection into a vein . the recommended starting dose of the medicine is 75 mg . this medicine will usually be given once every 7 days during your menstrual period . the dose of each medicine will normally be given
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with ovaleap : serious side effects in women allergic reactions such as skin rash and raised itchy areas of skin . severe allergic reactions may include weakness , drop in blood pressure , difficulty breathing and swelling of the face . 37 rare ( may affect up to 1 in 10 , 000 people ) this type of reaction occurs rarely . if you notice any of these signs after your ovaleop injection , stop using ovaleape and contact your doctor immediately . serious side side effectsin women lower stomach ache , nausea and
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the cartridge after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the cartridge in the outer carton in order to protect from light . this medicine may be stored for a maximum of 3 days below 25 . do this medicine if it is stored at room temperature ( up to 30 ) for a single period of not more than 3 days . once the cartridge has been removed from the refrigerator and has
what ovaleap contains the active substance is follitropin alfa . ovaleep 300 iu / 0 . 5 ml solution for injection each cartridge contains 300 iiu ( 22 micrograms ) follitroin ala in 0 . 0 ml solution . ovalesap 450 iu in 0. 75 ml solution each cartridge produces 450 iiu 33 microgram ( 23 microgram ) folliotropin alpha in 0 , 75 ml . ovalap 900 iu per 1 . 5ml solution for injections each cartridge releases 900 iiu / 66 microgram follitopin aloa in 1 . 0
voriconazole accord contains the active substance voriconazol . voronazole is an antifungal medicine that works by killing or stopping the growth of the fungi that cause infections . it is used in adults and children from the age of 2 years to treat invasive aspergillosis ( a type of fungal infection caused by aspergonillus sp .) and candidaemia ( a form of fun fungal illness caused by candida sp .) in non - neutropenic patients ( patients with abnormally low white blood cells count ) to prevent candida spine infections when the fungus is resistant to
do not take voriconazole accord - if you are allergic to voricleazole or any of the other ingredients of this medicine ( listed in section 6 ). - if taking any other medicines , including herbal medicines . the medicines listed below are not to be taken with voricoazole accord treatment : 46 terfenadine ( used to treat allergy ) astemizole ( used for allergy ) cisapride ( used in stomach problems ) pimozide ( used when treating mental illness ) quinidine ( used if you have irregular heart beat or problems with your heart ) rifampicin
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the dose will depend on your weight and the type of infection you have . the usual starting dose is 40 mg once a day . this will be increased to 40 mg twice a day for 24 hours . your doctor may increase your dose to 400 mg once daily for 12 hours . this is then increased to 200 mg once every 12 hours for 24 24 hours or 200 mg twice daily for 100 hours . the recommended dose is 300 mg once per day . if you have mild to moderate cirrhosis ( see section
like all medicines , this medicine can cause side effects , although not everybody gets them . if any side effects occur , they are usually mild to moderate . serious side effects stop taking voriconazole accord and tell your doctor straight away : rash , jaundice ( changes in blood tests of liver function ), pancreatitis . other side effects include : very common ( may affect more than 1 in 10 people ): visual impairment ( change in vision ), blurred vision , visual color alterations , abnormal intolerance to visual perception of light , colour blindness , eye disorder , halo vision , night blindness , swinging vision , seeing sparks , visual aura ,
what voriconazole accord contains the active substance is vorinazole . each tablet contains 50 mg voronazole ( as besilate ). voricoazole accord 50 mg film - coated tablets : each tablet has 200 mg vorbiconazose ( as mesilate ) voricleazoleaccord 200 mg film film - coating : the other ingredients are : tablet core : lactose monohydrate , pregelatinised starch , croscarmellose sodium , povidone , magnesium stearate . tablet coating : hypromellose , titanium dioxide ( e
mvabea is a vaccine to protect you against ebola virus disease in the future . adults and children from 1 year of age and older who are at risk of getting ebola virus : a 2 - dose course of vaccinations to protect against ebolas virus disease caused by the zaire ebolavirus and filovirus . this vaccine stops the spread of filov virus and the whole ebolairus in your body . to prevent you ebola fever disease is not spread by sexual contact . vaccinations to be given in combination with zabdeno vaccine 8 weeks later than mvabeas vaccine . there is no
your child will receive the vaccination course . if your child receives the vaccine , he or she will be carefully checked by their doctor . if he or her has a severe allergic reaction ( see section 6 . if you have a severe allergy reaction to an antibiotic called ' gentamicin ', the vaccine may not fully protect all children . if any of the above applies to your child ( or you are not sure ), talk to your doctor or nurse before your child is given mvabea . if the child has asevere allergic reaction to any other vaccine injection , tell your doctor . warnings and precautions talk to the doctor or pharmacist before
the recommended dose of vaccine is given by injection into a muscle ( intramuscular injection ) in the upper arm , thigh or blood vessel . the recommended dose is one dose of vaccination with zabdeno vaccine 8 weeks later . the second vaccine will be given with mvabea yellow cap vial . the first dose of the second dose is two doses . the third dose of a type of vaccine will also be given . primary vaccination first vaccination with a zab deno red cap vials . second vaccination with m vabea orange cap villed . the fourth dose is four doses of vaccination . booster vaccination with
like all medicines , this vaccine can cause side effects , although not everybody gets them . the following side effects may happen with mvabea : very common ( may affect more than 1 in 10 people ): pain , warmth and swelling where the injection is given very tired muscle ache joint pain common ( might affect up to 1 in10 people ): feeling sick ( vomiting ) itching where thejection is given uncommon ( may affects up to1 in 100 people ): redness and skin hardness where the injections are given generalised itching where this medicine is given common ( will affect up in 1 in 17 people ): common ( likely to affect up
what mvabea contains the active substance is zaire ebolavirus 29 produced in tai forest ebolovirus nucleoprotein marburg in 0 . 7 ml of solution for injection . the other ingredients are : 108 trace residues of chickenembryo fibroblast cells . this vaccine contains trace residues from gentamicin , sodium chloride , trometamol , water for injections , hydrochloric acid ( for ph adjustment ). what mvabaa looks like and contents of the pack mvagaa is a suspension for injection in a single - dose glass vial with a rubber stopper and
bondronat contains the active substance ibandronic acid . this belongs to a group of medicines called bisphosphonates . it is used to treat breast cancer that has spread to your bones ( called ' bone ametastases '). it helps to prevent your bones from breaking ( fractures ). it also helps to reduce the risk of other bone problems that may need surgery or radiotherapy bondronAT helps to stop a raised calcium level in your blood from building up . this reduces the risk that you have a tumour . it also reduces the amount of calcium that is lost from your bones . this helps to keep
do not take bondronat if you are allergic to ibandronic acid or any of the other ingredients of this medicine ( listed in section 6 ). if you have low levels of calcium in your blood . warnings and precautions talk to your doctor or pharmacist before taking bondronAT if you : have a side effect called osteonecrosis of the jaw ( onj ). onj can cause bone damage in the jaw . your doctor may decide to reduce your dose of bondronatin if you suffer from cancer or related conditions . onj may also occur after stopping treatment . on j is a painful condition that can be difficult to
this medicine is given to you by a doctor or nurse with experience in the treatment of cancer . it is given as an infusion into your vein . your doctor will do regular blood tests before you are given bondronat . your dose of this medicine depends on your illness . if you have breast cancer that has spread to your bones , it may take 3 - 4 weeks before you will have an infusion in your vein , which may take up to 15 minutes . if there is a raised calcium level in your blood , it can be given as a single dose of 1 mg or 2 mg once a day . if your illness is not controlled
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following serious side effects you may need urgent medical treatment : rare ( may affect up to 1 in 1 , 000 people ): persistent eye pain or inflammation new pain , weakness or discomfort in your thigh , hip or groin . this may be a sign of unusual fracture of the thigh bone . very rare ( might affect up in 1 to 10 , 000 persons ): pain or sore in your mouth or jaw . these may be signs of severe jaw problems ( necrosis ( dead bone tissue ) in the jaw bone
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). after dilution the infusion solution should be used within 24 hours . do this medicine if you notice particles in the solution or if the solution is discoloured . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what bondronat contains - the active substance is ibandronic acid . each 2 ml vial contains a concentrate for solution for infusion that contains 2 mg ibandronat . - the other ingredients are sodium monohydrate , sodium chloride , acetic acid , sodium acetate , water for injections . what bondronAT looks like and contents of the pack 1 ml vials with a bromobutyl rubber stopper .
what zeposia is zepoia belongs to a group of medicines that affect the number of white blood cells ( lymphocytes ). what zepOSia is used for zeposeia is a treatment for adults with relapsing remitting multiple sclerosis ( rrms ), a very rare but active disease that affects the nerves of the brain and spinal cord . symptoms include numbness , difficulty in walking and problems with vision and balance . relapsING remitting rel sclerosis is attacks on the nerve cells . the symptoms usually disappear within a few days or weeks . however , some problems may be serious and need immediate medical
do not take zeposia if you are allergic to ozanimod or any of the other ingredients of this medicine ( listed in section 6 ). if you have a severely weakened immune system . if you had a heart attack ( angina , stroke , mini - stroke or transient ischemic attack , tia ). if severe heart failure has occurred within the last 6 months . if any of these apply to you , tell your doctor . if your doctor thinks that you have irregular or abnormal heartbeats ( arrhythmia ). if your heart is not working properly after treatment . if the doctor thinks you have severe infection such
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take your doctor will work out the dose of zeposia you need to take and how often you need it . your doctor may also check your heart rate and may also give you a ' treatment initiation pack ' for the first 4 weeks . the recommended dose is 0 . 23 mg ozanimod once a day . this is taken once a morning . this will be taken once in the morning . then , 1 hour before the start of the first day of the 4 - week course of
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side side effects : very common ( may affect more than 1 in 10 people ): slow heart rate urinary tract infection ( raised blood pressure uncommon ( may affects up to 1 in 100 people ): allergic reaction . the signs may include a rash . other side effects include : very rare ( may effect more than1 in 10 , 000 people ): infections of the nose or nostrils , nasal cavity , mouth , throat ( pharynx ) or voice box ( larynx ).
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 25 . do this medicine as your doctor or pharmacist will check for any damage to the pack . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what zeposia contains the active substance is ozanimod . zeposeia 0 . 23 mg : each capsule contains 0 . 22 mg ozanimog ( as hydrochloride ). zeposa 0 . 46 mg : one capsule contains approximately 0 . 48 mg ozimod ( as hydration ). ozanimood 0 . 92 mg : two capsules contain approximately 0. 92 mg ozamanod (as hydrochlorine ). the other ingredients are microcrystalline cellulose , silica , colloidal anhydrous , croscarmellose sodium , magnesium stearate . capsule shell : 0 . 03
the active substances of temybric ellipta are fluticasone furoate , umeclidinium bromide and vilanterol . fluticastone fureate belongs to a group of medicines called corticosteroids ( steroids ). umecylidinia bromine and vilterol belong to agroup of medicines known as bronchodilators . what temybreric elliptfa is used for temybone ellipta is used to treat chronic obstructive pulmonary disease ( copd ). copd is a long - term condition characterised by breathing difficulties . in
do not use temybric ellipta - if you are allergic to fluticasone furoate , umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using temy bric elliptka - if your asthma is getting worse . warnings and precaution talk to the doctor or nurse before using this medicine : - if temyberric elliptha is used to treat asthma . your doctor may need to adjust your dose . - if any of these apply to you , tell your doctor before using
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation once a day . you should use this this medicine for 24 hours at the same time each day . try to use temybric ellipta at the start of each day and continue to use it until your doctor tells you otherwise . if you use more temybiric elliptka than you should if you have used more tembric ellipta than you have been told to use , contact your doctor immediately . symptoms of temybubric elliptfa may include
like all medicines , this medicine can cause side effects , although not everybody gets them . immediate breathing difficulties if your breathing or wheezing gets worse while taking this medicine , stop taking temybric ellipta and contact your doctor immediately . pneumonia ( infection of the lung ) in copd patients the most common side effect of temybarric elliptoe is symptoms of a lung infection such as fever and chills . increased mucus production , change in mucus colour , increased cough and increased breathing difficulties common side effects ( may affect up to 1 in 10 people ) are sore or raised patches in the mouth or throat . these
what temybric ellipta contains the active substances are fluticasone furoate , umeclidinium bromide and vilanterol . each delivered dose contains 92 micrograms of flutic asone firoate , 65 microgram of umeleclidatinium bromeide and 55 microgram / ml umelyclidine ( corresponding to 22 microgram per millilitre of vilancerol ) and trifenatate . the other ingredients are lactose monohydrate ( see section 2 under ' temy bric elliptac contains lactose '),
zinforo is an antibiotic medicine that contains the active substance cefaroline fosamil . it belongs to a group of medicines called 'cephalosporin antibiotics '. zinforo helps to treat infections of the skin and the tissues around the skin . it is used to treat an infection of the lungs called ' pneumonia '. how zininforoe works zin foro works by killing certain bacteria that cause serious infections .
do not take zinforo if you are allergic to ceftaroline fosamil or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic to othercephalosporin antibiotics . if you have had previous severe allergic reactions to other antibiotics ( such as penicillin or carbapenem ). warnings and precautions talk to your doctor or pharmacist before taking zin foro . if any of these apply to you , tell your doctor before taking this medicine . warnings and risks talk to the doctor or nurse before taking the medicine if you : have kidney problems .
the recommended dose of zinforo is 600 mg once a day . your doctor will tell you how many tablets to take . the recommended dose is one 600 mg tablet once a week for 8 weeks . if you have some infections that you cannot tolerate for 8 to 12 weeks , your doctor may increase your dose . zinforto is given as a drip into a vein ( intravenously ) over a period of 5 minutes . your dose may be increased to 60 mg or 120 mg once daily . your physician may prescribe an increased dose depending on how you respond to treatment . the first 5 to 14 doses are given to prevent skin
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following side effects : if you get any of these symptoms , you may need urgent medical treatment : sudden swelling of your lips , face , throat or tongue , a severe rash , swallowing or breathing problems , asevere allergic reaction ( anaphylaxis ), diarrhoea , stool , blood or mucus . treatment with zinforo may be interrupted or stopped , or medicines may slow bowel movement ( see section 2 ). this may affect up to 1 in 10 people . your doctor will do
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 30 . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what zinforo contains the active substance is ceftaroline fosamil . the other ingredients are arginine . what zinFORo looks like and contents of the pack zinofo is a pale yellowish to light yellow powder for concentrate for solution for infusion in a vial . it is supplied in packs containing 10 vials .
pregabalin pfizer belongs to a group of medicines used to treat epilepsy , neuropathic pain and generalised anxiety disorder ( gad ) in adults . peripheral and central neuropathicpain : pregabalin fizer is used to relieve long lasting pain caused by damage to the nerves . a variety of diseases can cause peripheral neuropathic Pain , such as diabetes or shingles . pain sensations may be described as hot , burning , throbbing , shooting , stabbing , sharp , cramping , aching , tingling , numbness , pins and needles . peripheral or central neuropathy pain may also be associated with mood
do not take pregabalin pfizer - if you are allergic to pregagabalin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking pregabil pfiser . some patients taking pregaabalin pumpfizer have reported symptoms suggesting an allergic reaction . these symptoms include swelling of the face , lips , tongue , and throat and diffuse skin rash . should you experience any of these reactions , you should contact your doctor immediately . pregibalin has been associated with dizziness and somnolence , which may increase
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . pregabalin pfizer is for oral use . peripheral and central neuropathic pain , epilepsy and generalised anxiety disorder the usual dose is 150 mg once a day . your doctor may prescribe a lower dose of 600 mg once daily . you should take pregagalin psfizer once a morning , once in the afternoon and once in a while . if you weigh 59 kg or more , you should continue to take pregaabalin fizer once in morning , twice a day , once a
like all medicines , this medicine can cause side effects , although not everybody gets them . very common : may affect more than 1 in 10 people dizziness , drowsiness , headache . common : might affect up to 1 in every 10 people increased appetite , feeling of elation , confusion , disorientation , decrease in sexual interest , irritability , disturbance in attention , clumsiness , memory impairment , loss of memory , tremor , difficulty with speaking , tingling feeling , numbness , sedation , lethargy , insomnia , fatigue , feeling abnormal , blurred vision , double vision , vertigo , problems with balance
what pregabalin pfizer contains the active substance is pregaboralin . each hard capsule contains 25 mg , 50 mg , 75 mg , 100 mg , 150 mg , 200 mg , 225 mg or 300 mg of pregibalin . the other ingredients are lactose monohydrate , maize starch , talc , gelatine , titanium dioxide ( e171 ), sodium laurilsulphate , anhydrous colloidal silica . the printing ink contains black ink , shellac , black iron oxide ( e172 ), propylene glycol ( e1520 ), potassium hydroxide ( e433 ).
xadago is a medicine that contains the active substance safinamide . it works by increasing the levels of dopamine in the brain . this is a chemical in the body that is important for movement . in parkinson ' s disease , the most common symptom of parkinson ', is sudden swings in movement . this may affect many people , including elderly people , who may not be able to move normally or who have difficulties moving at all . xadago can be used alone or in combination with levodopa ( other medicines used to treat parkinson' s disease ).
do not take xadago - if you are allergic to safinamide or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you are taking any of : - monoamine oxidase ( mao ) inhibitors ( e . g . selegiline , rasagiline ), moclobemide , phenelzine , isocarboxazid , or tranylcypromine . - treatment for parkinson ' s disease or depression - pethidine ( a strong pain killer ). warnings and precautions talk to your doctor or pharmacist before
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of xadago is 50 mg once a day . the dose may be increased to 100 mg once daily by mouth . your doctor will tell you how many tablets of xdago to take . if you have moderately reduced liver function , your doctor may prescribe a lower dose of 50 mg . take xadadago at the same time each day . you should swallow the tablets whole with a glass of water . xadagon can be taken with or without food . if taking more xad
like all medicines , this medicine can cause side effects , although not everybody gets them . hypertensive crisis ( very high blood pressure that may lead to collapse ) has been reported in patients taking xadago . neuroleptic malignant syndrome ( confusion , sweating , muscle rigidity , hyperthermia ), increase level of enzyme creatine kinase in your blood . serotonin syndrome ( lack of coordination , confusion , hypertension , muscle stiffness , hallucinations and hypotension ). the following side effects have been reported with other medicines used to treat parkinson ' s disease : very common ( may affect more than 1 in 10 people ): insomnia , difficulty in performing
what xadago contains - the active substance is safinamide . each tablet contains 50 mg or 100 mg safinam . - the other ingredients are methansulfonate , microcrystalline cellulose , crospovidone type a , magnesium stearate , silica colloidal anhydrous - tablet coating contains hypromellose , macrogol , titanium dioxide ( e171 ), iron oxide red ( e172 ). what xadag looks like and contents of the pack xadagon 50 mg film - coated tablets of 7 mm diameter with metallic gloss are marked with ' 50 ' on one
zytiga contains a medicine called abiraterone acetate which is used to treat prostate cancer in adult men , when other treatments have not worked or are not suitable . zytiga lowers testosterone in the blood , which is important in fighting prostate cancer . ztiga is used in patients who have disease that has not responded to hormone therapy , a treatment that lowers testosterone ( androgen deprivation therapy ) or who are unable to take another medicine called prednisone . prednisolone is used for high blood pressure in adult patients whose body is not able to absorb the medicine properly and which causes fluid retention in your
do not take zytiga - if you are allergic to abiraterone acetate or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor thinks you may be pregnant . warnings and precautions talk to your doctor before taking zytigo - if there is severe liver damage or prostate cancer . this medicine should not be taken if you have already taken this medicine . talk to a doctor before you take this medicine if any of these apply to you . - if any member of your family has ever had liver problems . - tell your doctor if you suffer from high blood pressure or heart failure . -
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet once a day . your doctor may increase your dose to 1 , 000 mg once a week . you should take this tablet at the same time each day . this medicine should be taken by mouth . swallow the tablet whole with a glass of water . do not crush or chew the tablet . take zytiga at least 2 hours before or 2 hours after food . take the tablet at about the same times each day , with or without food . swallow it whole with the glass of
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking zytiga and contact your doctor immediately if you experience : muscle weakness , muscle twitches , a pounding heart beat or palpitations . the level of potassium in your blood is low . your doctor may check your level of calcium more frequently . other side effects include : very common ( may affect more than 1 in 10 people ): fluid in your legs or feet ( low blood potassium or liver function test ) high blood pressure urinary tract infection , diarrhoea common ( might affect up to 1 in every 10 people ) high fat levels in
what zytiga contains - the active substance is abiraterone acetate . each tablet contains 250 mg abirate acetate - the other ingredients are microcrystalline cellulose , croscarmellose sodium , lactose monohydrate , magnesium stearate , povidone ( k32 ), colloidal anhydrous silica , sodium laurilsulfate . see section 2 " zytigo contains lactose ". what zytig looks like and contents of the pack - zytige tablets are white to off - white , round tablets with " 9 . 5 " debossed on one
hefiya contains the active substance adalimumab . it is a medicine used for the treatment of inflammatory diseases : polyarticular juvenile idiopathic arthritis , enthesitis - related arthritis , paediatric plaque psoriasis , paedile crohn ' s disease and paediatric non - infectious uveitis . adalumab is a monoclonal antibody . monoclal antibodies attach to specific proteins in the body . addalimumab attaches to a specific target called tumour necrosis factor ( tnfÎ± ). tnfsÎ± is involved in the inflammatory diseases and reduces the inflammation in
do not take hefiya if your child is allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). if your or your child ' s child has a severe infection , including tuberculosis ( sepsis ), blood poisoning or other opportunistic infections ( unusual infections caused by a weakened immune system ). symptoms of infections may include fever , wounds , feeling tired , dental problems . if your / your child has moderate or severe heart failure . if you / your son has a serious heart condition . warnings and precautions allergic reaction allergic reactions may occur with symptoms such as chest tightness , wheezing
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual dose is one 40 mg tablet once a day . your doctor may prescribe a different dose for you . your dose may be increased to 20 mg , 40 mg , 20 mg or 40 mg . polyarticular juvenile idiopathic arthritis age and body weight how much to use adults the usual starting dose is 2 30 mg once a week . your child ' s doctor may increase the dose to 40 mg once daily . children and adolescents the usual maintenance dose is 10 mg once weekly . your children and
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . tell your doctor straight away if you notice any of the following side effects ( see section 4 , " warnings and precautions "): - at the site of the last hefiya injection - allergic reaction ( e . g . heart failure ) - severe rash , hives , swollen face , hands , feet , trouble breathing , swallowing , shortness of breath , and swelling of the feet . - signs and symptoms of infection such as fever , feeling sick , wounds
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the pre - filled syringe in the outer carton in order to protect from light . after first opening , the product may be stored at room temperature ( up to 25 ) for a maximum period of 14 days . once removed from the refrigerator for room temperature storage , your pre -filled syringe must be used within 14 days or discarded
what hefiya contains - the active substance is adalimumab . each pre - filled syringe contains 20 mg of adalumab in 0 . 4 ml solution . - the other ingredients are adipic acid , citric acid monohydrate , sodium chloride , mannitol , polysorbate 80 , hydrochloric acid and sodium hydroxide and water for injections . what hefiYA looks like and contents of the pack hefiah 20 mg / 0 . 04 ml solution for injection is a clear to slightly opalescent , colourless to slightly yellowish solution . it is supplied in a clear type
what ritemvia is ritemv contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to the surface of a type a white blood cell called " b - lymphocyte ". when ritukimab sticks to this surface , it stops the cell from growing and dividing . what ritemva is used for ritemvi is used to treat adults with the following conditions : a ) non - hodgkin ' s lymphoma this is an advanced form of a disease of the lymph tissue that affects the immune system . b - cells
do not take ritemvia if you are allergic to rituximab , other proteins that are derived from ritukimab or any of the other ingredients of this medicine ( listed in section 6 ) if you have a severe active infection if you suffer from a weak immune system if you suffered from severe heart failure or severe uncontrolled heart disease if you know that you have granulomatosis , polyangiitis , microscopic polyangiaitis or pemphigus vulgaris warnings and precautions talk to your doctor or pharmacist before taking ritemvi if you : have ever had or might now have a
how much ritemvia is given your doctor will decide how much ritemvia you will receive and how often you will need this treatment . your doctor may decide to reduce the dose of this medicine or stop it altogether if you experience any side effects . how ritemv is given ritemva is given as a drip ( intravenous infusion ). medicines given before each ritemvi administration you will be given ritamvia together with other medicines ( pre - medication ) to reduce possible side effects during your treatment . if you are being treated for non - hodgkin ' s lymphoma , you will first be given
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . some of these reactions have been fatal . infusion reactions during the first 24 hours of the infusion you may experience fever , chills , shivering , pain at the infusion site , blisters , itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat discomfort , tongue or throat swelling , itchy , runny nose , vomiting , flushing , palpitations , heart attack , low number of plate
what ritemvia contains - the active substance is rituximab . each ml of concentrate contains 100 mg of ritukimab ( as besilate ). each vial of concentrate contents contains 10 mg of the active ingredient in ritudimab - the other ingredients are sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections . what ritemvs looks like and contents of the pack ritemvest is a clear , colourless solution for infusion in a glass vial . pack size of 2 vials .
capecitabine teva belongs to a group of medicines called " cytostatic medicines ", which stop the growth of cancer cells . capecitabrine teva contains capecitibine , which itself is not a cytostatics medicine . only after being absorbed by the body is it changed into an active anti - cancer medicine . capecabine cheva is used in the treatment of colon , rectal , gastric , or breast cancers . furthermore , capecitabiline teeva is used to prevent new occurrence of colon cancer after complete removal of the tumour by surgery . cape citabine jeva may be
do not take capecitabine teva if you are allergic to capecitabiline or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may have an allergy , ask your doctor for advice before taking this medicine . if you have severe reactions to fluoropyrimidine therapy ( a group of anticancer medicines containing fluorouracil ) if you can become pregnant if you suffer from low levels of white cells or platelets in the blood ( leucopenia , neutropenia or thrombocytopenia ) if any of these apply to you if you know you
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . capecitabine should only be prescribed by a doctor experienced in the use of anticancer medicines . your doctor will prescribe a dose and treatment regimen that is right for you . the dose of capecitabiline teva is based on your body surface area ( height and weight ). the usual dose for adults is 1250 mg / m2 of body surface surface area taken once daily . this is for example : - if you weigh 64 kg or more ; - if your height is 1 . 64 mb
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking capecitabine teva and contact your doctor immediately if you have any of these symptoms : diarrhoea : if you experience an increase of 4 or more bowel movements compared to your normal bowel movements , or any diarrhoehoea at night . vomiting : if vomiting is severe and you vomit more than once in a 24 - hour time period . nausea : if your stomach does not empty as expected and you lose your appetite . stomatitis : if pain , redness , swelling or sores in your mouth and / or
what capecitabine teva contains the active substance is capecitabiline . capecitabe teva 150 mg film - coated tablets each film - coating contains 150 mg capecitibine . furthermore , capecitabee teva 500 mg film film - coat contains 500 mg capecabine . the other ingredients are : tablet core : lactose , microcrystalline cellulose , hypromellose , croscarmellose sodium , magnesium stearate , macrogol 400 , hypromeellose, titanium dioxide ( e171 ), yellow iron oxide ( e172 ), red iron oxide red ( e 172
silodosin recordati contains silodosino recordati . this belongs to a group of medicines called alpha1a - adrenoreceptor blockers . silodosein recordat is used to lower the pressure in the prostate , bladder and urethra . this helps to maintain smooth muscle in these tissues . it also helps to reduce your symptoms . silosin Recordati is used in adults to treat the urinary symptoms associated with benign enlargement of the prostate ( prostatic hyperplasia ), such as difficulty in starting to pass water and a feeling of not completely emptying the bladder .
do not use silodosin recordati - if you are allergic to silodosein or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using silodosiin recordi - if your doctor has recently performed eye surgery - if there is cloudiness of the lens in your eye during cataract surgery 26 - if any of these apply to you , tell your doctor before using the product . silodousin recordat may be used in some cases when medicine has caused a loss of muscle tone in the iris ( the coloured part of
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of silodosin recordati is one capsule taken once a day , with or without food . the maximum recommended dose is 8 capsules taken once daily . if you have kidney problems if you suffer from moderate kidney problems , your doctor may prescribe a lower dose . for this purpose silodosein recordat is taken once every day , at about the same time of the day . you should take the capsule at about 4 - 6 times a day . if taking silodosiin recordatri
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions swelling of the face or throat , difficulty in breathing , feeling faint , itchy skin or hives are the most common side effect of silodosin recordati . dizziness . dizzy and occasionally fainting may occur . if you feel weak or dizzy , tell your doctor . the symptoms may include dizziness and faints . if any of the above apply to you , tell the doctor before taking silodnosin recordi . complications following a cataract surgery ( including eye surgery ), cloudiness of the
what silodosin recordati contains silodosein recordat 8 mg hard capsules : the active substance is silodusin . each capsule contains 8 mg silodasin . the other ingredients are mannitol , magnesium stearate , sodium laurilsulfate , gelatin , titanium dioxide ( e171 ). silodosiin recordatin 4 mg hard capsule : the ingredients are silodnosin , mannola , magnesium starchate , magnesium laurilulfate . the printing ink contains gelatin , stainless dioxide ( i171 ), yellow iron oxide ( e172 ). what silodosesin recordi
kinzalmono belongs to a class of medicines known as angiotensin ii receptor antagonists . angiotENSin ii is a substance produced in the body which causes your blood vessels to narrow , thus increasing your blood pressure . kinzalo blocks the effect of angiotenin ii so that the blood vessels relax , and your bloodpressure is lowered . kinzi is used to treat essential hypertension ( high blood pressure ) in adults . the high blood blood pressure is not caused by any other condition . high bloodpressure , if not treated , can damage blood vessels in several organs , which could lead sometimes to heart attack
do not take kinzalmono - if you are allergic to telmisartan or any of the other ingredients of this medicine ( listed in section 6 ). - if more than 3 months pregnant ( it is also better to avoid kinzalino in early pregnancy see pregnancy section ). - tell your doctor if you have severe liver problems such as cholestasis or biliary obstruction ( problems with drainage of the bile from the liver and gall bladder ) or any other severe liver disease . - tell the doctor if any of these apply to you . - if your doctor has prescribed diabetes or impaired kidney function and you are
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . you should take kinzalmono at the same time each day . the tablets should be swallowed whole with some water . you can take kin zalmonos with or without food . try to take your tablet at the right time each morning . it is important that you continue to take kinzonmono until your doctor tells you otherwise . treatment of high blood pressure the usual starting dose of kinzdalmono is 40 mg once a day to control
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects could be serious and need immediate medical attention : sepsis ( often called " blood poisoning "), a severe infection with whole - body inflammatory response , rapid swelling of the skin and mucosa ( angioedema ). these side effects are rare ( may affect up to 1 in 1 , 000 people ). other side effects of kinzalmono common side effects ( may effect up to1 in 10 people ): low blood pressure ( hypotension ) and cardiovascular events uncommon side effects : uncommon side effect ( may affects up to one
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . once your medicine has been taken out of your refrigerator , it should be used immediately . do this by referring to the new expiry day on the blister . do away with the blister and write the new expiration date on the outer carton . donot throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you
what kinzalmono contains - the active substance is telmisartan . each tablet contains 20 mg telmisantan . - the other ingredients are povidone , meglumine , sodium hydroxide , sorbitol , magnesium stearate . what kinzalao looks like and contents of the pack kinzalanmono 20 mg tablets are white to off - white , round and flat . kinzaloo is available in blister packs of 14 , 28 , 56 or 98 tablets . not all pack sizes may be marketed .
afstyla is a human clotting ( coagulation ) factor viii product produced by recombinant dna technology in the manufacturing process in the laboratory . the active substance is lonoctocog alfa . afstylfa is used to treat bleeding episodes in patients with haemophilia a ( inborn factor v iii deficiency ). factor vii is involved in blood clotting and helps blood to clot . patients with an increased tendency to bleed have been shown to have higher levels of factor v ii in their blood than in patients without haemphilia a . therefore , it is important that you continue to
do not use afstyla if you have had an allergic reaction to afstylea or any of the other ingredients of afstrya ( listed in section 6 ). if you are allergic to hamster proteins . warnings and precautions 46 talk to your doctor or pharmacist before using afstya . the batch number and frequency of administration are recorded in your treatment diary . do not use more afstilea than your doctor tells you to . allergic ( hypersensitivity ) reactions are rare in patients receiving afsteya . symptoms of allergic reactions may include allergic reactions such as hives , generalised skin rash ,
your treatment will be overseen by a doctor experienced in the treatment of blood clotting disorders . always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage the recommended dose of afstyla is based on the following conditions : dose and duration of treatment the site and location of the bleeding your clinical condition and the dose you receive the dose of the product are defined as follows : reconstitution and administration general instructions the powder and the solvent ( liquid ) must be dissolved before use to avoid aseptic conditions . afstlinga may be used with other medicines
like all medicines , afstyla can cause side effects , although not everybody gets them . symptoms of allergic reactions allergic reactions may include the following symptoms : hives generalised urticaria ( itchy rash ), tightness of the chest , difficulty in breathing , wheezing , low blood pressure , dizziness ( anaphylaxis ), bleeding . patients taking factor viii medicines may develop inhibitor antibodies ( see section 2 ' warnings and precautions '). very common ( may affect more than 1 in 10 people ) patients who have received previous treatment with factor v iii ( more than 150 days of treatment ) and who were treated with
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the afstyla powder in the outer carton in order to protect from light . after reconstitution , the product may be stored at room temperature ( up to 25 ) for a single period of up to 3 days . do away with the vial and keep it in theouter carton . do this until the recon
what afstyla contains the active substance is lonoctocog alfa . each vial contains 250 iu ( 2 . 5 mg / ml ). after reconstitution with 2 .5 mg / lonoectocog aluminium , the solution contains 200 iu lonoCTocog alpha . each 1000 iu vial provides one injection . after reconitution with 1 . 5mg / ml , the amount of lonoontocog aluminum produced is 400 iu / ml . each 2000 iu or 600 iu iu per vial provided one injection , the quantity of lanoctocag
what praxbind is praxbinding contains the active substance idarucizumab . idarucaizumb is a recombal agent of the form dabigatran ( pradaxa ), a blood thinner medicine used to prevent blood clot formation . what prax bind is used for praxBind is used to rapidlytrap dabigATran . what it is usedfor prax Bind is used in adults . it is given to adults only . how prax binds works pradxbind may be used in emergency surgery or urgent procedures to stop uncontrolled bleeding .
do not take praxbind if you are allergic to idarucizumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have a genetic disease called hereditary fructose intolerance ( haf ). if your doctor has told you that you have the substance sorbitol , which is similar to this medicine , you should not take this medicine . serious adverse reactions have been reported with the use of prax bind in patients taking this medicine in combination with dabigatran . other medicines to prevent blood clots dabigitran is a substance that is absorbed by the body and helps to prevent formation
the recommended dose is 5 mg / kg body weight ( equivalent to 2 . 5 mg dabigatran ). this medicine is given once every 5 weeks . your doctor will decide the dose that is right for you . your dose will be decided by your doctor . the recommended dose for adults is one 2 . 75 mg /kg body weight injection of dabigatriran once every 10 weeks . if you miss a dose of this medicine if you have missed a dose , it is important that you contact your doctor as soon as possible to reschedule your appointment . if it is more than 24 hours since you missed a scheduled dose of
like all medicines , this medicine can cause side effects , although not everybody gets them . reporting of side effects if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
what praxbind contains - the active substance is idarucizumab . - the other ingredients are sodium acetate trihydrate , acetic acid , sorbitol ( e420 ), polysorbate 20 and water for injections . what praxbinding looks like and contents of the pack prax bind is a clear to slightly opalescent , colourless to slightly yellow solution supplied in a glass vial with a butyl rubber stopper and an aluminium cap .
temomedac contains a medicine called temozolomide . this medicine is an antitumour agent . temomedac is used to treat specific forms of brain tumours : - in adults with newly - diagnosed glioblastoma multiforme . temormac is first given together with radiotherapy ( concomitant phase of treatment ) and then monotherapy phase oftreatment ( followed by a combination of 3 courses of treatment ). - in adult patients with malignant glioma , such as glioclastoma multififorme or anaplastic astrocytoma . temomac is given in combination
do not take temomedac if you are allergic to temozolomide or any of the other ingredients of this medicine ( listed in section 6 ). if you have had an allergic reaction to dacarbazine ( an anticancer medicine sometimes called dtic ). signs of allergic reaction may include feeling itchy , breathlessness or wheezing , swelling of the face , lips , tongue or throat . if blood cells are severely reduced ( myelosuppression ), your white blood cell count and platelet count may decrease . these blood cells help you in fighting infection and to prevent proper blood clotting . temomedic may
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage and duration of treatment your doctor will work out your dose of temomedac based on your height and weight . if you have a recurrent tumour that has not responded to chemotherapy treatment in the past and you are taking other medicines ( anti - emetics ) that are similar to temomedic ( see section " other medicines and temomedAC "). you should take temomedacon to prevent nausea and vomiting . if your doctor determines that you have newly - diagnosed glioblastoma multiforme
like all medicines , this medicine can cause side effects , although not everybody gets them . if you experience a severe allergic ( hypersensitive ) reaction , including hives , wheezing or other breathing difficulty , uncontrolled bleeding , seizures , convulsions , fever , chills and severe headache , stop temomedac treatment and contact your doctor immediately . there may be a reduction in certain kinds of blood cells . this can cause increased bruising or bleeding , anaemia ( a shortage of red blood cells ), fever and reduced resistance to infections . the reduction in blood cell counts is usually short - lived and can lead to anaemia (' apl
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store above 30 . do away with the capsules if you notice any change in the appearance of the capsules . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what temomedac contains the active substance is temozolomide . temomedacon 5 mg : each capsule contains 5 mg temozoleomide ( as mesolomides ). temomedack 20 mg : one capsule contains 20 mg tem ozolomine ( as temolomix ). temmedac 100 mg : two capsules contain 100 mg temzolomile ( as besolomid ). temarthac 140 mg : three capsules contain 140 mg temizolomime ( as esolomod ). temarmac 180 mg : four capsules contain 180 mg temuzolomice ( as des
cialis is a treatment for adult men with erectile dysfunction . this is when a man cannot get , or keep a hard , erect penis suitable for sexual activity . cialis allows a hard erect penis to be pleasurable for men . cialsis contains the active substance tadalafil which belongs to a group of medicines called phosphodiesterase type 5 inhibitors . calis works by stopping the blood vessels in your penis from tightening . this allows your penis to relax and allow you to have sex . this helps to maintain erectile function . ceralis is used to treat adult men who have erectile disease
do not take cialis - if you are allergic to tadalafil or any of the other ingredients of this medicine ( listed in section 6 ) - if your doctor has told you that you are intolerant of organic nitrate or nitric oxide donors such as amyl nitrite ( a group of medicines (" nitrates ") used to treat angina pectoris (" chest pain "). warnings and precautions talk to your doctor before taking ciali : - if any of these medicines can harm your kidneys . - if the amount of nitrate in your blood is too low . - tell your doctor if you have
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . cialis tablets are for oral use . swallow the tablet whole with a glass of water . the tablets can be taken with or without food . the usual dose is 5 mg twice a day ( one tablet in the morning and one tablet at the evening ). your doctor may increase your dose to 2 . 5 mg once a day depending on how you respond to cialises . if you take more cialnis than you should if you accidentally take too many tablets
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with the medicine : allergic reactions ( rashes , frequency not known ) chest pain when taking nitrates ( frequency not unknown ) priapsim may cause a prolonged and possibly painful erection . if this happens , stop taking cialis and seek medical help straight away . if you get an erection that lasts more than 4 hours , contact your doctor immediately . sudden loss of vision ( frequency unknown ). other side effects very common ( may affect more than 1 in 10 people ) uncommon ( may affects up to 1 in 100 people
what cialis contains - the active substance is tadalafil . each tablet contains 2 . 5 mg of tadalabil . - the other ingredients are : tablet core : lactose monohydrate ( see section 2 ' cialises contains lactose '), croscarmellose sodium , hydroxypropylcellulose , microcrystalline cellulose , sodium laurilsulfate , magnesium stearate . film - coating : lactate monohydrate , hypromellose , triacetin , titanium dioxide ( e171 ), iron oxide yellow ( e172 ), ironoxide red ( e132 ),
enyglid is an oral antidiabetic medicine containing repaglinide , which helps your pancreas produce more insulin and thereby lower your blood sugar ( glucose ). type 2 diabetes is a disease in which your pancrea does not produce enough insulin to control the sugar in your blood or where your body does not respond normally to the insulin it produces . enyglide helps control the level of sugar in the blood when you have type 2abetes by helping your pancryas produce better insulin and lower the sugar that your body is not able to use effectively . your doctor will prescribe the insulin that best controls the level and
do not take enyglid if you are allergic to repaglinide or any of the other ingredients of this medicine ( listed in section 6 ). if you have type 1 diabetes . if the acid level in your blood is too low ( diabetic ketoacidosis ). if your doctor has told you that you have a severe liver disease . if you take gemfibrozil ( a medicine used to lower increased fat levels ). if any of these apply to you , tell your doctor . if your dose is too high . if any combination of eny glid or gemfibrrozile ( a medicines used
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 0 . 5 mg tablet once a day . swallow the tablet whole with a glass of water . you can take enyglid with or without food . the maximum recommended dose for adults is 30 mg once a week . the dose may be increased by 4 mg once daily or by 30 mg daily for up to 16 weeks . your doctor will work out the right dose for you . if you take more enylid than you should if you accidentally take too many enyels
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia the most common side effect of enyglid is hypoglycasemia ( may affect up to 1 in 10 people ). hypoglycemic reactions are generally mild / moderate . hypocaemic unconsciousness may lead to coma . allergy allergy ( rare , may affect 1 in every 10 , 000 people ) symptoms include swelling , difficulty in breathing , rapid heartbeat , feeling dizzy and sweating . this may be a sign of anaphylactic reaction . other side effects include : common ( may affects up to1 in 10
what enyglid contains the active substance is repaglinide . each tablet contains 0 . 5 mg , 1 mg or 2 mg repagginide . the other ingredients are microcrystalline cellulose , calcium hydrogen phosphate , anhydrous , croscarmellose sodium , povidone k25 , glycerol , magnesium stearate , meglumine , poloxamer , yellow iron oxide ( e172 ) only in 1 mg tablet and red iron oxide (< e172 ). only in 2 mg tablet . what eny glid looks like and contents of the pack enylid
what azacitidine mylan is azacitonidine myl is an anti - cancer agent . what azaccitidine myan is used for azacididine myla is used to treat adults . what it is usedfor azac citidine myel is used in adults . azacilitidine mygal is used : after a stem cell transplantation in adults with higher - risk myelodysplastic syndromes ( mds ), chronic myelomonocytic leukaemia ( cmml ), acute myeloid leukaemic ( aml ). these are diseases that affect the bone marrow
do not take azacitidine mylan - if you are allergic to azaccitidine or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have advanced liver cancer . warnings and precautions talk to your doctor or pharmacist before taking azacacitine mylan : - if the patient has decreased counts of platelets , red or white blood cells . - if he / she has kidney disease . - in patients with liver disease . if the person has a heart condition that could lead to heart attack . - tell your doctor if the doctor has lung disease .
before starting azacitidine mylan , you will be given another medicine to prevent nausea and vomiting . the recommended dose is 75 mg once a day . your doctor will tell you how many tablets of this medicine you need to take . your dose will depend on your height and weight . azaccitidine myl is given every 3 weeks as part of this " treatment cycle " ( cycle 4 , 6 ). you will receive this medicine under the skin ( subcutaneously ) on the skin of your thigh , tummy or upper arm . if you have any further questions on the use of this product , ask your doctor or pharm
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience any of the following serious side effects : drowsiness , shaking , jaundice , abdominal bloating and easy bruising ( which may be symptoms of liver failure ). swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea , vomiting , reduced appetite , confusion , restlessness and fatigue ( which could be symptoms or signs of kidney failure ). a fever ( which might be a sign of an infection due to low levels of white blood cells ). chest
your doctor , pharmacist or nurse knows how to store azacitidine mylan properly . any unused azaccitidine myl must be disposed of in accordance with local requirements . this medicine will be stored by the health professionals at the hospital or clinic . the suspension must be used within 1 hour after preparation . the azacididine myla suspension must not be mixed with water for injections . thesuspension must be stored in a refrigerator ( 2 8 ). the azaconitidinemylan suspension must also be stored within a refrigerator , 2 8 , and not above 25 . if large particles are present in the suspension ,
what azacitidine mylan contains the active substance is azacitas . one vial of powder contains 100 mg azacacitine . after reconstitution with 4 ml of water for injections , the reconstituted suspension contains 25 mg / ml azaccitidine . the other ingredient is mannitol ( e421 ). what azacididine myl looks like and contents of the pack azacitonidine mylon is a white powder for suspension for injection in a glass vial containing 100 mg of azacito . pack sizes of 1 and 7 vials . not all pack sizes may be marketed
duotrav eye drop solution contains two active substances , travoprost and timolol . travostrost is a prostaglandin analogue in the eye . timolole is a beta blocker that reduces the amount of fluid within the eye and reduces pressure within theeye . duotraveye drops are used to treat high pressure in theeye in adults with an illness called glaucoma .
do not take duotrav - if you are allergic to travoprost , prostaglandins , timolol , beta blockers or any of the other ingredients of this medicine ( listed in section 6 ). - if your child has respiratory problems such as asthma , severe chronic obstructive bronchitis or severe lung disease ( e . g . wheeziness , difficulty in breathing , long - standing cough , breathing problems , severe hay fever ) - if the child has a slow heartbeat - if he / she has heart failure ( a disorder of heart rhythm , irregular heartbeat ), or if the coloured part of the eye becomes cloudy
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one drop in the affected eye or eyes once a day . do not use duotrav in the eyes unless your doctor tells you to . do this by mouth or in the shower . do it by mouth . do the same with other eye drops . do use duvetrav in your eyes . try to use duetrav at the same time each day . how to use eye drops the recommended doses are 1 drop in each affected eye each day , followed by 2 drops in each other
like all medicines , this medicine can cause side effects , although not everybody gets them . the drops should be swallowed whole with water . duotrav can cause very common side effects ( may affect more than 1 in 10 people ) effects on the eye eye redness . common side side effects these may affect up to 1 in every 10 people . effects on how the eye surface inflammation ( surface damage ) can cause eye pain , blurred vision , abnormal vision , dry eye , itchy eye and eye discomfort . signs and symptoms may include eye irritation , burning or stinging . uncommon side effects this may affect upto 1 in 100 people .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store above 30 . store in the original package in order to protect from light . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what duotrav contains - the active substances are travoprost and timolol . each vial contains 40 mg travostrost and 5 mg timolole ( as timololine maleate ). - the other ingredients are polyquaternium - 1 , mannitol , propylene glycol , polyoxyethylene hydrogenated castor oil 40 mg , boric acid , sodium chloride , sodium hydroxide , hydrochloric acid , purified water , sodium hydrochloride and hydrochlorIC acid . what duotra looks like and contents of the pack duotrave is a liquid ( a clear
nplate ' s active ingredient is romiplostim . it is a protein that helps to control low platelet counts in the immune ( idiopathic ) thrombocytopenic purpura ( itp ). itp is a disease that affects your body ' s immune system . platelets are important in protecting the blood from blood clots . very low platelets counts can lead to bruising and serious bleeding ( see section 1 ). if you have had your spleen removed , you may have chronic itp . you may previously be treated with corticosteroids or immunoglobulins . nplate works
do not take nplate - if you are allergic to romiplostim or any of the other ingredients of this medicine ( listed in section 6 ). - if allergic to other medicines containing escherichia coli ( e . coli ). warnings and precautions talk to your doctor or pharmacist before taking nplate if you have a low blood platelet count ( thrombocytopenia ). nplate may reduce your platelet counts , which may increase the risk of blood clots . blood clists are important for blood clotting . - if your doctor has told you that you have liver problems . - you are over 65
nplate is given to adults and adolescents ( aged 1 to 17 years ) who are able to take nplate . how nplate is administered nplate will be given as an injection under the skin ( subcutaneous ) at a dose of 1 mg / kg . how much nplate you will be treated with nplate your doctor will check your platelet counts regularly . you will have regular blood samples taken to count your platelets . your doctor may also check your white blood and your plateLET count regularly . your platelete count will be calculated using the following convention : children and adolescents 1 to and 17 years the table below shows
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with itp : common ( may affect up to 1 in 10 people ): headache , allergic reaction , upper respiratory tract infection common ( might affect up in 1 in every 10 people ) bone marrow disorder , increased bone marrow fibres , trouble sleeping ( insomnia ), dizziness , tingling or numbness of the hands or feet ( paraesthesia ), migraine , redness ofthe skin , flushing , blood clot in a lung artery ( pulmonary embolism ), nausea , diarrhoea , abdominal pain , ind
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do store above 30 . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what nplate contains the active substance is romiplostim . nplate 125 mg powder for solution for injection contains approximately 230 mg romiplopim . each vial contains 125 mg romplostim in a deliverable amount of 0 . 25 ml solution . each millilitre ( ml ) contains 125mg romipliplostime . each 500 mg vial of nplate 250 mg powder : each milliliter ( ml) contains 375 mg romoplostim ( as 25 mg ) in a delivered solution .each 250 mg vials of romiplustim in the delivered solution contains 250 mg romclostim
what tovanor breezhaler is this medicine contains an active substance called glycopyrronium bromide which belongs to a group of medicines called bronchodilators . what tovanOR breez inhaler is used for this medicine is used to help to relieve breathing difficulties in adults with a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways tighten , making breathing difficult . this medicine works by tightening these muscles in the lungs , making it easier for air to get in and out of the lungs . this helps to reduce the effects of this medicine on cop
do not use tovanor breezhaler - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using tovanOR breez inhaler - tell your doctor if you have kidney problems - tell the doctor if your doctor has told you that you have an eye problem called narrow - angle glaucoma ( difficulty passing urine ). your doctor may decide to temporarily stop treatment with tovaner . if you use more tovannor breez than you should contact your doctor immediately if
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much tovanor breezhaler to use the recommended dose of this medicine is 24 capsules ( in blisters ) once a day . your doctor will tell you how many capsules to use . the maximum recommended dose is 75 capsules ( per day ). you should use this leaflet every day to help you remember to use it . how to use this medicinal leaflet is provided in the pack ( tovanOR breez inhaler inhaler ). the medicine is supplied as inhalation powder . the capsules
what tovanor breezhaler contains - the active substance is glycopyrronium bromide . each capsule contains 63 micrograms glycopyroniumbromide and 50 microgramms glycopyrsronium . the delivered dose ( the delivered amount that leaves the mouthpiece of the inhaler ) is equivalent to 44 microgramrams glycopYRronium per inhalation dose . - the other ingredients of the inhale powder are lactose monohydrate and magnesium stearate . what tovanOR breez inhaler looks like and contents of the pack tovanir breezker 44 micro
adasuve contains the active substance loxapine and belongs to a group of medicines called antipsychotics . it works by relaxing the brain ' s natural dopamine and serotonin - releasing and calming effects and relieving aggressive behaviour . adasuve is used to treat acute symptoms of mild - to - moderate agitation in adults with schizophrenia and bipolar disorder . adasve is a treatment for diseases characterised by symptoms ( schizophrenia ) hearing , seeing or sensing things which are not there , mistaken beliefs , incoherent speech and behaviour , emotional flatness , depressed , guilty , anxious , tense or generally not being able to do anything . the
do not take adasuve if you are allergic to loxapine or any of the other ingredients of adasuvet ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking adasuves if you have symptoms such as wheezing or shortness of breath , as these may be signs of lung problems like asthma , chronic obstructive pulmonary disease ( copd ), narrowing of the airways ( bronchospasm ), wheeze , cough , chest tightness or short shortnessof breath ( see section 25 ) or neuroleptic malignant syndrome ( nms ). these may also
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 9 . 1 mg twice a day , taken once in the morning and once in 2 hours at the evening , taken twice a morning and one in the evening . your doctor may increase your dose to 4 . 5 mg twice daily depending on your condition . adasuve is taken by mouth . swallow the tablet whole with a glass of water . do not chew or crush the tablet . if you take more adasuva than you should if you accidentally take too many tablets , contact your doctor
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience any of the following side effects : any breathing symptoms , such as wheezing , cough , shortness of breath , chest tightness , irritating your airways ( asthma or copd ), light - headedness or fainting . these may be signs that your blood pressure is not being controlled as well as worsening agitation , confusion , fever and muscle stiffness . these could be signs of a severe condition called neuroleptic malignant syndrome . other side effects include : very common ( may affect more than 1 in
keep this medicine out of the sight and reach of children . do not use adasuve after the expiry date which is stated on the carton and on the blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . do away with adasuvet if you notice any visible signs of physical damage . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what adasuve contains - the active substance is loxapine . each single - dose inhaler contains 5 mg of loxepine . when it delivers , adasuves delivers 4 . 5 mg loxapeine . what adasuva looks like and contents of the pack adasuvel 4 .5 mg is a white to off - white plastic inhaler , imprinted with " loxpine " on one side and " adasuv 4 . 0 " on the other side . each inhaler is packed in a sealed foil pouch . adasuvet 4 . 95 mg is available in packs containing 1
what azacitidine betapharm is azacitonidine betabarm is an anti - cancer agent . it belongs to a group of medicines called ' anti - metabolites '. what azaccitidine betafarm is used for azaciticidine betaparm is for use in adults . what azaconitidinebetapharm works for azapitidine tetapharm will be given to you as a stem cell transplantation in adults with higher - risk myelodysplastic syndromes ( mds ). it is also used in adults for chronic myelomonocytic leukaemia ( cmm
do not take azacitidine betapharm - if you are allergic to azaccitidine or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have advanced liver cancer . warnings and precautions talk to your doctor or pharmacist before taking azacacitine betapham : - if the patient has decreased counts of platelets , red or white blood cells . - if he / she has kidney disease . - tell your doctor if the person has liver disease . if the doctor has recently told you if you have a heart condition such as heart attack or lung
before starting azacitidine betapharm , you will be given another medicine to prevent nausea and vomiting . the recommended dose is 75 mg once a day . your doctor will tell you how much azacita betapham you need . your dose of this medicine will be adjusted by your doctor based on your height and weight . azaccitidine betafarm is given every 3 weeks as part of this " treatment cycle " ( cycle 4 , 6 ). this medicine is given under the skin ( subcutaneously ) on the skin of the thigh , tummy or upper arm . if you have any further questions on the use
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience any of the following serious side effects : drowsiness , shaking , jaundice , abdominal bloating and easy bruising ( which may be symptoms of liver failure ). swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea , vomiting , reduced appetite , confusion , restlessness and fatigue ( which could be symptoms or signs of kidney failure ). a fever ( which might be a sign of an infection due to low levels of white blood cells ). chest
your doctor , pharmacist or nurse knows how to store azacitidine betapharm properly . they are also responsible for the correct storage of any unused azaccitidine betabarm . this medicine is for single use only . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . the suspension must be stored below 45 Âºc . the azacituidine betafarm suspension must not be stored in the refrigerator . it must be used immediately after preparation . the recommended storage time for injections is 8 hours
what azacitidine betapharm contains - the active substance is azacitonidine . each vial contains 100 mg azacitasidine . after reconstitution with 4 ml of water for injections , the reconstituted suspension contains 25 mg / ml azaccitidine . - the other ingredient is mannitol ( e421 ). what azacididine betafarm looks like and contents of the pack azac citidine betabarm is a white to off - white powder supplied in a glass vial containing 100 mg of azacito .
cerdelga contains the active substance eliglustat . it is used for the long term treatment of gaucher disease type 1 in adults . gaucher dementia type 1 is inherited condition in which the body produces too much glucosylceramide . this is especially toxic for the organs in your body such as the spleen , liver and bones . your doctor has prescribed eliglustit to work by reducing the amount of glucosyleceramide in your affected organs . your physician will test you regularly to check that this medicine is working . if you have any further questions on the use of this medicine , ask your doctor or pharmacist
do not take cerdelga - if you are allergic to eliglustat or any of the other ingredients of this medicine ( listed in section 6 ). - if your body is not able to tolerate medicines called moderate cyp2d6 inhibitors ( e . g . quinidine , terbinafine ) 31 - if it is not possible to tolerate moderate cyc3a inhibitors ( i . e . erythromycin or itraconazole ). these medicines are used to improve your body ' s ability to absorb nutrients . warnings and precautions talk to your doctor before taking cerdelg . cerdelgas is
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet twice a day with food . the amount of metaboliser that you need to take varies depending on the type of metabolizer you are taking . the usual dose is two tablets twice a morning . swallow the tablets with a glass of water . the maximum recommended dose for adults is 84 tablets once a day . if you take more cerdelga than you should if you accidentally take too many tablets , contact your doctor immediately . to open the blister / wallet , remove the sleeve , and
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): headache dizziness change in taste ( dysgeusia ) palpitations throat irritation heartburn ( dyspepsia ) feeling sick ( nausea ) diarrhoea constipation abdominal pain stomach ache ( upper abdominal pain ) acid reflux disease ( gastrooesophageal reflux diseases ) bloating ( abdominal distension ) inflammation of the stomach ( gastritis ) 34 difficulty swallowing ( dysphagia ) vomiting dry mouth gas ( flatulence ) dry skin hives ( urtic
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and sleeve after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what cerdelga contains - the active substance is eliglustat . each capsule contains 84 mg of eliglustate . - the other ingredients are microcrystalline cellulose , lactose monohydrate ( see section 2 ' cerdelaga contains lactose '), hypromellose , glycerol dibehenate , gelatin , potassium aluminium silicate , titanium dioxide ( e171 ), yellow iron oxide ( e172 ), indigotine ( e132 ). printing ink : shellac , black iron oxide , propylene glycol and ammonia solution . what cerdelg looks like and contents of the pack cerdelgas capsules
the active substance in zoledronic acid hospira is zoledron acid , which belongs to a group of substances called bisphosphonates . zoledor acid works by attaching itself to the bone and slowing down the rate of bone change . it is used to prevent bone complications , e . g . fractures , in adult patients with bone metastases ( spread of cancer from primary site to the original bone ). it reduces the amount of calcium in the blood in adult people when it is too high due to the presence of a tumour . tumours can accelerate normal bone change in such a way that the release of calcium from
your doctor will carry out blood tests before you start treatment with zoledronic acid hospira and will check your response to treatment regularly during treatment . do not use zoledron acid hospir if you are allergic ( hypersensitive ) to zoledor acid , another bisphosphonate ( the group of substances to which zoledrine acid belongs ). warnings and precautions talk to your doctor or pharmacist before using zoledric acid hospiral : if you think any of the above applies to you , or if you have been in close contact with someone who has zoledoredronic acid , tell your doctor . if you suffer
zoledronic acid hospira must only be given by healthcare professionals trained in administering bisphosphonates intravenously ( into a vein ). ' iv ' administration is recommended in order to reduce dehydration . how much zoledronic acidic hospira is given the recommended dose is 4 mg . if you have a kidney problem , your doctor may decide to lower the dose . if your kidney problem is not well controlled with zoledron acid hospir , you may be at increased risk of bone complications ( bone metastases ). how zoledic acid hospiar is given your doctor will decide how much infusion you need . zoledicle acid
like all medicines , zoledronic acid hospira can cause side effects , although not everybody gets them . the most common side effects are : common ( may affect up to 1 in 10 people ): severe kidney impairment ( will be determined by your doctor with certain specific blood tests ). low level of calcium in the blood . uncommon ( may effect up to1 in 100 people ): pain in the mouth , teeth and / or jaw , swelling or non - healing sores inside the mouth . jaw discharge , numbness or a feeling of heaviness , or loosening of a tooth . these could be signs of bone damage in the jaw (
your doctor , pharmacist or nurse knows how to store zoledronic acid hospira properly .
what zoledronic acid hospira contains the active substance is zoledron acid . one vial of zoledor acid contains 4 mg zoledicle acid . the other ingredients are monohydrate , mannitol , sodium citrate and water for injections . what zoledic acid hospir looks like and contents of the pack zoledable acid hospire is a liquid concentrate for solution for infusion (' sterile concentrate '). each pack contains one vials of concentrate .
varuby contains rolapitant which is used to treat adults with cancer feeling sick ( nauseous ) or being sick ( vomiting ) during cancer treatment chemotherapy . these nerve cells are important in helping your body fight against cancer . they help your body to make better use of its own medicine . varuby works by blocking the nerve cells that help your brain fight nausea and vomiting . this helps your body make better sense of being sick . rolapit works by stopping the nerve cell from working properly , which may cause nausea and / or vomiting .
do not take varuby if you are allergic to rolapitant or any of the other ingredients of this medicine ( listed in section 6 ). if you take an herbal medicine called st john ' s wort ( hypericum performatum ). if your doctor has told you that you have depression or difficulty sleeping ( see section 2 " warnings and precautions "). if you have not taken this medicine for more than 27 days . if you suffer from severe liver or kidney problems . if your dose of certain medicines ( e . g . rifampicin , used to treat tuberculosis or other infections ) is not adequate . if any
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 180 mg once a day for a total of 90 days . swallow the tablet whole with a glass of water . you can take varuby with or without food . you may take varubsy with food or between meals for up to 2 weeks before your chemotherapy cycle . if you take more varubys than you should if you have taken more varubsys than your doctor tells you to , contact your doctor straight away . if possible , show them the pack . if sickness occurs ,
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with varuby : very rare ( may affect more than 1 in 1 , 000 people ): symptoms of an allergic reaction may include sudden shortness of breath , swelling of the lips or tongue , change in taste , swellingof skin or tissue , sudden rash , fever and faster heartbeats . tell your doctor immediately , and he or she may decide to give you appropriate treatment . other side effects include : very common ( may affects more than1 in 10 people ): headache ; constipation ; feeling tired uncommon ( may
what varuby contains - the active substance is rolapitant . each tablet contains 90 mg rolapit . - the other ingredients are : tablet core : lactose monohydrate ( see section 2 under ' varubiy contains lactose '), pregelatinised starch , microcrystalline cellulose , povidone ( k - 30 ), croscarmellose sodium , colloidal silicon dioxide , magnesium stearate . film - coating : polyvinyl alcohol , titanium dioxide ( e171 ), macrogol , polysorbate 80 . what varubey looks like and contents of the pack var
what enerzair breezhaler is enerzaire breez inhaler contains two active substances : indacaterol and glycopyrronium - mometasone furoate indacterol and microcopyrroneium belong to a group of medicines called bronchodilators . they relax the muscles in the lungs , making it easier for air to get in and out of the lungs . mometsone fruate belongs to agroup of medicines known as corticosteroids and is used to treat asthma . corticoposteroids reduce the swelling and irritation ( inflammation ) in the small
do not use enerzair breezhaler if you are allergic to indacaterol , glycopyrronium , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor before using enerzaire breez inhaler if : you have heart problems , such as an irregular or fast heartbeat , thyroid gland problems , diabetes , high blood sugar , seizures , severe kidney problems , severe liver problems , low level of potassium in your blood , you have an eye problem
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the medicine should be inhaled by mouth or inhaled through a syringe . you should inhale the content of one capsule each day . it is important that you continue to use enerzair breezhaler until your asthma is controlled . if your symptoms do not improve , your doctor may prescribe a different dose . how to use and when to use use enerzezhalzer your doctor will tell you how to prepare and use enertzair breezez inhaler . you will find an inhal
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious stop taking enerzair breezhaler and see a doctor immediately if you notice any of the following : very common ( may affect more than 1 in 10 people ): difficulty breathing or swallowing , swelling of the tongue , lips or face , skin rash , itching and hives ( signs of allergic reaction ). other side effects other sideeffects include the following side effects : very commonly ( may affects more than1 in 10 users ): sore throat , runny nose , sudden difficulty breathing , feeling of tightness , wheez
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special temperature storage conditions . store in the original package in order to protect from moisture . the capsules should be used immediately after opening . do this if you notice any change in the appearance of the capsules . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what enerzair breezhaler contains the active substances are indacaterol ( as acetate ), glycopyrronium ( as bromide ), and mometasone furoate . each capsule contains 150 micrograms of indacate and 63 microgram of glycopreyronium bromides . each delivered dose contains 50 microgram ( glycopyronium ) and 160 microgram( mometsone furuate ). the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is equivalent to 114 microgram / gram of indiacaterol , 58 micro
clopidogrel acino pharma gmbh contains the active ingredient clopidgin which belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). clopidineogrelacino pharmÃ¡ gmbhs is taken to prevent blood clubs ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombotic events , which can lead to
do not take clopidogrel acino pharma gmbh if you are allergic ( hypersensitive ) to clopidaogrel or any of the other ingredients of clopidineogrel agibilise . if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if your doctor has told you that you suffer from severe liver disease . if this applies to you , tell your doctor before taking clopridogrelacino pharmace kinase . if any of these apply to you ( or you are not sure ), talk to your doctor or pharm
always take clopidogrel acino pharma gmbh exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the usual dose is one 75 mg tablet of clopridogrel a gmbhl per day to be taken orally with or without food . you can take clapidogl acino pharma gmb h with or just after food . if you take more clopidoogrel agmbh than you should contact your doctor , pharmacist or the nearest hospital emergency department because of the increased risk of bleeding . if possible take the
like all medicines , clopidogrel acino pharma gmbh can cause side effects , although not everybody gets them . the most common side effects are : common ( affects 1 to 10 users in 100 ) uncommon ( affects less than 1 user in 1 , 000 ) rare ( affects up to 1 user of 10 , 000 ). very rare ( affecting less than1 user in 10 ,000 ). very rarely ( affects fewer than 1 patient in 10, 000 ). if you notice any of the following : contact your doctor immediately : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of
store in the original blister in order to protect from moisture . keep out of the reach and sight of children . do not use clopidogrel acino pharma gmbh after the expiry date which is stated on the carton and on the blister after exp . the exp date refers to the last day of that month . donot use cloplogrelacino pharmÃ¡ gmbhl if you notice any visible sign of damage of blister or film - coated tablets . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will
what clopidogrel acino pharma gmbh contains the active substance is clopridogrel . each tablet contains 75 mg of clopidaogrel ( as besilate ). the other ingredients are : tablet core : macrogol 6000 cellulose , microcrystalline ( e460 ), crospovidone type a castor oil , hydrogenated film - coating : macromol 6000 ethylcellulose ( e462 ) titanium dioxide ( e 171 ) what clopIDogrelacino pharmÃ¡ gmbH looks like and contents of the pack clopideogrel acid
delstrigo is used to treat hiv (' human immunodeficiency virus ') infection in adults . it is one of a group of medicines called ' antiretroviral medicines '. it contains the active substances doravirine , a non - nucleoside reverse transcriptase inhibitor ( nnrti ), lamivudine , which is a nucleosides analogue reverse transcriptases inhibitor ( trti ). tenofovir disoproxil , which are also known as a nucleositide analogue reverse transcriptase inhibitor , ( nrti ) and is used for the treatment of hiv
do not take delstrigo if you are allergic to doravirine , lamivudine , tenofovir disoproxil or any of the other ingredients of this medicine listed in section 6 . if you take any of these medicines : - carbamazepine , oxcarbazepine or phenobarbital , phenytoin ( medicines to prevent seizure ) - rifampicin or rifapentine ( medicines used to treat tuberculosis ) - st . john ' s wort ( hypericum perforatum , a herbal remedy used to help depression and anxiety ) - products containing
always take delstrigo exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is a complete regimen of one tablet a day . a single tablet is sufficient for treating hiv infection . the dose is 1 tablet a night . if you take certain medicines ( such as doravirine ) your doctor may prescribe medicines that lower the amount of this medicine swallow the tablet whole with a glass of water . do not crush , chew or break the tablet . taking this medicine take the tablet at about the same time each day . if possible take delstigo with food
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking this medicine and tell your doctor immediately if you notice any of the following : very common ( may affect more than 1 in 10 people ): abnormal dreams difficulty in sleeping ( insomnia ) headache dizziness sleepiness cough nasal symptoms feeling sick ( nausea ) diarrhoea stomach pain vomiting wind ( flatulence ) hair loss rash muscle symptoms ( including pain and stiffness ) feeling tired fever blood tests showing increased levels in liver enzymes uncommon ( may effect up to 1 in 100 people ): nightmares , depression , anxiety , irritability , confusion , suicidal thoughts 45 trouble
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and carton after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . keep the bottle tightly closed in order to protect from moisture . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what delstrigo contains the active substances are : 100 mg doravirine , 300 mg lamivudine , 245 mg tenofovir disoproxil ( as fumarate ) the other ingredients are : tablet core : croscarmellose sodium e468 , hypromellose acetate succinate , magnesium stearate , microcrystalline cellulose e460 , silica , colloidal anhydrous , sodium stearyl fumar . a coating material : carnauba wax e903 , hypramellose , iron oxide yellow ( e172 ), lactose monohydrate
spravato contains esketamine . it belongs to a group of medicines called anti - depressants . this medicine helps to control your depression . it also helps to reduce the symptoms of depression , such as feeling sad , anxious or worthless , sleeping difficulties , change in appetite , loss of interest in favourite activities and a feeling of being slowed down . spravato is used in adults who are also taking another antidepressant . it is important to keep following the advice about diet and exercise given to you by your doctor , pharmacist or nurse . if you have any further questions on the use of this medicine , ask your doctor or pharmacist
do not use spravato - if you are allergic to esketamine , ketamine or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have an aneurysm ( a weak spot in a blood vessel wall that bulges out due to bleeding in the brain ). - have recently had a heart attack . within 6 weeks of starting treatment , a temporary increase in blood pressure can lead to serious complications in these conditions . if any of these apply to you , tell your doctor before using spravo . warnings and precautions talk to your doctor or pharmacist before
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much spravato to use the spravat nasal spray is a clear , colourless to pale yellow solution . the nasal spray device is available in packs containing 1 , 2 or 3 nasal spray devices . one nasal spraydevice is sufficient for 4 doses . if you use more spravatos than you should if you have used more spradato than you have been told to use , contact your doctor immediately . if possible , show them the pack . if more than 4 doses have been used , contact
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with spravato : very common ( may affect more than 1 in 10 people ) feeling disconnected or having feelings and things around you feeling dizzy headache change in sense of taste feeling sleepy decreased feeling or sensitivity to touch in the mouth area spinning sensation ( vertigo ) vomiting nausea common ( might affect up to 1 in every 10 people ): feeling extremely happy ( euphoria ) feeling agitated feeling anxious feeling in the eyes or ears a crawling feeling increased sensitivity to noise and sounds persistent ringing in the ears ( tinnitus )
what spravato contains - the active substance is esketamine . each nasal spray device contains esketam hydrochloride equivalent to 28 mg esketa . - the other ingredients are citric acid monohydrate disodium edetate sodium hydroxide ( for ph adjustment ) water for injections what spravat looks like and contents of the pack spravatos is a nasal spray solution . this medicine is a clear , colourless solution for use in children . spravata is available in packs containing : one single - use nasal spraydevice . spreamato is available as packs containing 1 , 2 , 3 or 6
zerbboraf is an anticancer medicine that contains the active substance vemurafenib . it is used to treat melanoma that has spread to other parts of the body or cannot be removed by surgery . it can be used if you have a type of cancer that has a change ( mutation ) in a gene called melanoma . zelboraf targets proteins that are involved in the growth and spread of your cancer .
do not use zelboraf if you are allergic to vemurafenib or any of the other ingredients of this medicine ( listed in section 6 ). symptoms of allergic reactions may include swelling of the face , lips or tongue , difficulty breathing , rash and fainting sensation . if any of these apply to you , tell your doctor or nurse before using zelberaf . allergic reactions if allergic reactions occur during treatment with zelbouraf , tell the doctor or hospital pharmacist immediately if you have any symptoms of an allergic reaction such as swelling ofthe face , lip or tongue ), difficulty breathing or rash and / or
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 4 mg once a day . your doctor may increase your dose to 8 mg once daily . your dose may be increased to 4 mg twice a day depending on side effects . your treatment may be stopped if you take more zelboraf than you should if you experience vomiting , contact your doctor immediately . taking zelbaf take zelberaf on an empty stomach . swallow the tablets whole with a glass of water . if you forget to take zezboraf if you miss
like all medicines , zelboraf can cause side effects , although not everybody gets them . serious allergic reactions may occur , including swelling of the face , lips or tongue , difficulty breathing rash fainting sensation . zelberaf may be used during radiation treatment . tell your doctor immediately if you experience any of the following symptoms : skin rash , blistering , peeling , discoloration of the skin shortness of breath , a cough , fever or chills ( pneumonitis ) difficulty or pain when swallowing , chest pain , heartburn or acid reflux ( esophagitis ) tell your skin doctor if you
keep out of the reach and sight of children . do not use zelboraf after the expiry date which is stated on the carton and the blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do this after the first opening of the blister . do away with the blister if you notice that the blister is damaged or shows signs of tampering . do these measures to protect the environment ?
what zelboraf contains the active substance is vemurafenib . each film - coated tablet contains 240 mg of vemurabenib ( as a co - precipitate of veMurafenb ). the other ingredients are : tablet core : hypromellose acetate succinate , colloidal anhydrous silica , croscarmellose sodium , hydroxypropyl cellulose , magnesium stearate film - coating : iron oxide , macrogol 3350 , polyvinyl alcohol , talc and titanium dioxide ( e171 ). what zelberaf looks like and contents of the pack
duoplavin contains clopidogrel and acetylsalicylic acid ( saa ). saa belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood which clump together during blood clotting . by preventing this clumping , blood vessels relax . antiplatelets medicinal products reduce the chances of blood clots forming ( a process called atherothrombosis ). duoplavic is taken by adults to prevent blood cl clots from forming in hardened arteries , a process known as atherostrombotic events , which can lead to stroke ,
do not take duoplavin if you are allergic to clopidogrel , acetylsalicylic acid ( arsa ) or any of the other ingredients of this medicine ( listed in section 6 ) if you think you may be allergic to other products called non - steroidal anti - inflammatory products if you have painful and / or inflammatory conditions of muscles or joints if you suffer from a medical condition ( such as asthma , nasal discharge , runny nose or polyps ) if your child has a certain type of growth in the nose if your baby has a medicalcondition that is currently causing bleeding such as a stomach ul
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . you should take duoplavin at the same time each day . your doctor will tell you how many tablets of your medicine to take . if you take more duoplin than you should if you have accidentally taken too many tablets , or if someone else has taken your tablets , tell your doctor immediately . if possible , take your medicine and this leaflet with you . if a child has had a heart attack , take duaplavin immediately and contact
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the exp date refers to the last day of that month . do store below 25 . do this medicine if you notice any visible sign of deterioration . donot throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what duoplavin contains duoplin 75 mg film - coated tablets each tablet contains 46 tablets of the active substances , clopidogrel , acetylsalicylic acid (asa ), and acetylsulic acid . each 75 mg tablet contains clopridogrel ( as hydrogen sulphate ). each 75mg tablet contains acetylSalicylicacid , mannitol , macrogol 6000 , microcrystalline cellulose , low substituted hydroxypropylcellulose , maize starch , hydrogenated castor oil . see section 2 ' duopllin contains hydrogenatedcastor oil '
simbrinza contains two active substances , brinzolamide and brimonidine tartrate . brin zolamide belongs to a group of medicines called carbonic anhydrase inhibitors . brimonine tartrate belongs to an active group of medicine called alpha - 2 adrenergic receptor agonists , which reduce pressure within the eye . simbrinz is used to treat pressure in the eyes in adults aged 18 years and older who have eye conditions such as glaucoma , ocular hypertension ( high pressure in both eyes ).
do not take simbrinza if you are allergic to brinzolamide , brimonidine tartrate or any of the other ingredients of this medicine ( listed in section 6 ) if you think you may be allergic to sulphonamides if you have ever taken medicines for diabetes or infections if you take diuretics ( water tablets ) or a monoamine oxidase ( mao ) inhibitors if you do not take medicines for depression or parkinson ' s disease if you currently take certain antidepressants . if you know that you may need to stop taking any antidepressant medicines if you : have severe kidney problems have too much acid
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . simbrinza is for use in both eyes . use in the eyes only . avoid touching your eyes with your hands . step 1 step 2 step 3 step 4 step 5 step 6 step 7 step 7 remove the cap and snap collar . hold the medicine by your fingers . twist the bottle , pointing down . pull the bottle back . pull down the eyelid with a clean finger and insert a ' pocket ' between the eyelids and the eye . the drop will go in here . step 4 steps 1
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : if you have a reaction to the medicine ( frequency not known ), you may have an allergic reaction . severe skin reactions ( such as rash , redness , itching all over your body and / or eyes trouble breathing , chest pain , or irregular heart beat ) tell your doctor immediately extreme tiredness or dizziness . the other side effects that may occur with simbrinza are : other medicines containing brinzolamide or brimonidine . common side effects ( may affect up to 1 in
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and carton after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . after first opening , use within 4 months to prevent infections . if you use more simbrinza than you should if you accidentally use too much simbrinaza , tell your pharmacist or nurse straight away . if possible , use a new bottle . do away with the bottle .
what simbrinza contains - the active substances are brinzolamide and brimonidine tartrate . each ml of suspension contains 10 mg of brin zolamide ( corresponding to 2 mg of of brimonate tartrate equivalent to 1 . 3 mg of Brimonidine ). - the other ingredients are benzalkonium chloride ( see section 2 " simbrinusza contains benzalkonaium chloride "), propylene glycol , carbomer 974p , boric acid , mannitol , sodium chloride , tyloxapol , hydrochloric acid , sodium hydroxide , purified water
filgrastim ratiopharm contains the active substance filgrastam . filgrasterim is a protein produced by biotechnology in the body called escherichia coli . it is very similar to a natural protein produced in the cells called granulocyte - colony stimulating factor ( g - csf ). filgrasteim stimulates the bone marrow to produce new blood cells . more blood cells are needed than white cells . white cells are important as they help your body fight infection . filgrimastim helps your body to produce more white blood cells quickly . filgnastim riopham will be given to
do not use filgrastim ratiopharm - if you are allergic ( hypersensitive ) to filgrasteim or any of the other ingredients of filgrustim ratisopharm . warnings and precautions talk to your doctor or pharmacist before using filgrateim ratitopharm : - if a cough , fever or difficulty breathing has been reported . - if your doctor thinks you may have a pulmonary disorder . - tell your doctor if you have any of these side effects . - sickle cell disease 57 - if left upper abdominal pain or pain at the tip of your shoulder . - your doctor may decide
how much filgrastim ratiopharm is given the amount of filgrastaim ratisopharm you will receive will depend on your condition and on how well you respond to filgrasteim ratitopharm . your doctor will tell you exactly how many tablets of filgrimastim ratiopharm to give to you . filgrateim ratiotopharm treatment will be started by a doctor who is experienced in the use of chemotherapy . the recommended dose is 0 . 5 mg per kilogram bodyweight given once every 60 days . your treatment will last approximately 14 days . some disease types may be
you must not be given filgrastim ratiopharm if you have sickle cell disease 57 you should not be treated if you get left upper abdominal pain or pain at the tip of your shoulder . if you suffer from a spleen disorder . see section 4 . possible side effects . your doctor will carry out regular blood tests before you are given filbrastim ratiopharm . this is to check the number of neutrophils ( a type of white blood cells ) in your blood . before treatment , your doctor may check the amount of these cells in your body . other medicines and filgrasteim rat
keep out of the reach and sight of children . do not use filgrastim ratiopharm after the expiry date which is stated on the carton and on the blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . donot use filgrimastim piriopham if the solution is cloudy or contains particles . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what filgrastim ratiopharm contains - the active substance is filgrasim . each ml of solution for infusion contains 60 mg of filgrasteim . filgraspim ratisopharm 30 mg : each pre - filled syringe contains 0 . 5 ml of filgnastim in 0 . 05 ml solution . filgnaspim ratiopharm 48 mg : one pre -filled syringe containing 48 mg of filmgrastrim in 0. 8 ml solution , each pre pre - fill syringe delivers 48 mg / ml of the active ingredient sorbitol ( e420 ), water for
what riluzole zentiva is riluxole zenta contains rilusole which belongs to the nervous system . what rilizole zENTiva is used for rilustole zertiva is given to adult patients with amyotrophic lateral sclerosis ( amy ) motor neurone disease ( ms ). ms affects the nerve cells responsible for sending signals to the muscles causing weakness , muscle waste and paralysis . ms is caused by the destruction of nerve cells . motor neurONE disease may also be caused by too much glutamate ( a chemical messenger ) in the brain and spinal cord . rilzole zant
do not take riluzole zentiva - if you are allergic to rilazole or any of the other ingredients of this medicine ( listed in section 6 ). - if any liver disease has been reported . - if your doctor has found that you have increased blood levels of some enzymes of the liver called transaminases . - tell your doctor if you think you may be pregnant . warnings and precautions talk to your doctor or pharmacist before taking rilizole zenta - if : you have any liver problems - you have yellowing of your skin or the whites of your eyes ( jaundice ), itching ,
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . the tablets should be taken by mouth once a day , preferably at the same time each day . your doctor will tell you how many tablets to take . the maximum recommended dose for adults is 12 tablets a day ( one tablet in the morning ). if you take more riluzole zentiva than you should contact your doctor , pharmacist or your nearest hospital emergency department immediately . if you forget to take rilzole zenta if you miss a dose
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : fever ( increase in temperature ). riluzole zentiva may cause a decrease in the number of white blood cells . this is shown in a blood sample . white blood cell counts are important for fighting infections . if you have any of the following symptoms : yellowing of your skin or the whites of your eyes ( jaundice ), itching , feeling sick or being sick . these may be signs of liver disease ( hepatitis ). your doctor may do regular blood tests before you start rilizole z
what riluzole zentiva contains the active substance is rilusole . the other ingredients are : anhydrous dibasic calcium phosphate , micro crystalline cellulose , anhydrated colloidal silica , magnesium stearate , croscarmellose sodium , hypromellose , macrogol 6000 , titanium dioxide ( e171 ). what rilizole zenta looks like and contents of the pack the tablets are white , round and scored with 50 mg of rilu on one side and 202 mg on the other side . riluxole zENTiva is available in packs
emgality contains the active substance galcanezumab . this is a medicine that blocks the activity of a protein called calcitonin gene ( cgrp ), which is involved in migraine . increased levels of cgrm in the blood can lead to an increased risk of migraine . emgality is used to treat migraine in adults , adolescents and children aged 4 years and older . migraines are not usually severe . emmgality can reduce the frequency of migraine headache and improve your quality of life .
do not use emgality if you are allergic to galcanezumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have a serious cardiovascular disease warnings and precautions serious cardiovascular diseases allergic reactions emg abnormality may cause serious allergic reactions . these reactions may be life - threatening . see section 40 for more information about signs of a serious allergic reaction . if you notice such signs , tell your doctor straight away . you may be more at risk of side effects listed in sections 4 . children and adolescents emgally is not recommended for children and teenagers under the age of 18 years . other
always use emgality exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 240 mg once daily . emgally is given as an injection under your skin ( subcutaneous injection ). you may receive your emgalis injection at home or at a hospital or clinic where proper training is required . if you have been given more emgals than you should if you think you have received too much emgal , tell your doctor straight away . if possible , show them the pack of emgaly . if a dose is missed , you should not receive
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects allergic reactions to emgality may include rash and itching . serious allergic reactions ( rare , may affect up to 1 in 1 , 000 people ) may include : difficulty breathing or swallowing , low blood pressure , dizziness or light - headedness , swelling of the neck , face , mouth , lips , tongue or throat , severe itching of the skin , a red rash , raised bumps . other side effects tell your doctor or nurse if you notice any of the following : very common side effects ( may affect more than 1 in 10 people
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after first opening use within 7 days or store below 30 . do this medicine if you notice that the solution is not clear or contains particles . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what emgality contains - the active substance is galcanezumab . each pre - filled pen contains 120 mg of galcaneszumb in 1 ml solution . - the other ingredients are l - histidine , l - ethidine hydrochloride monohydrate , polysorbate 80 , sodium chloride , water for injections . what emgalis looks like and contents of the pack emgally is a solution for injection in a clear glass syringe . the colour is clear to slightly yellow . the syringe is provided in a pack containing one single - dose pen . pack sizes of 1 , 2 and
defitelio is a medicine that contains the active substance defibrotide . it is used to treat a condition called hepatic veno - occlusive disease ( when the blood vessels in the liver become damaged ) in which blood clots form and which cannot be removed with medicines obtained prior to a stem cell transplantation . defibrorotide works by helping the blood vessel to open and blood clasts to form . this medicine is used in adults , adolescents and children aged one month and older .
do not use defitelio if you are allergic to defibrotide or any of the other ingredients of this medicine ( listed in section 6 ) if you have been taking other medicines to prevent blood clots ( tissue plasminogen activator warnings and precautions ) if any of these apply to you , tell your doctor before using this medicine . warnings and measures talk to your doctor or pharmacist before using defitgelio if : you have a history of bleeding ( heavy bleeding ) if your doctor has recently given you a blood transfusion or surgery if you suffer from problems with blood circulation ( a constant blood pressure )
the treatment with defitelio will be started by a doctor who is experienced in stem cells transplantation . it will be given to you by your doctor or nurse as an ' intravenous infusion ' ( drip ). you will be monitored during this treatment for 21 days until your symptoms improve . if you are given more defitilio than you should if you have been given too much , tell your doctor , nurse or pharmacist immediately . if possible , you should contact your doctor . if more than 18 doses have been missed , tell the doctor , pharmacist or nurse . if a missed dose is missed , do not worry .
like all medicines , defitelio can cause side effects , although not everybody gets them . stop taking defiteloio and talk to a doctor or go to a hospital straight away if you notice any of the following side effects . these side effects are very common and need immediate medical attention : very common ( may affect more than 1 in 10 people ) low blood pressure common ( might affect up to 1 in every 10 people ): bleeding in general bleeding in the nose bleeding in parts of the brain bleeding in part of the gut vomiting in part with blood bleeding in one of the lungs bleeding in blood in the urine in the mouth bleeding
keep this medicine out of the sight and reach of children . do not use defitelio after the expiry date which is stated on the carton and on the vial label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . do do not put defiteloio near heat or if the infusion storage is damaged . if you notice any particles in the solution , immediately contact your doctor . do away with defitlioio if you see any particles or the solution is cloudy . do throw away any medicines via wastewater or household waste .
what defitelio contains the active substance is defibrotide . each ml of solution contains 2 . 5 mg or 200 mg of defibroide . after dilution , each ml solution contains 80 mg of the active substances in defibriide . the other ingredients are sodium citrate dihydrate , hydrochloric acid , sodium hydroxide ( for ph - adjustment ), water for injections . what defitELio looks like and contents of the pack defiteloio is a clear , colourless to pale yellow solution for infusion . it is supplied in a 10 ml vial containing 2 . 0 mg
daklinza contains the active ingredient daclatasvir . hepatitis c is an infectious disease that affects the liver , caused by the hepatitis c virus . this medicine works by stopping the hepatitisc virus from multiplying in your body . it reduces the amount of the virus in your blood . daklinz is used in combination with other medicines to treat hepatitis c infection . the other medicines that you will be given are : daklineza with food and drink daklonza is taken with other medicine to treat the hepatitis k infection . your doctor will discuss with you which combination of the other treatments is best for you .
do not take daklinza if you are allergic to daclatasvir or any of the other ingredients of this medicine ( listed in section 6 ) if you take daclinza by mouth with the following medicines : phenytoin , carbamazepine , oxcarbazepine and phenobarbital ( used to treat epileptic seizures ) rifampicin , rifabutin and rifapentine ( antibiotics used to prevent tuberculosis ) dexamethasone ( a steroid used to correct allergic and inflammatory diseases ) medicines called st . john ' s wort ( hypericum
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of daklinza is 60 mg once a day . do not take more than this recommended dose . do this if you get a very unpleasant taste . your doctor may tell you to stop taking daklanza . some other medicines may affect the way daklonza works . if you take more daklineza than you should if you have taken more daclinza than your doctor tells you to , talk to your doctor . if possible , take these medicines with a meal
like all medicines , this medicine can cause side effects , although not everybody gets them . when daklinza is used in combination with sofosbuvir or ribavirin , the following side effects have been reported : very common ( may affect more than 1 in 10 people ): headache fatigue common ( might affect up to 1 in every 10 people ) difficulty sleeping dizziness migraine nausea ( feeling sick ) diarrhoea abdominal pain joint pain aching or tender muscles when dakinza is given in combination of sofosebuvir and ribavir the following other side effects are reported : common ( likely to affect up in
what daklinza contains the active substance is daclatasvir . each film - coated tablet contains 30 mg or 60 mg of daclasvir ( as dihydrochloride ). the other ingredients are : tablet core : anhydrous lactose , microcrystalline cellulose , croscarmellose sodium , silicon dioxide , magnesium stearate , hypromellose , titanium dioxide ( e171 ), macrogol 400 , indigo carmine aluminum lake ( e132 ), yellow iron oxide ( e172 ) 51 what daklineza looks like and contents of the pack 30 mg film
proquad is a vaccine that helps protect against measles , mumps , rubella and chickenpox ( varicella ) viruses . when a person is given the vaccine , the immune system ( the body ' s natural defence system ) will produce antibodies against the measles , rubles , rubell and varicelluses . the antibodies help to prevent diseases caused by these viruses . proquad is given to adults and adolescents aged 9 years and older who have already received national vaccination schedules containing measles , with or without live viruses . it is given in two different types : measles , which may be associated with mumps and rubella
do not use proquad if you are allergic to any varicella vaccine , measles , mumps or rubella vaccine , or any of the other ingredients of this vaccine ( listed in section 6 ) if you have been given neomycin if you suffer from a blood disorder or type of cancer that affects the immune system , treatment with medications that weaken the immunesystem , including low - dose corticosteroid therapy if you know you have asthma or replacement therapy if your doctor thinks you have a weakened immune system if you do not have a disease ( including aids ) that suppresses your immune system ( congenital or hereditary immunod
proquad is given as an injection into the muscle or under the skin ( usually in the thigh or upper arm ). injections will be given into the upper muscle ( usually the thigh area ) or upper upper arm . if you have a blood clotting disorder or low levels of platelets , the vaccine should not be given under the sun . bleeding may occur after injection into a muscle . proquad is injected into a blood vessel . prorant is given to infants and children from 9 weeks of age and adolescents from 12 years of age . it is given for the treatment of chickenpox and measles . pro quad is given every 12 weeks to
like all vaccines and medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions ( hives ) these reactions may cause difficulty in breathing or swallowing . if you have an allergic reaction , contact your doctor immediately . other side effects that have been reported with proquad include : uncommon ( may affect up to 1 in 100 people ): seizures ( fits ) and a fever rare ( may effect up to1 in 1 , 000 people ): bronchiolitis ( difficulty breathing , cough , unsteadiness with walking ). other side side effects reported with the use of proquad are : very common ( may affects more than
what proquad contains the active substances are : measles virus1 , edmonston strain , 3 . 00 mg mumps virus1 ( jeryllynnâ¢ level b ) strain , 4 . 30 mg rubella virus2 , strain , 6 . 00mg varicella virus3 , merck strain , 9 . 99 mg merck . the other ingredients are : tissue culture : plaque - forming units ( mrc ), 1 , 2 , 3 , 4 , 5 , 6 , 8 , chickembryo cells , fibroblasts ( mcc ). the other ingredient is : powder sucrose , hydrolysed gelatin ,
jylamvo is a substance that is absorbed by the body and is an anticancer medicine which reduces unwanted reactions . it is an immunosuppressive agent . by reducing the inflammatory effect jylamo is used to treat rheumatic and skin diseases : active rheumatoid arthritis ( where the polyarthritic forms of the joints are damaged ) severe juvenile idiopathic arthritis ( jia ) in children 3 years of age and older . it has been given to you by your doctor to reduce the use of non - steroidal anti - inflammatory drugs ( nsaids ) in adults with inadequate o severe or
do not use jylamvo if you are allergic to methotrexate or any of the other ingredients of this medicine ( listed in section 6 ) if you have a severe kidney impairment if you suffer from a liver impairment if your doctor has told you that you have blood disorders such as bone marrow hypoplasia , leukopenia or thrombocytopenia if you know that you are suffering from significant anaemia 34 if you think you may have a weakened immune system if you still have a serious infection such as tuberculosis or hiv if you develop ulcers in the stomach or intestines if you experience an
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . jylamvo can cause severe side effects , sometimes leading to even death . your doctor will discuss these with you and will adjust the dose and duration of the treatment . rheumatoid arthritis , severe juvenile idiopathic arthritis , and severe psoriasis , in combination with severe psoriatic arthritis , jylimvo is used as a long - term treatment . jymlamvo is also used for rheumatic and skin diseases , such as jia , psorism and ps
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience : wheeziness , difficulty in breathing , swelling of the eyelids , face or lips , rash or itching , especially affecting your whole body . other possible side effects include breathing problems , feeling of illness , dry , irritating cough , shortness of breath , difficulty or breathing , chest pain ( fever ), spitting or coughing blood , serious peeling or blistering of the skin unusual bleeding ( vomiting blood ), bruising nose bleeds nausea , vomiting , abdominal discomfort , severe diarrhoea mouth ulcers , black or t
keep this medicine out of the sight and reach of children . do not use the medicine after the expiry date which is stated on the carton and vial after exp . the exp date refers to the last day of that month . do store below 25 . do this to protect the medicine from accidental spillage . after reconstitution , the product should be used within 3 hours . any unused medicine or waste material should be disposed of in accordance with local requirements for cytotoxic products .
what jylamvo contains - the active substance is methotrexate . each ml of solution contains 2 mg of methotRexate . - the other ingredients are macrogol 400 , glycerol , orange flavour , sucralose , ethyl parahydroxybenzoate ( e218 ), sodium methyl parahhydroxybenzzoate (( e218 )), citric acid , tri - sodium citrate , purified water ( see section 2 " jylimvo contains ethyl parahydroxy benzoate and sodium methyl parahydrobenzozoate "). what jyarmvo looks
what enurev breezhaler is this medicine contains a substance called glycopyrronium bromide . this belongs to a group of medicines called bronchodilators . what enurevo breez inhaler is used for this medicine is used to help adults and children with breathing difficulties when they have a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways tighten , making breathing difficult . this medicine prevents this tightening of these muscles in the lungs , making it easier for air to get in and out of the lungs . this helps to reduce the effects of this
do not use enurev breezhaler - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have kidney problems . - if the doctor has given you an eye problem called narrow - angle glaucoma ( difficulty passing urine ). warnings and precautions talk to your doctor or pharmacist before treatment with enurevi breez inhaler : if you have any of these conditions , stop using this medicine and tell your doctor immediately : - tightness of the chest , coughing , wheezing
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose is one inhaler once a day . this medicine is for inhalation use . you should use this for 24 hours at a temperature of 75 to 75 Âºc . do not use this product if you notice that the capsules are not clear or have particles in them . how to use this medicinal product comes as an inhaler and capsules ( in blisters ) that contain the medicine . the medicine is inhaled using inhalation powder . the capsules should be swallowed whole with
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious : uncommon ( may affect up to 1 in 100 people ) irregular heart beat high level of blood sugar ( hyperglycaemia ) typical symptoms are excessive thirst , hunger ( frequent urination ), rash , itching , hives , difficulty breathing or swallowing , dizziness . allergic reaction including swelling mainly of the tongue , lips , face or throat ( angioedema ). if any of the side effects gets serious , tell your doctor . some possible side effects ( frequency cannot be estimated from the available data ) are listed below
what enurev breezhaler contains - the active substance is glycopyrronium bromide . each capsule contains 63 micrograms glycopyroniumbromide equivalent to 50 microgram glycopYRronium . - the delivered dose that leaves the mouthpiece of the inhaler is 44 microgram of glycopyrsronium per inhalation dose . - other ingredients of the powder are lactose monohydrate and magnesium stearate . what enurevan breez inhaler looks like and contents of the pack enurevo breezker 44 microlitre inhalation powder is a white powder
what riximyo is riximusyo contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to a target in a type called a white blood cell called " b - lymphocyte ". when ritukimab sticks to the target of this cell , it stops the cell from growing and dividing . what rixima is used for rixiemyo is used to treat adults with two different types of cancer : a ) non - hodgkin ' s lymphoma this is usually a disease of the lymph tissue . it affects
do not use riximyo if you are allergic to rituximab , other proteins that are derived from ritukimab or any of the other ingredients of this medicine ( listed in section 6 ). if you have a severe active infection at the moment . if you suffer from a weak immune system . if your doctor has told you that you have severe heart failure or severe uncontrolled heart disease . if any of these apply to you , tell your doctor . warnings and precautions talk to your doctor before using riximusyo : if you currently have a condition that increases the risk of getting granulomatosis ,
your doctor will decide how much riximyo you will receive and how often you will need this treatment . always use this medicine exactly as your doctor has told you . check with your doctor if you are not sure . if you have any side effects , your doctor may decide to change your dose . riximusyo is given as a drip ( intra - venous infusion ). medicines given before each riximeyo administration you will be given rixamyo together with other medicines ( premedication ) to reduce the risk of side effects . your doctor will determine the dose you need and will adjust your dose depending on how
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . some of these reactions have been fatal . infusion reactions during the first 24 hours of the infusion you may experience fever , chills , shivering , pain at the infusion site , blisters , itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat discomfort , tongue or throat swelling , itchy , runny nose , vomiting , flushing , palpitations , heart attack , low number of plate
what riximyo contains the active substance is rituximab . each 10 ml vial contains 100 mg of ritukimab in 10 ml . each 50 ml vials contains 500 mg of the active substances . the other ingredients are : ritiumimab 10 mg : sodium citrate , polysorbate 80 , sodium chloride , sodium hydroxide , hydrochloric acid ( see section 2 " rixima contains sodium "). what rixamyo looks like and contents of the pack riximusyo is a clear , colourless to slightly yellowish solution for infusion . it is
topotecan actavis contains the active substance topotecin . topotecaan actis is used to treat small cell lung cancer that has come back after chemotherapy . it is also used to prevent advanced cervical cancer that cannot be removed by surgery or radiotherapy . in this case topotican acti treatment is combined with medicines containing cisplatin .
do not use topotecan actavis - if you are allergic to topotecaan or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using topotocan actis . your doctor will check your blood cell counts and may decide if they are too low . do not use more topotican actez than your doctor has recommended . if you have any kidney problems , tell your doctor before using more toprotecanactavis . if any of these apply to you , tell the doctor before you are given topotot
your doctor will determine the dose of topotecan actavis you will receive based on your age and the disease being treated . your doctor will also carry out blood tests before you start treatment and regularly during treatment . the usual dose for adults small cell lung cancer : 1 . 5 mg per square metre of body surface area for the first 5 days of this treatment cycle . for cervical cancer : 0 . 75 mg per sq metre of surface area , for the second 3 days of the treatment cycle and for cervical disease when combined with another anticancer medicines , cisplatin . cisplin is used to treat patients with impaired kidney function
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious sideeffects : infections ( very common , may affect more than 1 in 10 people ): fever . this is a sign of your general condition . local symptoms may include sore throat , burning sensation , severe stomach pain , fever , diarrhoea and bowel inflammation ( neutropenic colitis ). topotecan actavis may reduce your ability to fight infections . lung inflammation ( rare , may effect up to 1 in 1 , 000 people ): difficulty in breathing , cough and
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . the expiratory date refers to the last day of that month . keep the vials in the outer carton in order to protect from light . reconstitution and dilution chemical and physical in - use stability has been demonstrated for 24 hours at 25 and 2 to 8 , when stored in a refrigerator ( 2 to 9 ). the drug product solution for dilution in solutions for infusion ( nacl 0 . 9 %) has been stored
what topotecan actavis contains the active substance is topotecaan . each vial contains 1 mg or 4 mg topotican ( as hydrochloride ). after reconstitution 1 ml contains 1mg topotan . the other ingredients are mannitol ( e421 ), tartaric acid , hydrochloric acid and sodium hydroxide . what topotnican actis looks like and contents of the pack topottecan acti is supplied in glass vials with grey bromobutylic stopper and aluminium seals with plastic flip - off caps and a protective sleeve . pack sizes
the active substance of rivastigmine hexal is rivustigmine . rivestigmine belongs to a class of substances called cholinesterase inhibitors . in patients with alzheimer ' s dementia or dementia due to parkinson ' s disease , certain nerve cells die in the brain , resulting in low levels of the neurotransmitter acetylcholine ( a substance that allows nerve cells to communicate with each other ). rivasta works by blocking the enzymes that break down acetyl acetylCHoline : acetylchlorolinescerase and butyrylcholinesternase . by
do not take rivastigmine hexal - if you are allergic to rivasta ( the active substance in rivostigminehexal ) or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have a previous skin reaction ( allergic contact dermatitis ). warnings and precautions talk to your doctor or pharmacist before taking rivstigmine Hexal . if any of these apply to you , tell your doctor before taking the medicine . warnings and risks talk to the doctor or nurse before taking any of your following : - if any patient has irregular or
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how to start treatment your doctor will tell you what dose of rivastigmine hexal to take . treatment usually starts with a low dose . depending on how you respond to treatment , the highest dose may be 6 . 0 mg twice a day . your doctor may also increase your dose depending on your weight . your dose will depend on your general condition and your response to this medicine . if you take more rivasta hexal than you should if you have taken more rvastigmin hex
like all medicines , this medicine can cause side effects , although not everybody gets them . you may experience side effects more often when you start your medicine or when your dose is increased . the side effects listed below have been observed with rivastigmine hexal : very common ( may affect more than 1 in 10 people ) feeling dizzy loss of appetite stomach problems such as feeling sick ( nausea ) or being sick ( vomiting ) diarrhoea common ( might affect up to 1 in every 10 people ): anxiety sweating headache heartburn weight loss stomach pain feeling agitated feeling tired or weak generally feeling unwell trembling or feeling confused decreased appetite
keep out of the reach and sight of children . do not use rivastigmine hexal after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 30 . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what rivastigmine hexal contains 64 the active substance is rivastaigmine hydrogen tartrate . the other ingredients are hypromellose , magnesium stearate , microcrystalline cellulose , colloidal anhydrous silica , gelatin , yellow iron oxide red iron oxide ( e172 ), titanium dioxide ( e171 ), shellac . each rivustigminehexal 1 . 5 mg capsule contains 1 . 95 mg of rivostigmine . each vial of each ritastigmin hexal 3 mg capsule releases 3 mg of the active ingredient in each riustig
cabometyx is a cancer medicine that contains the active substance cabozantinib . it is used to treat kidney cancer ( renal cell carcinoma ) or liver cancer that has spread to other organs . it can be given alone or in combination with a specific anticancer medicine containing sorafenib . what cabometyx does cabometx works by blocking the action of proteins called receptor tyrosine kinases ( rtks ), which are involved in the development of new blood vessels . by blocking these proteins , cabomety can block the action and kill high amounts in cancer cells . if you have any questions about
do not take cabometyx 45 - if you are allergic to cabozantinib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking cabomety : - if your doctor has told you that you have high blood pressure - if the doctor has recently told you you have an aneurysm ( enlargement or weakening of a blood vessel wall ) or a tear in a blood valve wall - if diarrhoea has been reported - if any of these apply to you - if a recent occurrence of significant bleeding - if surgery has taken place
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will determine the correct dose of this medicine and will adjust your dose depending on your condition . your treatment should be started as soon as possible , if you experience no signs of serious side effects . your dose may be adjusted depending on how you respond to treatment . the recommended starting dose of cabometyx is 60 mg once a day . you should take cabometometyx once a morning , twice a day for 2 hours . you may take cabostyx for 1 hour before breakfast . the medicine should
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with cabometyx and other medicines : tell your doctor or nurse straight away if your side effects become serious . tell your healthcare professional straight away : if you notice any of the following serious side effects you may need urgent medical treatment : symptoms include pain in the abdomen ( nausea ), vomiting , constipation , fever , and a gastrointestinal perforation ( a hole that develops in the stomach or intestine ). severe or uncontrollable bleeding . symptoms include vomiting blood , black stolls , bloody urine , headache , coughing up blood ,
what cabometyx contains the active substance is cabozantinib ( s )- malate . cabometx 20 mg tablets : each tablet contains cabozatinib_( s ) - malate equivalent to 20 mg cabozabab . cabostyx 40 mg tablets: each tablet contain cabozutinib - malates equivalent to 40 mg cabezantinab . each tablet of cabometometyx 60 mg tablets contains cabobozanthinib (s ) - talate equivalent of 60 mg caboxantinaf . the other ingredients are : tablet core : microcrystalline cellulose
pemetrexed hospira is a medicine used in the treatment of cancer . pemetrexED hospira in combination with cisplatin , another anti - cancer medicine , is used for treatment of malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , in adults who have not received prior chemotherapy . petrexed hospira in addition to cisplin is also used for the initial treatment of patients with advanced stage of lung cancer . when pemetreed hospiera is used in combination , you may be at greater risk of lungcancer if your disease has responded
do not use pemetrexed hospira - if you are allergic ( hypersensitive ) to pemetreed or any of the other ingredients of this medicine ( listed in section 6 ). - if breast - feeding is not possible during treatment with pemetemetrexED hospira . - if your child has recently received or is about to receive a vaccine against yellow fever . warnings and precautions talk to your doctor or pharmacist before using pemetretted hospir if you have or have ever had problems with your kidneys . before you receive pemetroed hospiar , your doctor will check before each infusion that your blood is
the recommended dose of pemetrexed hospira is 500 mg for every square metre of your body ' s surface area . your height and weight are measured to work out the surface area of your whole body . your doctor will work out this body surface area according to your weight and will adjust your dose and frequency of treatment depending on your blood cell counts and on your general condition . your healthcare professional will have mixed the pemetreed hospir powder with 9 mg / ml ( 0 . 9 %) sodium chloride solution before it is given to you . pemetemetrexED hospira will be given to your doctor by infusion
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : fever or infection ( common ): if you have a temperature of 38Âºc or greater , sweating or other signs of infection ( since you may have less white blood cells than normal which is very common ). infection ( sepsis ) may be severe and could lead to death . if you get chest pain ( common ) or have a fast heart rate ( common ). if you develop pain , redness , swelling or sores in your mouth ( very common ) allergic reaction : if you notice skin rash ( common
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . the expiratory date refers to the last day of that month . this medicine does not require any special storage conditions . reconstituted and infusion solution : the product should be used immediately . chemical and physical in - use stability of reconstituuted and infused solutions of pemetrexed were demonstrated for 24 hours at refrigerated temperature . the reconstuted solution should be administered immediately after preparation . parenteral medicines : the
what pemetrexed hospira contains the active substance is pemetre . pemetreyed hospir 100 mg : each vial contains 100 mg of pemetereed ( as pemetaled disodium hemipentahydrate ). pemetoxed hospiry 500 mg : one vial of 500 mg contains 500 mg of dispemetrexED ( as dispemetaled sodium hemipertahydrates ). pemrexedospira 1 , 000 mg : the active ingredient is petrexed . after reconstitution , the solution contains 25 mg / ml of pememetrexede . further
ganfort contains two active substances called bimatoprost and timolol which work together to reduce pressure in the eye . bimAToprost belongs to a group of medicines called prostamides , which work by interfering with a prostaglandin analogue . timolole belongs to medicines called beta - blockers . what ganfort is used for ganint is used in the back of the eye to deliver a clear , watery liquid into the eye ( glaucoma ). ganFort eye drops are used to reduce high pressure in an eye in adults with glaucera . ganant
do not use ganfort eye drops - if you are allergic to bimatoprost , timolol , beta - blockers or any of the other ingredients of this medicine ( listed in section 6 ) - if your child has respiratory problems such as asthma or severe chronic obstructive bronchitis - if he / she has severe lung disease - if the child has wheeziness or difficulty in breathing - if his / her child has long - standing cough - if they have heart problems - if their child has low heart rate - if there is a history of heart block or heart failure warnings and precautions talk to your doctor or
always use ganfort exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how to use treatment the bottle is for single use only . the bottle should be put into a neck pouch . how much to use 5 . 1 . wash your hands . do not touch your head . 2 . pull down your eyelid , which is closed by a small pocket . 3 . gently squeeze the bottle until the drops are in your eye . after treatment , 4 . gently press down on the lid of your eye ( picture 2 ). gently squeeze your eye with a finger until the drop is in
like all medicines , ganfort can cause side effects , although not everybody gets them . the drops can cause them . side effects of ganart ( multi - dose or single - dose ) are : very common side effects ( may affect more than 1 in 10 people ) the eye redness . common side side effects these may affect up to 1 in 9 people ( or 100 people ) of the eye burning , itching , stinging or irritation of the conjunctiva ( the transparent layer at the back of the coloured eye ), sensitivity to light , eye pain , sticky eyes , dry eyes , feeling of something in the eye ,
keep this medicine out of the sight and reach of children . do not use ganfort after the expiry date which is stated on the carton and on the label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . if you notice that the solution is not clear or contains particles , it should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 4 hours at 2 - 10 , unless dilution has taken place in controlled and validated
what ganfort contains - the active substance is bimatoprost ( 0 . 3 mg / 0 . 5 ml ) timolol ( 5 mg / ml ) and timolole maleate ( 6 . 8 mg / l ). - the other ingredients are benzalkonium chloride ( a preservative ), sodium chloride , sodium phosphate dibasic heptahydrate , citric acid monohydrate , purified water , hydrochloric acid and sodium hydroxide . what ganFort looks like and contents of the pack ganst is a clear to slightly yellow , clear , colourless to slightly brown
gefitinib mylan contains the active substance gefitinib . this protein is involved in the growth and spread of cancer cells . gefitoninib melan is used to treat adults with non - small cell lung cancer . this cancer is a disease in which malignant ( cancer ) cells form in the tissues of the lung .
do not take gefitinib mylan - if you are allergic to gefitoninib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking gefnitinib melan . - if your child has any other lung problems . some lung problems may get worse while taking gekitin ib mylan . tell your doctor if your baby has problems with your liver . children and adolescents do not give gefinib to children and teenagers under 18 years of age . other medicines and geftinib tell your
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 250 mg tablet once a day . you can take the tablet with or without food . you should take antacids on an empty stomach at least 2 hours before or 2 hours after food . the tablet can be taken with or just after a meal . take gefitinib mylan at about the same time each day . if you have trouble swallowing the tablet whole , you can crush it and mix it with any other liquids . the total recommended dose for adults is 20 mg
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following serious side effects you may need urgent medical treatment : allergic reaction with symptoms such as swollen face , lips , tongue or throat , difficulty to swallow , hives , nettle rash , difficulty breathing , serious breathlessness , sudden worsening breathlessness with a cough or fever . these may be signs of an inflammation of the lungs called ' interstitial lung disease ' ( i . e . uncommon may affect up to 1 in 100 people ). gefitinib may cause severe skin reactions affecting your
what gefitinib mylan contains - the active substance is gefinib . each film - coated tablet contains 250 mg of gefiib . - the other ingredients are lactose monohydrate , microcrystalline cellulose , crospovidone ( type a ), povidon ( k30 ), sodium laurilsulfate , magnesium stearate . - in the tablet coating are polyvinyl alcohol , macrogol 4000 , titanium dioxide ( e171 ), red iron oxide ( e172 ) and yellow iron oxide red ( e 172 ). what gefitoninib melan looks
reblozyl contains the active substance luspatercept which is used to treat myelodysplastic syndromes ( mds ). mds is a condition where many different blood and bone marrow disorders occur and red blood cells become abnormal . signs and symptoms include a low red blood cell count and anaemia . red blood infusion is usually given to patients with mds who cannot receive red bloodcell transfusions . reblozey is used in adults to treat anaemia associated with md and who cannot be given red blood stem cell transplusions ( erythropoietin therapies ) in patients with beta -
do not take reblozyl if you are allergic to luspatercept or any of the other ingredients of this medicine ( listed in section 6 ) if you think you may be pregnant ( see pregnancy section ). warnings and precautions talk to your doctor before taking this medicine if you have thalassaemia ( a condition where your spleen removed ) or have had a blood clot . if you receive hormone replacement therapy after a previous blood clot , your doctor may recommend preventive measures ( including medicines used to prevent a blood clot ). if you suffer from high blood pressure , your dose of reblazyl may need to be
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will carry out blood tests to make sure that you are fully protected . how much reblozyl is given the recommended dose of rebl ozyl is one injection under the skin . your dose will depend on how much you weigh . the injections will usually be given in the morning and evening . the recommended starting dose is 1 . 0 mg for every kg of body weight . your physician may increase your dose if this dose is not used at the right time , depending on your blood pressure . how
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor immediately if you experience : difficulty in walking or speaking , dizziness , loss of balance and coordination , numbness or paralysis in the face , leg or arm , or blurred vision . these may be symptoms of a stroke . blood clots swelling in the area around the eyes , face , lips , mouth or tongue and throat allergic reactions with rashes 36 reporting of side effects if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . very common
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after reconstitution , reblozyl may be stored at room temperature ( up to 8 ) for up to 25 hours or at room temperatures ( up up to 24 ) for a single period of 2 weeks . do away with any unused medicinal product or waste material . ask your pharmacist how to throw away medicines you no longer
what reblozyl contains the active substance is luspatercept . each ml of solution contains 25 mg or 75 mg of luspormcept . after reconstitution , each mlof solution contains 50 mg of the active ingredient luspaterscept . the other ingredients are excipients , citric acid monohydrate , sodium citrate 80 , sucrose , hydrochloric acid ( for ph adjustment ), sodium hydroxide ( for pct adjustment ). what rebl ozyl looks like and contents of the pack reblizyl is a white to off - white powder . reblazyl is supplied in v
fotivda contains the active substance tivozanib , a protein kinase inhibitor . tiv zanib works by stopping the growth of the cancer . it stops the growth and spread of cancer cells by blocking new blood vessels . fotivd is used in adults with advanced kidney cancer when other treatments ( alpha or interleukin - 2 ) have not helped to stop your disease or have not worked .
do not take fotivda - if you are allergic to tivozanib or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you are taking st . john ' s wort ( hypericum perforatum ), a herbal remedy used for depression and anxiety . warnings and precautions talk to your doctor before taking fotiveda . high blood pressure tell your doctor if you think any of these apply to you . fotiva may raise your blood pressure . your doctor will test your blood blood pressure before you start taking a medicine . fotalda may lower
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of fotivda is 1340 mg once a day for 21 days ( 7 days ). you will take 1 capsule of capsules in the morning and 4 capsules in a night . do not take more than the recommended dosage of fofivda once a night , as this may cause unacceptable side effects . if you experience severe side effects , stop taking fotivada therapy and contact your doctor . the usual daily dose of the fotive diet is 890 mg once daily for 21
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects high blood pressure is a very common side effect ( may affect more than 1 in 10 people ). if you notice any of the following , talk to your doctor or pharmacist immediately : high bloodpressure : symptoms include severe headaches , blurred vision , shortness of breath , changes in your mental state , feeling anxious , confused or disorientated . your doctor may want to lower your blood pressure . fotivda is used to treat high blood hypertension in adults . your healthcare professional will prescribe a medicine to treat your high blood blood pressure
what fotivda contains the active substance of fotivex is tivozanib . each tablet contains 890 mg of tivzanib ( as tiv ozanib hydrochloride monohydrate ). the other ingredients are : tablet core : 890mg tivuzanib , mannitol , magnesium stearate , gelatin , titanium dioxide ( e171 ), indigo carmine ( e132 ), yellow iron oxide ( e172 ), propylene glycol ( e1520 ) and strong ammonia solution ( titanium dioxide , e171 ). tablet coating : tartrazine aluminium lake ( e129
stribild contains two active substances : elvitegravir , an antiretroviral medicine known as an integrase inhibitor cobicistat , which acts as a booster ( pharmacokinetic enhancer ) of the levels of elvitesgravira emtricitabine , an antiviral medicine ( known as a nucleoside reverse transcriptase inhibitor or nrti ) tenofovir disoproxil , an antitroviral medication known as known as " a nucleotide reverse transcriptases inhibitor ". stribild is given as a single tablet regimen for the treatment of human immunod
do not take stribild - if you are allergic to elvitegravir , cobicistat , emtricitabine , tenofovir , ten ofovir disoproxil or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before taking stribil . during treatment , you should tell your doctor if you have ever taken any medicine containing tenofoviir disopicroxil . your doctor may also check your kidney function and may change your dose of these medicines . alfuzosin ( used to treat an enlarged prostate
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . adults and adolescents 12 to less than 18 years of age 35 the recommended dose is one tablet once a day by mouth . you should take your medicine at the same time each day . your doctor may change the dose or stop the treatment if you take medicines ( oral supplements , antacids , laxatives containing minerals , magnesium , aluminium , calcium , iron , zinc ) that lower your blood sugar . take the tablet at least 4 hours before or at least one hour after food . swallow the tablet whole with
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of bloodlipids sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everybody gets them . when treating hiv infection , it is not always possible to tell whether the unwanted effects of stribild are caused by the hiva disease itself or by the medicines themselves , but serious side effects can occur . tell your doctor immediately if you experience any of the following
what stribild contains the active substances are elvitegravir , cobicistat , emtricitabine and tenofovir disoproxil . each stribil film - coated tablet contains 150 mg elvitesgravira , 150 mg cobicista , 200 mg emtracitabin , 245 mg tenofovegravor disoprocessil and 300 mg ten ofovir desoproxel fumarate . each tablet contains 136 mg ten Ofovir . the other ingredients are : tablet core : croscarmellose sodium , hydroxyprop
zyprexa contains the active substance olanzapine . zyprexa belongs to a group of medicines called antipsychotics and is used to treat the following conditions : schizophrenia , a disease with symptoms such as hearing , seeing or sensing things which are not there , mistaken beliefs , unusual suspiciousness , and becoming withdrawn . people with this disease may also feel depressed , anxious or tense . moderate to severe manic episodes , a condition with symptoms of excitement or euphoria . zzyprex has been shown to prevent recurrence of these symptoms in patients with bipolar disorder whose manic episode has responded to olan zapine treatment
do not take zyprexa - if you are allergic ( hypersensitive ) to olanzapine or any of the other ingredients of this medicine ( listed in section 6 ). an allergic reaction may be recognised as a rash , itching , a swollen face , swollen lips or shortness of breath . - if your doctor has told you that you have eye problems such as certain kinds of glaucoma ( increased pressure in the eye ). warnings and precautions talk to your doctor or pharmacist before taking zyprixa . zypitxa is not recommended for use in elderly patients with dementia because it may have serious side
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . zyprexa tablets should be taken once a day . you should take zypxa between 5 and 20 mg once a morning . your doctor may increase your dose if your symptoms return or if you feel better . swallow the tablets whole with a glass of water . do not chew or crush them . zzyprexa can be taken with or without food . you can take your zypitxa tablets with or just after food . it is important that you take your tablets at the same time each
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience : unusual movement ( a common side effect that may affect up to 1 in 10 people ) mainly of the face or tongue ; blood clots in the veins ( a rare side effect which may affect upto 1 in 100 people ) especially in the legs ( symptoms include swelling , pain , and redness in the leg ), which may travel through blood vessels to the lungs causing chest pain and difficulty in breathing . if you notice any of these symptoms seek medical advice immediately ; a combination of fever , faster breathing , sweating
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . zyprexa should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what zyprexa contains - the active substance is olanzapine . each zyprixa tablet contains 2 . 5 mg , 5 mg or 7 . 5mg , 10 mg , 15 mg or 20 mg of olanza . - the other ingredients are lactose monohydrate , hyprolose , crospovidone , microcrystalline cellulose , magnesium stearate , hypromellose , titanium dioxide ( e171 ), carnauba wax . the different zypyxa tablet strengths are : - zy prexa 2 . 4 mg , 6 mg , 7 . 4mg
what prolia is prolia contains denosumab , a protein ( monoclonal antibody ) that is similar to another protein that is produced naturally in the body . it is used to prevent bone loss in adult patients with osteoporosis when treatment is not suitable . prolia helps to make bone stronger by making it easier for bone to break . it reduces the amount of oestrogen that is made by the bones . this helps to prevent bones from becoming thin and fragile . what osteopORosis is osteoporeosis is caused by the lack of testosterone in the blood . when osteopoorosis is
do not use prolia if you have low calcium levels in the blood ( hypocalcaemia ). if you are allergic to denosumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using prolia . if you think any of these apply to you , tell your doctor before using this medicine . if any of them apply to your child , tell the doctor or nurse before using it . warnings and symptoms talk to the doctor before starting prolia : if you develop a skin infection with symptoms such as a swollen , red area of skin ( usually
what prolia is prolia contains one pre - filled syringe with 60 ml of solution for injection , which should be given within 6 hours . it is given as a single injection under the skin ( subcutaneous ) in the front of your thighs , abdomen or upper arm . you can inject prolia with or without stickers . you should take calcium and vitamin d supplements at the same time as you are taking prolia . how prolia works prolia comes as a clear , colourless solution . it can be given either once or twice a day . you will receive injections for 6 hours after the last injection . if you use
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking prolia and see a doctor immediately if you develop skin infections ( cellulitis ). if you have any of these symptoms while taking prolium : - swollen , red area of skin , usually in the leg , which feels hot and tender . - symptoms of fever ( see section 2 ). if any of the above apply to you , tell your doctor before taking proleria : - pain in the mouth and / or jaw , swelling or non - healing of sores in themouth or jaw ( discharge , numbness , feeling of heaviness or
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . you may remove your pre - filled syringe from the refrigerator and store it at room temperature ( not above 25 ) for a single period of maximum three months . after the injection , the pen may be stored at room temperatures ( not below 25 ) or below 30
what prolia contains - the active substance is denosumab . each ml of solution contains 1 mg or 60 mg of denosumaab ( 60 mg / ml ). - the other ingredients are acetic acid , glacial , sodium hydroxide , sorbitol ( e420 ), polysorbate 20 and water for injections . what prolia looks like and contents of the pack prolia is a clear to slightly yellow solution for injection in a pre - filled syringe with a needle guard .
what ambirix is ambirrix is a vaccine used to protect adults and children from 1 to 15 years of age against two diseases : hepatitis a and hepatitis b . infection with the hepatitis a virus causes the liver to become swollen and inflamed . the virus can also cause the virus to infect faeces , serum or saliva . symptoms usually occur 3 to 6 weeks after infection . if you feel sick , have a fever , aches or pains , feel very tired , dark urine , pale faececes or yellowish skin or eyes ( jaundice ). the severity and type of symptoms can vary from person to person
you must not be given ambirix if you are allergic to ambirax or any of the other ingredients of this vaccine ( listed in section 6 ). signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of your face or tongue . if you have an allergic response to any vaccine , including hepatitis a or hepatitis b diseases . if any of these apply to you , tell your doctor straight away . if a severe infection with a high temperature has been reported , the vaccine should be given at the same time . a minor infection such as a cold should not be a problem . warnings and precautions talk
your doctor or nurse will give you ambirix as an injection into the muscle of your upper arm . ambirux will be given into a vein . the injection will be injected into the thigh muscle . you will receive a total of two injections . the injections will be repeated within 12 months . you may receive the first injection at the same time and the second injection between 6 and 12 months after the first . if you miss an appointment for the first dose , ask your doctor when to schedule your next scheduled injection . if it is not possible to schedule the second dose , you may be given two injections at the usual time . if
like all medicines , this vaccine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side side effects you may need urgent medical treatment : allergic and anaphylactic reactions . the signs may include a rash , itchy , blistering , swelling of the eyes and face , difficulty in breathing or swallowing , a sudden drop in blood pressure and loss of consciousness . other side effects reported in clinical trials with ambirix were : common ( may affect up to 1 in 10 people ): headache loss of appetite feeling tired irritable pain or redness where the
what ambirix contains 26 the active substance is hepatitis a virus . 1 ml solution contains 720 micrograms of elisa units ( equivalent to 0 . 05 mg / ml ). the other ingredients are : hepatitis b surface antigen 20 microgram ( mrc ) cells , aluminium hydroxide , hydrated in 0 . 04 ml , saccharomyces cerevisiae , aluminium phosphate in 0. 4 ml , sodium chloride and water for injections . what ambirax looks like and contents of the pack suspension for injection in a pre - filled syringe . ambirood is a white , slightly milky liquid . each pack
what bexsero is bex serumo is a meningococcal group b vaccine . what bex sero is used for bexsoro is given to adults , adolescents and children aged 2 years and older who have a disease caused by the neisseria meningitidis group b bacteria . these bacteria cause infections ( such as meningitis , inflammation of the brain and spinal cord ) and sepsis ( blood poisoning ). the vaccine works by helping your body to produce its own protection ( antibodies ) against the disease .
do not use bexsero if you are allergic to any of the ingredients of this vaccine or any of those listed in section 6 ). warnings and precautions talk to your doctor or nurse before using bex serumo if : you have a severe infection with a high temperature . vaccination should be postponed until you have recovered from a minor infection such as a cold . your doctor may decide to delay vaccination if you have haemophilia a or any other problem that may prevent your blood from clotting properly . you are using blood thinners ( anticoagulants ) as part of treatment for the immune system ( eculiz
your doctor or nurse will give you bexsero at the recommended dose . the recommended doses are 5 micrograms given into a muscle ( usually the thigh or upper arm ). injections will be given at least 2 weeks apart . the first dose will be administered at least 5 days apart . after three injections , the vaccine may be given as an additional injection ( booster ). the first injection will be made at least 1 month apart . if the interval between injections is longer than 2 months , the dose may be adjusted . if you are given more bex serumo than you should if you have received more than one injection , the doctor
like all vaccines , this vaccine can cause side effects , although not everybody gets them . stop using bexsero and see a doctor immediately if you notice any of the following side effects : very common ( may affect more than 1 in 10 people ): pain / tenderness at the injection site , redness of the skin at the site of injection , swelling of theskin at the place of injection site hardness of the area of the injection at the area where the injection is injected . if any of these side effects occur , stop using this vaccine and tell your doctor immediately . common ( might affect up to 1 in every 10 people )
what bexsero contains the active substances are recombinant neisseria meningitidis group b nhba fusion protein 1 , 2 , 3 and 50 micrograms recombinant nisseria maningitidi group b noada protein 1 and 2 , 2 and 3 50 microgna produced in recombinant neoisseria meingitis group b fhbp fusion protein 3 and 3 , 50 micromgna produced by recombinant dna technology . the other ingredients are : recombinant e . coli cells ( e . g . maize ), aluminium hydroxide , nhb ( neisserial he
nitisinone mdk contains the active substance nitisinome . this medicine is used to treat a rare disease called hereditary tyrosinemia ( hdk ) in adults , adolescents and children aged 1 year and above . in this disease your body does not make enough of the amino acid tyrosine ( amino acids are substances that are important in building the body ). nitisinnone helps to reduce the amount of tyrosinine in the body and the harmful substances that can be produced . this helps to remove tyrosrine from your body by lowering the amount low tyrosines and phenylalanine (
do not take nitisinone mdk if you are allergic to nitisine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking this medicine . pregnancy and breast - feeding nitisinnone md k is not recommended for use in children . your doctor will check your eyes regularly during nitisginone treatment . if you develop red eyes , tell your doctor immediately . your physician may recommend an eye examination . if any of these apply to you , tell the doctor . eye problems due to inadequate dietary control ( see section 4 ) your doctor may
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage and duration of treatment your doctor will determine the dose of this medicine to be used for the disease ( hereditary tyrosinemia type 1 ). the recommended dose is 1 capsule for every kg of body weight taken orally once a day . the dose may be increased to 20 capsules once a daily . in this patient population , the dose is based on body weight . swallow the capsules whole with a small amount of water or formula diet . if you take more nitisinone mdk than you should if you
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . store below 2 8 . store at a temperature not above 25 . do away with the blister . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what nitisinone mdk contains the active substance is nitisino . nitisinnone md k 2 mg : each capsule contains 2 mg nitisine . nisinone MDk 5 mg : one capsule contains 5 mg nisine . each capsule of nitishinone mdks 10 mg : two capsules contain 10 mg ninone . the other ingredients are gelatin , titanium dioxide ( e171 ), black iron oxide ( e172 ), shellac glaze . what nitisginone mdK looks like and contents of the pack nitisatinone mdky capsules are 15 . 7 mm long , hard
what docetaxel accord is docetxel accord contains the active substance docetacel . docetaceel belongs to the group of anti - cancer medicines called taxoids . docelaxel accord has been prescribed by your doctor for the treatment of breast cancer , special forms of lung cancer ( non - small cell lung cancer ), prostate cancer , gastric cancer and head and neck cancer : - for the diagnosis of advanced breast cancer : docetailel could be administered either alone or in combination with doxorubicin , or trastuzumab , or capecitabine . - for
do not use docetaxel accord - if you are allergic ( hypersensitive ) to docetxel or any of the other ingredients of docetixel accord ( listed in section 6 ) - if your number of white blood cells is too low - if there is a severe liver disease warnings and precautions before you are given docetacord , you will have blood tests to check that you have enough blood cells and sufficient liver function to receive docetaceel accord . white blood cell disturbances may cause fever and infections . tell your doctor immediately if you have abdominal pain , tenderness , diarrhoea , rectal ha
docetaxel accord will be given to you by a healthcare professional . the dose will depend on your weight and your general condition . your doctor will calculate your body surface area in square meters ( mÂ² ) and will determine your dose . method and route of administration docetaxell accord will usually be given by infusion into one of your veins . the infusion will last approximately one hour during which you will be in the hospital . frequency of administration you should usually receive your infusion once every 3 weeks . your dose may be adjusted by your doctor based on your blood tests and yourgeneral condition . in particular , docetacel accord
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss these with you and will explain the potential risks and benefits of your treatment . the most commonly reported adverse reactions of docetaxel accord are reduction in the number of red blood cells and white blood cells , alopecia , nausea , vomiting , sores in the mouth , diarrhoea and tiredness . the severity of adverse events of docelaxel alone may be increased when docetacel is given in combination with other chemotherapeutic agents . during the infusion , allergic reactions ( may affect up to
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the exp date refers to the last day of that month . store below 25 . store in the original package in order to protect from light . the vial is for single use only . after dilution , the medicine should be transferred from the infusion bag to the infusion vial and stored for 6 hours below 25 ( in non - pvc bags ). the infusion solution should be used within 6 hours of dilution . do away with the vials and v
what docetaxel accord contains - the active substance is docetacel . each ml of concentrate for solution for infusion contains 20 mg docetagel . 1 vial of concentrate contains 20mg docetapel . 4 vials of concentrate contain 80 mg docelaxel . 8 vials ( 8 ml ) of concentrate ( 160 mg docenaxel ). - the other ingredients are polysorbate 80 , ethanol anhydrous ( see section 2 " docetaceel accord is a concentrate for ethanol "), citric acid anhydrated ( see " docel accord and ethanol "). what doc
intuniv contains the active substance guanfacine . this medicine belongs to a group of medicines that affect the brain . this medicinal product stops the brain from working normally , allowing the brain to produce its own signals . this helps to reduce the amount of impulsive and hyperactive signals . your doctor has prescribed this medicine for you to help treat ' attention deficit hyperactivity disorder ' ( adhd ) in adults who are not receiving current stimulant medication . current medication is not controlling adhd symptoms . the medicine is used in combination with a treatment programme consisting of psychological therapy , educational therapy and social therapy . intuniv is used
do not take intuniv if you are allergic to guanfacine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking this medicine if you have low or high blood pressure . heart problems tell your doctor if you suffer from heart problems . you have ever fainted or have recently had thoughts or feelings of suicide . you are at risk of any other psychiatric conditions ( withdrawal symptoms ). increased heart rate . high bloodpressure . this medicine should not be used if you think you have these problems . children and adolescents intunv is not recommended for children
your treatment should be started and monitored by a doctor experienced in the treatment of adolescentbehavioural disorders . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet once a day . your doctor will determine the dose you need to take . the dose will depend on your condition and your response to your treatment . the starting dose is 1 tablet once daily . your dose will be gradually increased during treatment . this will be increased every 1 - 3 weeks . your daily dose will then be gradually decreased until the desired effect is achieved . the maximum
like all medicines , this medicine can cause side effects , although not everybody gets them . if you feel unwell , talk to your doctor or pharmacist straight away . your doctor may need to change your dose of your medicine . serious side effects tell your doctor straight away if you notice any of the following serious side side effects : feeling drowsy , feeling dizzy ( hypotension ), slow heart beat ( bradycardia ), feeling faint , loss of concentration ( syncope ), a serious withdrawal side effect with high blood pressure . symptoms include headaches , feeling confused , nervousness , agitation and tremors ( hypertensive encephalopathy
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister pack after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . the tablets should be used within the first week of opening the blister pack . do this if you notice any change in the appearance of the tablets . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what intuniv contains the active substance is guanfacine hydrochloride . 1 mg prolonged - release tablets : each prolonged -release tablet contains guanfuine . 2 mg prolonged release tablets ( 2 mg ): each prolonged prolonged - releases tablet contains 1 mg guanjuine . 3 mg prolonged prolonged release tablet ( 3 mg ): every prolonged - releasing tablet contains 3 mg guinfacine . 4 mg prolonged : each extended - release tablet contains 4 mg guaconfacine ( see section 2 ). the other ingredients are hypromellose 2208 , methacrylic acid - ethyl acrylate copolymer
ecalta contains the active substance anidulafungin and is used in adults ( from 1 to 18 years old ) to treat fungal infection in the blood or other internal organs ( invasive candidiasis ). it works by preventing the infection by stopping the growth of fungal cells called candida . ecalta belongs to a group of medicines called echinocandins . these medicines are used to treat serious fungal infections caused by the lack of fungillus fungal cell walls . ecalda is used when fungalcells have incomplete or defective cell walls , which may make them fragile and unable to grow .
do not use ecalta if you are allergic to anidulafungin , other echinocandins , caspofungin acetate or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or nurse before using ecaltra if you have liver function problems . your doctor may decide to reduce the dose of ecalten or stop your treatment with anaesthetics . your treatment may need to be delayed or stopped . if you think you may have an allergic reaction , such as itching , wheezing , blotchy skin , you should tell your doctor
the treatment will be given to you by a doctor or nurse . the recommended dose is 200 mg / 100 mg given once a week . the dose is 1 dose in every 18 weeks . the doctor will decide the dose that is right for you . the starting dose is 3 . 0 mg / 200 mg given every 1 . 5 weeks . your doctor will then increase the dose to 100 mg /100 mg given each week depending on the patient ' s weight . ecalta is given as a slow infusion ( a drip into a vein ) over a period of 1 . 4 to 3 hours . the loading dose will be adjusted by your
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following serious side effects : - threatening allergic reactions , including difficulty breathing or wheezing or an existing rash . ecalta can cause serious sideeffects , including convulsion ( seizure ), flushing , rash , pruritis ( itching ), hot flush , hives , sudden contraction of the muscles , wheezezing , coughing or difficulty of breathing other side effects very common side effects ( may affect more than 1 in 10 people ): - low blood potassium ( hypokalaemia ), diarrhoe
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . the reconstituted solution should be used immediately after dilution . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 - 10 . the infusion solution should not be stored at room temperature ( below 25 ) for longer
what ecalta contains - the active substance is anidulafungin . each vial of powder contains 100 mg of aniduafungan . - the other ingredients are mannitol , polysorbate 80 , tartaric acid , sodium hydroxide and hydrochloric acid 30 . what ecaltas looks like and contents of the pack ecaltfa is supplied as a box containing 1 vial containing 100 mg concentrate for solution for infusion . the powder is white to off - white .
adenovi contains the active substance rurioctocog alfa pegol , which is a copy of pegylated human coagulation factor viii ( human cogulation factor iii ). factor v iii is necessary for the blood to form clots and stop bleedings . in patients with haemophilia a , factor v viii is missing or not working properly . adynovi is used for the treatment and prevention of bleeding in patients 12 years of age and older with haemaophilia b , an inherited bleeding disorder caused by lack of factor v ii .
do not use adynovi - if you are allergic to rurioctocog alfa pegol , octocog aluminium or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor or pharmacist before using adynov : - if your child has had an anaphylactic reaction ( a severe , sudden allergic reaction ) to adyno . allergic reactions may include rash 95 , hives , wheals , generalised itching , swelling of lips and tongue , difficulty in breathing , wheez
treatment with adynovi will be started by a doctor experienced in the care of patients with haemophilia a . your doctor will decide how much adynov you need and will determine the dose you need . treatment of bleeding your doctor may decide to stop adynova or to start the replacement therapy with adnovi . adynoc is a life - long treatment . always use this medicine exactly as your doctor has told you . check with your doctor if you are not sure . prevention of bleeding the recommended dose of adyno is 40 mg once a day . your dose may be increased to 50 mg once daily for
like all medicines , this medicine can cause side effects , although not everybody gets them . sudden allergic reactions ( anaphylactic ) may occur within minutes of the injection . early symptoms of allergic reactions may include rash , hives , wheals , generalised itching , swelling of lips and tongue , difficulty in breathing , wheezing , tightness in the chest , feeling of being unwell , dizziness and loss of consciousness . if severe symptoms of difficulty in breath or fainting occur , prompt emergency treatment is needed . patients who have received previous treatment with factor viii ( more than 150 days of treatment ) inhibitor antibodies (
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . the powder vial may be stored at room temperature ( up to 30 ) for a single period of up to 3 months . do this medicine if it is not used within 3 months or if it has been stored at a temperature not above 30 for a longer period
what adynovi contains the active substance is rurioctocog alfa pegol ( pegylated human coagulation factor viii produced by recombinant dna technology ). each powder vial contains nominally 250 , 500 , 1000 or 2000 iu of ruricoctocag alfa peol . the solvent vial is provided with 5 ml sterilised water for injections . the other ingredients are mannitol , trehalose dihydrate , histidine , glutathion , sodium chloride , calcium chloride dihydrates , tris ( hydroxymethyl ) aminomethane ,
rekovelle contains follitropin delta , a follicle stimulating hormone that belongs to a group of hormones called gonadotropins . gonadotropicins are involved in female fertility and are present in assisted reproduction programs , in vitro fertilisation ( ivf ) and intracytoplasmic sperm injection . they work by helping the ovaries produce many egg sacs .
you should not be given this medicine if any of the following apply to you : - you have your fertility problems - you are allergic to follicle stimulating hormone or any of those other ingredients of this medicine ( listed in section 6 ) - you had a tumour in the uterus , ovaries , breasts , pituitary gland or hypothalamus - you now have enlarged ovaries or cysts on your ovaries - you suffer from polycystic ovarian disease ( bleeding from the vagina ) - have an early menopause - you may have malformations of the sexual organs ( see section " pregnancy and breast - feeding ")
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the rekovelle dose will be given as your first treatment cycle . your doctor will also give you anti - MÃ¼llerian hormone to stimulate your ovaries to produce more stimulation with gonadotropins . the dose will depend on the amount of medicine in your blood . your dose will also be calculated from your body weight . your physician will take a blood sample during the last 12 months to work out the dose you should receive . the total dose of rekole treatment will depend upon your bodyweight
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects caused by hormones that cause infertility have been reported in women taking this medicine . there may be a high level of activity in the ovaries . ovarian hyperstimulation syndrome ( symptoms include pain , discomfort , swelling of the abdomen ), nausea , vomiting , diarrhoea , weight gain , difficulty breathing . if you notice any of these symptoms , seek medical advice straight away . a side effect that may affect up to 1 in 10 women is headache . nausea ( ovarian hyper stimulation syndrome ) pelvic pain or discomfort ( ovarian origin tiredness ( fatigue
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . store at room temperature ( up to 25 ) for a single period of up to 3 months . after this period , the product should be used within 3 months or disposed of . however , if not used within 28 days , the solution should be stored at room temperatures ( up up to 30 ) and disposed of at the end of the 3 -
what rekovelle contains the active substance is follitropin delta . each multidose cartridge contains 12 mg of follitroin delta in 0 . 36 millilitre of solution . after dilution , each ml of solution contains 33 . 3 mg of the active ingredient follitrotin deltain each millilitere of solution ( corresponding to 12 mg follitruin delta per ml ). the other ingredients are phenol , polysorbate 20 , l - methionine , sodium sulphate decahydrate , disodium phosphate dodecahydrates , concentrated phosphoric acid , sodium hydrox
the active substances of revinty ellipta are fluticasone furoate and vilanterol . each inhalation of revminty elliptone contains flutic asone fureate and 92 mg vilancerol . the 22 mg / 22 mg inhalation dose is based on the following : - the daily dose of fluticAsone furyate is 184 mg / day , and vilterol 22 mg/ 22 mg is 92 / 22 . chronic obstructive pulmonary disease ( copd ) in adults and adolescents ( 12 years of age and older ) weighing 184 mg or more . asthma in adults
do not use revinty ellipta - if you are allergic to fluticasone furoate , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using revintchy ellipta . if you have liver disease , tell your doctor straight away if you notice any of these side effects . if your doctor determines that you have moderate or severe liver disease . the lower strength of revintty ellipta 92 / 22 mg / kg is recommended for patients with heart problems , high blood pressure , tuberculosis ( tb ) of the
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . asthma the usual dose for asthma is one inhalation twice a day ( one inhaler each day ). the dose should not exceed one inhalant of fluticasone furoate 22 mg twice a morning ( one tablet each day ), and should not be exceeded by the usual daily dose of vilanterol . copd the usual starting dose for copd is one aeration twice daily ( one and a half tablets each day ) with flutic asone firoate 22
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions to ellipta are rare ( may affect up to 1 in 1 , 000 people ). if you experience any of the following symptoms while using ellipta stop using this medicine and tell your doctor immediately : skin rash , hives , redness swelling , especially of the face or mouth ( angioedema ), feeling very wheezy or coughing , difficulty in breathing , feeling weak or light headed ( which may lead to collapse or loss of consciousness ) immediate breathing difficulties immediate breathing problems stop using revinty ellipta and tell a
what revinty ellipta contains the active substances are fluticasone furoate and vilanterol . each 92 micrograms inhalation delivers 92 microlitres of flutic asone firoate and 22 microlitre of vilanternol ( as trifenatate ). each 184 microgramS inhalation provides 184 microliters of flilitasonefuroate , and 22 milligrams of vilenatine . the other ingredients are lactose monohydrate ( see section 2 " revintchy ellipta is a powder for concentrate for solution for inhalation "), magnesium
atripla contains three active substances that are used to treat human immunodeficiency virus ( hiv ) infection : efavirenz , a non - nucleoside reverse transcriptase inhibitor ( nnrti ) emtricitabine , a nucleosides reverse transcriptases inhibitor ( tnrtis ) tenofovir , a nucleotide reverse transcript enzyme inhibitor (nnrtti ) these active substances are all taken together in antiretroviral medicines . they work by interfering with the activity of an enzyme ( reverse transcriptasing ) that is essential for the virus to multiply . at
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet taken by mouth once a day . take atripla on an empty stomach ( 1 to 2 hours apart ). some side effects may be more common , such as dizziness and drowsiness . if you take more atripola than you should if you accidentally take too many atripera tablets , contact your doctor immediately . if possible , take your tablets with you . atriplea can be taken with or without food . if a person accidentally takes too
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of bloodlipids sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects lactic acidosis ( excess lacticacid in the blood ) is rare ( may affect up to 1 in 1 , 000 people ). if you experience any of the following serious side effect , stop taking atripla and contact your doctor immediately :
what atripla contains the active substances are efavirenz , emtricitabine and tenofovir disoproxil . each atriblea film - coated tablet contains 600 mg efavairenz and 200 mg emtracitabin , corresponding to 245 mg of tenofiovir disopicroxil ( as fumarate ). the other ingredients are croscarmellose sodium , hyprolose , magnesium stearate , microcrystalline cellulose , sodium laurilsulfate ( see section 2 " atriplea contains sodium "). the
orgalutran contains ganirelix which belongs to a group of medicines called anti - gonadotrophin . the natural gonadodotrophine releasing hormone ( gnrh ) is produced by the body . after release of gonadotropins , follicle stimulating hormone is produced . gonadotsrophins play an important role in the growth and development of follicles in the ovaries . follicles are small round sacs that contain the egg cells . they release the immature egg cells and make follicles that are then grown in the laboratory . they are then collected and given to you by your doctor or
do not use orgalutran if you are allergic to ganirelix or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be hypersensitive , ask your doctor for advice . warnings and precautions talk to your doctor before using orgalurutran : if you have been previously treated with gonadotrophin releasing hormone ( gnrh ) or a gnrh analogue . if you suffer from a moderate or severe kidney or liver disease . if your doctor thinks you may have an increased risk of becoming pregnant . warnings , precautions and precautions before using the product , tell your doctor
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . orgalutran is only used in women who have completed the treatment with assisted reproduction techniques ( i . e . in vitro fertilisation ( ivf ), ovarian stimulation , follicle stimulating hormone ( fsh ), or corifollitropin . on day 2 or 3 of each cycle , you will receive orgaluitran under the skin ( subcutaneously ) for 5 to 6 days . you will be given orgaluchran either alone or in combination with fsh . the preparations are given
like all medicines , this medicine can cause side effects , although not everybody gets them . a side effect that may affect more than 1 in 10 people is local skin reactions ( redness and swelling ). the local reaction usually disappears after a few days . see section 4 for more information . uncommon ( may affect up to 1 in 100 people ) headache nausea ( malaise ). rare ( may affects up to1 in 10 , 000 people ) allergic reactions such as rash facial swelling , difficulty breathing ( dyspnoea ) swelling of face , lips , tongue , and / or throat , which may cause difficulty in breathing or swallowing ( ang
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and syringe after exp . the exp date refers to the last day of that month . syringes should be clear , liquid - free solutions . do this to protect from light . do do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what orgalutran contains - the active substance is ganirelix ( 0 . 5 mg / ml ). - the other ingredients are acetic acid , mannitol , water for injections ( for the ph ), sodium hydroxide and acetic acids . what orgalustran looks like and contents of the pack orgaluitran is a clear , colourless aqueous solution for injection . the solution is clear and colourless . it is for subcutaneous administration . the needle is inserted into a dry natural rubber / latex . orgaluchran is available in packs containing 1 or 5 vials .
what blitzima is blitzima contains the active substance rituximab , a " monoclonal antibody ". it sticks to a target in a type of white blood cell called " b - lymphocyte ". when ritukimab sticks to the target of this target , it stops the cell from growing and dividing . what blitzima used for blitzima has been given to treat : a ) non - hodgkin ' s lymphoma this is a disease of the lymph tissue that affects the immune system . it affects a type a of whiteblood cell called b - lipocytes . blitzima can be given alone
do not use blitzima - if you are allergic to rituximab , other proteins that are derived from ritukimab or any of the other ingredients of this medicine ( listed in section 6 ). - if your child has a severe active infection . - if he / she has a weak immune system . - warnings and precautions talk to your doctor or pharmacist before using blitzima : - if the child has severe heart failure or severe uncontrolled heart disease . - granulomatosis , polyangiitis , microscopic polyangiopitis or pemphigus vulgaris . warnings and risks talk to the
how blitzima is given your doctor will decide how much blitzima you will receive and how often you will need this treatment . always use this medicine exactly as your doctor has told you . check with your doctor if you are not sure . if you have any side effects , your doctor may reduce your dose . how blitzima will be given blitzima should be given as a drip ( intravenous infusion ). it is given in combination with medicines given at the same time as each blitzima administration . you will be treated with blitzima together with other medicines ( pre - medication ) to reduce the risk of side effects . your treatment will be
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . some of these reactions have been fatal . infusion reactions during the first 24 hours of the infusion you may experience fever , chills , shivering , pain at the infusion site , blisters , itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat discomfort , tongue or throat swelling , itchy , runny nose , vomiting , flushing , palpitations , heart attack , low number of plate
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what blitzima contains the active substance is rituximab . each 10 ml vial contains 100 mg of ritukimab in 10 ml . each 50 ml vials contains 500 mg of the active substances in ritudimab 10 ml solution . the other ingredients are sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections . what blitzima looks like and contents of the pack blitzima is a clear , colourless solution for infusion . it is supplied in 2 glass vials containing 50 ml . packs of 1 vial . not all pack sizes may be
roactemra contains the active substance toilizumab , a type of monoclonal antibody ( a type in the body ) that attaches to a specific target in the brain called interleukin - 6 ( interlekine ) and blocks the inflammation in your body . roactemrea can cause symptoms such as pain and swelling in your joints . roactoremra prevents the damage to the cartilage and bone in the joints caused by the disease . roACTemra is used to treat moderate to severe active rheumatoid arthritis ( an autoimmune disease ) in adults who have not received previous therapies
do not use roactemra if you are allergic to tocilizumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have an active , severe infection . during the infusion with roactemnra , you may experience allergic reactions such as chest tightness , wheezing , severe dizziness , light - headedness , swelling of the lips or skin rash . these reactions usually disappear after a few days . if you develop any signs of infection or infections , tell your doctor immediately . if your body ' s ability to fight infections is reduced , you should tell your physician . if an
the doctor or nurse will give you roactemra into a vein by a nurse . you will be given the intravenous infusion once a day . your doctor will decide on the treatment that you need . the recommended dose of roactemera is 8 mg / kg body weight . the usual dose is 4 mg /kg body weight given once a week . the dose of rifampicin given once every 8 weeks is 8mg / kg ( given as a drip in the vein ( intravenous infusion ). the usual starting dose is 2 mg / kilogram body weight once a month . the maximum dose of the ro
like all medicines , roactemra can cause side effects , although not everybody gets them . the following side effects have been reported in the post marketing setting ( see section 3 ): stop taking roactemnra and see a doctor straight away : serious side effects ( may affect up to 1 in 10 people ) allergic reactions , including difficulty with breathing , chest tightness , light - headedness , rash , itching , hives , swelling of the lips , tongue or face . serious infections , including fever and chills , which may travel through the mouth and skin blisters and stomach ache signs and symptoms of liver toxicity ( may
keep this medicine out of the sight and reach of children . do not use roactemra after the expiry date which is stated on the outer carton and the vial label after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what roactemra contains the active substance is tocilizumab . each 4 ml vial contains 80 mg of tociluzumab in 20 ml . each 10 ml vials contains 200 mg of of tocelizumumab ( 20 ml ). each 20 ml vray contains 400 mg of the active substances of tocizumb ( 20 mg ). the other ingredients are sucrose , polysorbate 80 , disodium phosphate dodecahydrate , sodium dihydrogen phosphate dihydrate and water for injections . what roactemetra looks like and contents of the pack roactrem
what onbrez breezhaler is onbrezezhalers contains the active substance indacaterol which belongs to a group of medicines called bronchodilators . these relax the muscles in the walls of the small air passages in the lungs . what onbreez breez inhaler is used for onbrezer is used to treat breathing difficulties in adults with a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways tighten , making breathing difficult . this medicine works by relaxing these muscles in your lungs , making it easier for air to get in and out of
do not use onbrez breezhaler - if you are allergic to indacaterol or any of the other ingredients of this medicine ( listed in section 6 ). - if your asthma is not controlled with onbreez breez inhaler . - if any of these apply to you , tell your doctor before using onbrezer breezhhaler . warnings and precautions talk to your doctor or pharmacist before using this medicine : - if : - you have heart problems , epilepsy , thyroid gland problems , thyrotoxicosis ( diabetes ). treatment with on brez breezezhalER should be stopped immediately if
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual dose is one 150 microgram capsule twice a day ( one 300 microgram ) twice a week . your doctor will tell you how many capsules to use . your dose may be adjusted by your doctor depending on how you respond to the treatment . you should use your inhaler at least 24 hours after you last inhaled it . onbrez breezhaler is for inhalation use . you will need an inhaler and capsules ( in blisters ) to inhale the medicine . the medicine
what onbrez breezhaler contains - each onbrex breez inhaler 150 mg capsule contains 150 mg indacaterol ( as indacathol maleate ). - the other ingredients are lactose and the capsule is made of gelatin . - eachonbrez bronzhalER 300 mg capsule delivers 300 mg indiacaterol , as indiacathol femaleate . - the ingredients are made of lactose or the capsule contains gelatin . what onbreez breezeler looks like and contents of the pack onbrezy breezer 150mg capsules are white to off - white capsules and
clopidogrel hcs contains clopidigrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). clopridogrel clcs is taken by adults to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombotic events ( such as stroke , heart attack , or death ). you
do not take clopidogrel hcs - if you are allergic to clopidineogrel or any of the other ingredients of this medicine ( listed in section 6 ). - if your bleeding is currently being treated with a stomach ulcer or bleeding within the brain . - if severe liver disease is a possibility . if any of these apply to you , tell your doctor before taking clopridogrel clcs . warnings and precautions if any one of the situations mentioned below applies to you ( or you are not sure ), talk to your doctor or pharmacist before taking the combination of clopideogrel ccs :
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel hcs per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of clapidogl hcs ( 4 tablets of 75 mg ) once at the start
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
what clopidogrel hcs contains the active substance is clopridogrel . each film - coated tablet contains 75 mg of clopide ( as hydrochloride ). the other ingredients are ( see section 2 ' clopidaogrel hexamides '): tablet core : microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 and hydrogenated castor oil . tablet coating : polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow iron oxide , talc and macrogoline 3000
feccroja contains the active substance cefiderocol . this is an antibiotic medicine that belongs to a group of antibiotics called " cephalosporins ". antibiotics are used to fight bacteria that cause infections . fetcroja is used to treat infections caused by bacteria that you have not previously been able to fight with other antibiotics .
do not use fetcroja if you are allergic to cefiderocol or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor or pharmacist before using fetcroj if you have had a severe allergic reaction to certain antibiotics ( e . g . penicillins or carbapenems ). if this happens , tell your doctor straight away . if you experience severe skin peeling or swelling of the hands , face , feet , lips , tongue or throat that may cause difficulty swallowing or breathing , stop
this medicine is given by a doctor or nurse as an infusion ( a drip ) into a vein . it usually takes about 3 to 2 weeks . your doctor will decide how long fetcroja treatment will last . your dose will be decided by your doctor . your infection will be treated as soon as possible . you should not feel any pain during the fetcrofa infusion . it is recommended that you continue to receive fetcrora for as long as your doctor prescribes it for you . if you have kidney problems tell your doctor if you suffer from kidney problems . if your dose of fetcroJA is reduced , your doctor may increase
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side side effects you may need urgent medical treatment : severe allergic reaction : sudden swelling of your lips , face , throat or tongue , a severe rash or other severe skin reactions , difficulty swallowing or breathing . this reaction may lead to diarrhoea , stools , blood or mucus . treatment may be stopped or medicines may slow bowel movement . other side effects include : very common side effects ( may affect more than 1 in 10 people ): feeling sick ( nausea ) or
what fetcroja contains - the active substance is cefiderocol sulfate tosylate . each vial contains 1 mg cefIDERocol . - the other ingredients are sucrose , sodium chloride and sodium hydroxide . what fetcroJA looks like and contents of the pack fetcrojia is a white to off - white powder for solution for infusion . it is supplied in packs containing 10 vials .
depocyte is used to treat lymphomatous meningitis . lymphomatinous menenitis is a condition in which tumour cells accumulate in the membranes of the brain and spinal cord . depocyte is prepared from lymphoma tumour cell material .
do not use depocyte - if you are allergic to cytarabine or any of the other ingredients of this medicine ( listed in section 6 ). - if your child has a meningeal infection . warnings and precautions talk to your doctor or pharmacist before using depocyte . severe neurological side effects have been reported with depocyte , with symptoms related to the nervous system such as convulsions , pain , numbness , tingling , blindness , visual disturbances . if you experience any of these symptoms , stop using depocytes and contact your doctor immediately . if any dexamethasone tablets are used to treat unwanted effects
before starting treatment with depocyte , your doctor will decide the dose you need . if you have cancer , your surgeon will decide on the correct dose . the amount of depocyte that will be injected will depend on the size of the lumber sac . depocyte will be given to you by your doctor or nurse . the recommended dose is one vial of 1 mg or 5 mg of dexamethasone per day . the dose may be increased or decreased depending on the severity of 5 - day treatment . your doctor may adjust each depocyte dose depending on any side effects that you experience . the correct amount of the depocyte given
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with your treatment : very common side effects ( may affect more than 1 in 10 people ): common ( may affects up to 1 in 100 people ): uncommon ( may affecting up to1 in 10 , 000 people ): very common ( frequency cannot be estimated from the available data ): very rare ( may effect up to one in 10 ), very rare : very rare cases : very rarely : very commonly : very few cases : if you get any side effects at the start of your treatment , talk to your doctor or pharmacist .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the vial label after exp . the exp date refers to the last day of that month . depocyte should be stored in a refrigerator ( 2 - 8 ). store in the original package in order to protect from light . after preparation , depocyte must be used within 4 hours . do this if you notice that the solution is discoloured or has a changed appearance . do away with the vials and discard them . do do not throw away any medicines via wastewater or household waste
what depocyte contains - the active substance is cytarabine . each ml of suspension contains 10 mg cytarabiline . one vial of 5 ml solution contains 50 mg cytabine ( as cholesterol , triolein ). - the other ingredients are dioleoylphosphatidylcholine , dipalmitoylophosphatylglycerol , sodium chloride , water for injections . what depocyte looks like and contents of the pack depocyte is a solution for injection . it is supplied in a 5 ml glass vial as a single injection . a single vial is also available
what bemrist breezhaler is bemist breez inhaler contains two active substances , indacaterol and mometasone furoate . indacatorol belongs to a group of medicines called bronchodilators . it relaxes the muscles in the lungs , making it easier for air to get in and out of the lungs . mometsone fruate belongs to an important group of medicine called corticosteroids . corticostromes reduce the swelling and irritation ( inflammation ) in the small airways in the lung , which can lead to breathing problems . cortics reduce
do not use bemrist breezhaler - if you are allergic to indacaterol , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). - if any of these apply to you , tell your doctor before using bemrid breez inhaler . - if your doctor thinks you may be allergic . - tell your physician if you have heart problems , such as an irregular or fast heartbeat . - you have thyroid gland problems . - have diabetes , high blood sugar , seizures or low level of potassium in your blood . - suffer from severe liver problems . tell
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . bemrist breezhaler capsules should be swallowed whole with water . you can take the medicine with or without food . it is important that you continue to use the medicine until your asthma is controlled and your symptoms improve . if you have any further questions on the use of bemist breez inhaler , ask your doctor , pharmacist or nurse . how bemrid breezcaler is used bemrit breezhaleer is an inhaler and capsules are for inhalation use
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious . tell your doctor immediately if you experience any of the following : very common ( may affect more than 1 in 10 people ): difficulty breathing or swallowing , swelling of the tongue , lips , or face , skin rash , itching and hives . allergic reaction uncommon ( may effect up to 1 in 100 people ): swelling of either the tongue or lips , face or throat ( angioedema ). other side effects other sideeffects include the following listed below : very commonly ( may affects more than1 in 10 users ): sore
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special temperature storage conditions . store in the original blister in order to protect from light . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what bemrist breezhaler contains the active substances are indacaterol ( as acetate ) and mometasone furoate . bemist breez inhaler 125 micrograms / 62 . 5 microgram inhaled in a single inhalation each contains 173 microgram of indacate . each 150 microgram inhalation contains 150 microram of indiacaterol and 80 microgrammometason furoates . the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is equivalent to 125 microram indacatedol and 62 . 95 microgram momet
zyllt contains clopidogrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). zyllt is taken by adults to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombotic events ( such as stroke , heart attack , or death ). you have been prescribed zyllT to help
do not take zyllt - if you are allergic to clopidogrel or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor thinks you may have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . - if severe liver disease . warnings and precautions talk to your doctor or pharmacist before taking zylltt if any of these apply to you : - if any other reason why you are taking zllt is not known ( cannot be estimated from the available data ). - you have a risk of bleeding such a medicalcondition that puts
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of zyllt per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of zllt ( 4 tablets of 75 mg ) once at the start of treatment . then , the recommended daily
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
what zyllt contains the active substance is clopidogrel . each film - coated tablet contains 75 mg of clopridogrel ( as hydrogen sulphate ). the other ingredients are : tablet core : lactose ( see section 2 under ' zyllT contains lactose '), microcrystalline cellulose , pregelatinised maize starch , macrogol 6000 and hydrogenated castor oil in the tablet core and hypromellose ( e464 ), titanium dioxide ( e171 ), red iron oxide ( e172 ), talc and propylene glycol in the film - coating . what zyllts
lamivudine teva contains the active substance lamivudin . lamivudaine tella is used to treat long term ( chronic ) hepatitis b infection in adults . lamivaludineteva is an antiviral medicine that works by stopping the hepatitis b virus from multiplying . it belongs to a group of medicines called nucleoside analogue reverse transcriptase inhibitors ( nrtis ). hepatitis b is a virus that infects the liver . long term (" chronic " infection can lead to liver damage . lamlivudine eva works by reducing the amount of hepatitis b in your liver . this will improve your condition and
do not take lamivudine teva - if you are allergic to lamivudaine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions 28 lamividine tevas may be taken with other similar medicines . serious side effects if you have liver disease , such as hepatitis c . if you become overweight , your doctor may need to do blood tests . your doctor will monitor your medication more closely ( see section 4 " warnings and risks "). if you take more lamivuine teeva than you should if your hepatitis is getting worse , you should stop taking lamivude te
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage your doctor lamivudine teva is used to treat your hepatitis b infection . it is important that you take it every day until your infection is gone . this will help you to remember to take it . it also helps you to stay alert to signs of your illness . you should continue to take lamivodine teeva every day as long as your health is improving . if you take more lamividine tevas than you should if you accidentally take too many lamivudsine te
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with lamivudine teva in clinical trials for other conditions linked to hepatitis b . the most serious side effects reported during therapy for hepatitis b are listed below . the side effects that have been observed during lamivudaine clinical trials include tiredness , respiratory tract infections , throat discomfort , headache , stomach discomfort , pain , nausea , vomiting , diarrhoea and increases in liver enzymes . these are signs that the liver is not working properly . the enzymes in the muscles may also be increased . allergic reaction (
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . lamivudine teva should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what lamivudine teva contains - the active substance is lamivu . each film - coated tablet contains 100 mg of lamivude . - the other ingredients are microcrystalline cellulose , sodium starch glycolate , magnesium stearate . tablet film - coating : hypromellose , titanium dioxide ( e171 ), macrogol , polysorbate 80 , iron oxide yellow ( e172 ), iron oxide red ( e 172 ). what lamivodine teeva looks like and contents of the pack orange , biconvex film - coat : 32 lamivondine tevas is supplied
nespo ( an anti - anaemic ) is used to treat your anaemia . anaemia occurs when your blood does not contain enough red blood cells . the symptoms are fatigue , weakness and shortness of breath . it is given in combination with the natural hormone erythropoietin . erythrothropoioin works by encouraging your kidneys to produce more red bloodcells . darbepoetin alfa is used for the treatment of chronic renal failure . symptomatic anaemia is caused by chronic renal fail . kidney failure is caused when kidney failure occurs . it reduces the amount of red blood produced .
do not use nespo : if you have high blood pressure or are taking other medicines . if you are allergic to nespos ( darbepoetin alfa ) or r - huepo . if this applies to you , tell your doctor . warnings and precautions talk to your doctor before using nesp : if your doctor has high bloodpressure and you are taking medicines to treat sickle cell anaemia . if your child has epileptic fits ( seizures ). if your newborn has convulsions or fits . if he / she has liver disease . if any of the above apply to you ( or
your doctor will carry out blood tests before you start nespo to check your haemoglobin level . the usual starting dose is 10 mg . your doctor will then increase your dose to a haemogl level of 10 mg every 12 hours . the pre - filled syringe is for injection into a vein . patients with chronic renal failure the usual dose is a single injection ( under the skin ) into a veins ( intravenous ). your doctor may change the dose if your anaemia does not respond to nespos . the dose is calculated based on your body weight . the recommended dose is 0 . 75 mg / kg or 0
like all medicines , nespo can cause side effects , although not everybody gets them . the following side effects have been reported with nespos : very common ( may affect more than 471 people ) uncommon ( may affects up to 10 in 100 people ) high blood pressure ( hypertension ) fluid retention ( oedema ) uncommon : ( may effect up to 1 in 100 , 000 people ) blood clots ( thrombosis ) pain in the area injected rash , redness and / or the skin rare : ( might affect up to1 in 10 , 000 , 000 patients ) serious allergic reactions sudden life - threatening allergic
keep out of the reach and sight of children . do not use nespo after the expiry date which is stated on the carton and on the syringe label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep your syringe in the original package in order to protect from light . after first opening , you may take nespos out of its refrigerator and keep it at room temperature ( not above 30 ) for no longer than 7 days . do this once a month . donot use nnespo if you notice it is coloured
what nespo contains the active substance is darbepoetin alfa . each ml of solution for injection contains 10 , 15 , 20 , 30 , 40 , 50 , 60 , 80 , 100 , 130 , 150 , 300 or 500 iu . the active substances darbiepoeteetin aluminium are produced by recombinant dna technology . the other ingredients of nespos are sodium phosphate monobasic , sodium phosphate dibasic ( e470b ), sodium chloride , polysorbate 80 and water for injections . what nespol looks like and contents of the pack n
macugen is a solution for the eye that contains the active substance pegaptanib . this medicine works by preventing abnormal formation of new blood vessels in the eye . macugen is used for the treatment of adults with macular degeneration . this disease causes vision loss due to damage to a part of the retina ( macula ) that lines the front part of your eye . the macula is the thin layer between the eye and the eye , and is the glue that holds the macular together . macula , the thin part of our eye , is the maculine . macular is the layer that lines up between the
do not use macugen if you are allergic to pegaptanib or any of the other ingredients of this medicine ( listed in section 6 ). if you have an active or suspected infection in your eye . warnings and precautions talk to your doctor or pharmacist before using macugen . if you think you have or have ever had an infection or bleeding in the eye , stop using macug injection and contact your doctor immediately . if any of these apply to you , tell your doctor straight away . if your doctor thinks you may have an infection , or bleeding or other signs of macugen injection , tell the doctor immediately , as you may
mugen injections will be given to you by a doctor or nurse . your doctor or pharmacist will decide how much macugen you need . macugen is given as a single injection into your eye . it is given every 6 to 9 weeks . the injection will be injected into the vitreous part of the eye ( the front part of your eye ). macugen must be used in combination with antibiotic eye drops . your eyes will be treated with some local anaesthetic (umbing medicine ) to reduce any pain you may have after the injection . if you are allergic to antibiotic eyedrops , you may be told to avoid the eye during
like all medicines , this medicine can cause side effects , although not everybody gets them . serious allergic reaction ( anaphylactic reaction or angioedema of which symptoms include breathing difficulty , wheezing , swollen mouth , face , hands or feet , itching skin , fainting , rapid pulse , stomach cramps , nausea , vomiting and diarrhoea ) the frequency of these side effects is not known . an infection in the internal portion of the eye has been reported following macugen treatment . the symptoms described in section 2 . if you experience any of these symptoms , contact your doctor immediately . other side effects very common (
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do this to protect from light . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what macugen contains - the active substance is pegaptanib . each single dose pre - filled syringe contains 0 . 3 mg of pegaptenib in 90 ml solution . - the other ingredients are sodium chloride , monobasic sodium phosphate monohydrate , dibasicodium phosphate heptahydrate , sodium hydroxide , hydrochloric acid ( for ph adjustment ) and water for injections . see section 2 . what macugen looks like and contents of the pack macugen solution for injection in a single dose pack is supplied in a pouch . each pack contains a pre -filled syringe containing 0
palifermin contains the active substance escherichia coli . palifermin works by stopping the growth of epithelial cells in the mouth and digestive tract and in the tissues of the skin . paliflifermin is used to treat oral mucositis ( soreness , dryness or inflammation of the mouth ) as an additional side effect that may be associated with treatments for your blood cancer . if your bloodcancer is not being treated with chemotherapy , radiotherapy or autologoushematopoietic stem cell transplantation ( a procedure that removes blood cells ) it may be more likely that you will be given side effects
do not take kepivance if you are allergic to palifermin , escherichia coli derived proteins or any of the other ingredients of this medicine ( listed in section 6 ). children and adolescents do not give this medicine to children and teenagers under 18 years of age . other medicines and kepivalance tell your doctor or pharmacist if you take , have recently taken or might take any other medicines . in particular , tell your pharmacist or nurse if you have recently been given heparin . pregnancy and breast - feeding kepvelance is not recommended if you plan to become pregnant or if you think you may
how kepivance is given your doctor will decide how much kepivanance you will receive . your doctor or nurse will decide the dose you will need . your dose of cancer treatment will depend on your condition . the usual dose of kepivalance is 60 mg . the recommended dose of your doctor ' s medicine is one kilogram ( kg ) given as an intravenous injection into a vein . how kepvelance is administered kepiper will be given to you in hospital . you will be treated with kepiveance three days before chemotherapy ( radiotherapy ). you will have chemotherapy andradiotherapy at
like all medicines , this medicine can cause side effects , although not everybody gets them . common ( may affect up to 1 in 10 people ): side effects include skin rash , itching , redness ( pruritus and erythaema ), an increase in the thickness in the mouth or tongue , change in colour of the mouth , tongue , generalised swelling ( oedema ), swelling of hands , ankles or feet , pain , fever and aching joints ( arthralgia ), altered taste , decrease in lipase and amylase levels , and in levels of digestive enzymes in the blood . treatment may be continued for
what kepivance contains - the active substance is palifermin . each vial contains 6 . 25 mg of paliferin . - the other ingredients are mannitol , sucrose , l - histidine , polysorbate 20 and diluted hydrochloric acid . what kepvelance looks like and contents of the pack kepickance is a white powder for concentrate for solution for injection . each pack contains 6 vials .
cinacalcet accordpharma contains the active ingredient cinacalcit which reduces the levels of calcium and phosphorous in the blood . it is used to treat problems with organs called parathyroid glands . parathyroids are four small glands in the neck , which are connected to the thyroid gland . cinaconalcate accordphara is used : to treat secondary hyperparathyroidism in adults with serious kidney disease who are not on dialysis because they cannot take waste products to reduce the amount of calcium in the bloodstream ( hypercalcaemia ). to treat parathy thyroid cancer that reduces the
do not take cinacalcet accordpharma - if you are allergic to cinacealcate or any of the other ingredients of this medicine ( listed in section 6 ). - if there are low levels of calcium in your blood . your doctor will check your blood calcium levels regularly before and during treatment with cinocalcut accordpha . warnings and precautions talk to your doctor or pharmacist before taking cinicalcordpharma : - if any of these apply to you , tell your doctor before taking this medicine . - if your doctor has told you that you have a history of
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . cinacalcet accordpharma must be taken orally with or without food . cinnacalcitpharma should be taken with or shortly after meals . the tablets should be swallowed whole with some water . your doctor will take regular blood samples during treatment to monitor the progress of secondary hyperparathyroidism . the usual starting dose of cinaconalcordpharma is 30 mg once a day ( one tablet in the morning ). c
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience : numbness or tingling around the mouth , muscle aches or cramps , seizures , as these may be signs that your calcium levels are too low ( hypocalcaemia ). swelling of the face , lips , mouth , tongue or throat that may cause difficulty in swallowing or breathing ( angioedema ). very common ( may affect more than 1 in 10 people ): nausea and vomiting . if you notice any of these side effects seek medical advice immediately . common ( might affect up to 1 in every
what cinacalcet accordpharma contains - the active substance is cinacealc . each film - coated tablet contains 30 mg , 60 mg or 90 mg of cinaconalcate ( as hydrochloride ). - the other ingredients are cellulose , microcrystalline - crospovidone - magnesium stearate , hypromellose , titanium dioxide ( e171 ), triacetin , indigo carmine aluminum lake ( e132 ), iron oxide yellow ( e172 ). what cinacyalcel accordpharmaceutical looks like and contents of the pack ciniac
jentadueto contains two active substances called linagliptin and metformin . linaglioptin belongs to a group of medicines called dpp - 4 inhibitors ( dipeptidyl peptidase - 4 inhibitor ) metformina belongs to the group of substances called biguanides . they work together to lower blood sugar levels in adult patients with a type of diabetes called ' type 2 diabetes mellitus '. this medicine works by helping your body make better use of insulin . this medicine can be used alone or with certain other medicines used to treat diabetes ( such as sulphonylureas or empag
do not take jentadueto - if you are allergic to linagliptin , metformin or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have severely reduced kidney function . - if any of these apply to you , tell your doctor before taking jentadoueto . warnings and precautions talk to your doctor or pharmacist before taking this medicine : - if the patient has severely reduced liver function . this can be a sign of uncontrolled diabetes ( e . g . severe hyperglycaemia ( high blood glucose ), nausea , vomiting , diarrhoe
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . jentadueto should be taken with or without food . if you currently take metformin or individual tablets containing linagliptin and metformine , do not take this medication and continue to take this other medicine . if an upset stomach occurs , take the medicine as soon as possible and then lie down . the recommended dose is one 5 mg linaglptin tablet once a day . your doctor may prescribe a higher dose of 2 , 000 mg metformina hydrochloride once a week
like all medicines , this medicine can cause side effects , although not everybody gets them . some symptoms may be serious and require immediate medical attention . stop taking jentadueto and contact a doctor immediately if you experience any of the following symptoms : low blood sugar ( hypoglycaemia ) trembling , sweating , anxiety , blurred vision , tingling lips , paleness , mood change , confusion . hypoglycemia is very rare ( may affect up to 1 in 10 , 000 people ). the most serious side effect that may occur with jentadaeto plus sulphonylurea is due to the combination jentaden
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . blister : store in the original package in order to protect from light . do this medicine if you notice any visible signs of tampering . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what jentadueto contains the active substances are linagliptin and metformin hydrochloride . each jentadinueto 2 . 5 mg / 850 mg film - coated tablet contains 2 . 25 mg linaglioptin and 850 mg metformine hydrochlorides . the other ingredients are arginine , copovidone , magnesium stearate , maize starch , silica , colloidal anhydrous , hypromellose , titanium dioxide ( e171 ), talc , propylene glycol . what jentadaeto looks like and contents of the pack jentadoeto 2.
edurant contains the active substance rilpivirine . edurant is used to treat human immunodeficiency virus ( hiv ) infection in adults , adolescents and children aged 12 years and older who are already taking hiv medicines called non - nucleoside reverse transcriptase inhibitors ( nnrtis ). edurants is used in combination with hiv medications to treat adults and adolescents aged 12 months and older infected with hick . it is not recommended that you take hiv medicine together with edurent . if you have any further questions on the use of medicines , ask your doctor or pharmacist
do not take edurant if you are allergic to rilpivirine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking edurants if you : are taking any of any of : the following medicines : carbamazepine , oxcarbazepine ; phenobarbital ; phenytoin ; medicines used to treat some bacterial infections ( e . g . tuberculosis ); omeprazole , esomeprazole ; lansoprazole or pantoprazol ; rabeprazoles ; proton pump
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . adults and adolescents ( aged 18 years and over ) the recommended dose of edurant is one tablet once a day . the dose may be adjusted by your doctor . the recommended dosage is one half tablet once daily . if you take more edurent than you should if you accidentally take too many tablets , contact your doctor immediately . if possible , take your tablet with food . if your doctor thinks that you may be taking rifabutin , contact a doctor immediately to take the dose of your next
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you have : headache , nausea , difficulty falling asleep , insomnia , dizziness , or changes in your routine liver tests ( transaminase ), increase in cholesterol and pancreatic amylase in your blood , abnormal dreams , rash , stomach pain , depression , tiredness , vomiting , drowsiness , decreased appetite , sleep disorders , stomach discomfort , depressed mood , dry mouth 36 low white blood cell and / or platelet count , decrease in haemoglobin in your bloodstream ( triglycerides , lipase , bilirub
what edurant contains the active substance is rilpivirine . each tablet contains rilpalpiviraine hydrochloride . each film - coated tablet contains 25 mg of ril pivirrine . the other ingredients are : tablet core : lactose monohydrate , croscarmellose sodium , povidone k30 , polysorbate 20 , silicified microcrystalline cellulose , magnesium stearate . film - coating : lactate monohydrate and hypromellose 2910 ( e464 ). tablet coating : 6x1 , titanium dioxide ( e171 ),
avandamet tablets are used together with two different medicines called rosiglitazone and metformin . these two medicines are used to treat type 2 diabetes . people with type 2abetes either don ' t make enough insulin to control their blood sugar levels or don 'T respond normally to insulin ( rosigslitazione and met formin ). the insulin that your body makes does not work as well as it should . when this happens , your blood sugar may go up . avandamvet is also used as a sulphonylurea ( a type of diabetes medicine ) in adults .
follow all your doctor ' s instructions carefully . check with your doctor , pharmacist or nurse if you are not sure . how to treat your diabetes your doctor will decide what dose of avandamet you need . do not take avandamanet if you : are allergic ( hypersensitive ) to rosiglitazone , metformin or any of the other ingredients of avANDamet ( listed in section 6 ) have had a heart attack have severe angina have heart failure have had heart failure in the past have severe breathing difficulties have liver disease have diabetic ketoacidosis ( a complication of diabetes causing rapid
always take avandamet tablets exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 2 mg rosiglitazone ( equivalent to 1000 mg metformin ). this dose is achieved by taking 1 tablet in the morning and 1 tablet during the evening . your doctor may increase your dose to 8 mg once a day . the maximum dose is 4 mg rosciglitizone ( corresponding to 1000mg metforma ). thisdose is achieved through 1 tablet per day . your dose may be increased by up to 8 tablets . themaximum dose is
like all medicines , avandamet can cause side effects , although not everybody gets them . allergic reactions to avandamanet may include raised and itchy rash ( hives ) swelling mainly of the face or mouth ( angioedema ), with difficulty in breathing collapse . if you get any of these symptoms , stop taking avandandamnet and contact your doctor straightaway . lactic acidosis ( build - up of lacticacid in the blood ( lactic acidsosis is a common side effect in patients taking metformin , especially if they have severe kidney disease ). symptoms of lact acidosis include rapid
keep out of the reach and sight of children . do not use avandamet after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicinal product does not require any special storage conditions . do this if you notice any change in the appearance of the tablets . do away with the blister after you have taken them . do do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what avandamet contains the active substances are rosiglitazone and metformin . avandamanet tablets come in different strengths : 1 mg rosIGlitazon 500 mg metforma , 2 mg rosciglitizone 500 mg meetformin , 2mg rosigllitazione 1000 mg met formin , 4 mg rossiglitrazone 1000 mg meet formin . the other ingredients are sodium starch glycollate , hypromellose , microcrystalline cellulose , lactose monohydrate , povidone , magnesium stearate , titanium dioxide
clopidogrel mylan contains clopidigrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). clopridogrel melan is taken by adults to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombotic events ( such as stroke , heart attack , or death ). you
do not take clopidogrel mylan 31 if you are allergic to clopiprel or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if any of these apply to you , tell your doctor before taking clopridogrelmylan . warnings and precautions talk to your doctor or pharmacist before taking any of your medicines : if you think any of this applies to you ( or you are not sure ), talk to the doctor or nurse
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel mylan per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of clapidogl mylan ( 4 tablets of 75 mg ) once at the start
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
what clopidogrel mylan contains the active substance is clopridogrel . each film - coated tablet contains 75 mg of clopide ( as hydrochloride ). the other ingredients are microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 , hydrogenated castor oil ( see section 2 ' clopidaogrel Mylan contains hydrogenatedcastor oil '), polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow iron oxide , talc , macrogrol 3000 . what
doptelet belongs to a group of medicines called thrombopoietin receptor agonists . doptelet is used to treat chronic liver disease with low platelet count ( thrombolocytopenia ), in adults , in a medical procedure to prevent and reduce bleeding . it works by reducing the number of platelets . platelets are blood cells that are needed in the blood to clot and prevent bleeding .
do not use doptelet if you are allergic to avatrombopag or any of the other ingredients of this medicine ( listed in section 6 ). if you have a history of blood clots in the veins or arteries . if you think any of these apply to you , tell your doctor . warnings and precautions talk to your doctor before using dopteLET : if you currently have or have had blood clops , as this medicine may increase the risk of bloodclots in cancer . if your doctor has recently switched you from the contraceptive birth control pill to hormone replacement therapy . if recently had surgery or are seriously injured .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual dose for your procedure is 5 mg once a day . your doctor may increase your dose to 8 mg once daily depending on your response to doptelet . your dose of dopteLET may be increased by 20 mg , 40 mg or 60 mg once every 5 days . your platelet counts may be reduced by taking this medicine for 10 to 13 days after your planned medical procedure . swallow the tablet whole with some water . do not chew or crush the tablet . if you take more doptelets
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with doptelet : very common ( may affect more than 1 in 10 people ): feeling tired uncommon ( may effect up to 1 in 100 people ): low red blood cell count ( anaemia ) blood clot in the portal vein ( a blood vessel that transports blood from the liver to the intestines ) upper abdominal pain , swelling bone pain muscle aches fever reporting of side effects if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet
what doptelet contains - the active substance is avatrombopag . each film - coated tablet contains avatormbopog maleate equivalent to 20 mg avatrambopg . - the other ingredients are lactose monohydrate ( see section 2 ' doptelets contains lactose '), microcrystalline cellulose , crospovidone type b [ e ], silica , colloidal anhydrous , magnesium stearate . - film - coating : vinyl alcohol , talc , macrogol 3350 , titanium dioxide ( e171 ), iron oxide yellow ( e172 ). what
rapiscan belongs to a group of medicines called ' coronary vasodilators '. it works by helping to widen the heart arteries , thus increasing heart rate and helping to relax the muscles of the heart . rapiscan is used for diagnostic use only . it is used in adults for a type of heart scan called ' myocardial perfusion imaging '. the scan contains a radioactive substance called a ' radiopharmaceutical '. these images are taken to help to see the muscles in the heart using a readmill . a scan contains only a small amount of radiopharma and is carried out by a healthcare professional . it has been
do not take rapiscan if you have slow heart rate , high degree heart block , sinus node disease or a pacemaker . if you experience chest pain ( unstable angina ) during treatment , please inform your doctor . if your doctor has prescribed rapiscin for you . if any of the above apply to you ( or you are not sure ), talk to your doctor before taking rapiscen . warnings and precautions talk to you doctor before you take rapican : if you : have a recent serious heart problem , including a heart attack , have abnormal heart rhythms ( a heart rhythm where the heartbeat is very fast or uneven
rapiscan will be given to you by a doctor or nurse who is experienced in the treatment of your heart and blood pressure . it will be injected into a vein ( intravenously ) over a period of 400 minutes . the recommended dose is a 5 ml solution the injection will be administered over a minimum of 5 minutes . your doctor will decide how much rapiscan you need and how often you need to be given . the dose may be increased or decreased depending on your weight . your dose may also be given as an injection of sodium chloride 9 mg / kg ( 0 . 9 %) solution for injection ( injection in a vein
like all medicines , rapiscan can cause side effects , although not everybody gets them . the side effects usually disappear after the rapiscin injection within 30 minutes of any treatment . tell your doctor immediately if you notice any of the following side effects : sudden stopping of the heart , which may be due to damage to the heart ( heart block ), a disorder of theheart ' s electrical signal , rapid heart beat low blood pressure , fainting , ministrokes , weakness of the face and inability to speak . rapiscans may cause a stroke or cerebrovascular accident . an allergic reaction may include rash , wheals
viagra contains the active substance sildenafil which belongs to a group of medicines called phosphodiesterase type 5 ( pde5 ) inhibitors . it works by helping to relax the blood vessels in your penis , allowing blood to flow into your penis when you get sexually excited . viagra will only help you to get an erection if you are sexually stimulated . viagag is a treatment for adult men with erectile dysfunction or impotence . this is when a man cannot get , or keep a hard , erect penis suitable for sexual activity .
do not take viagra - if you are allergic to sildenafil or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you are taking medicines called nitrates , which could lead to a dangerous fall in your blood pressure . these medicines are used to treat angina pectoris ( " chest pain "). if you have not been told that you have this condition before , talk to your doctor . - if the medicines you are using are nitric oxide donors such as amyl nitrite , which can lead to an increased risk of a dangerous drop in your
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 50 mg once a day . viagra film - coated tablets are for oral use . viag orodispersible tablets are also for oral administration . swallow the tablets whole with a glass of water . viaga can be taken with or without food . viampic acid is for oral treatment . swallow your tablets whole . do not crush or chew the tablets . taking viagra with food viagra will help you to get an erection . you may find it easier to take it if
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects reported with viagra are usually mild to moderate . if you experience any of the following side effects while taking viagra : an allergic reaction ( may affect up to 1 in 100 people ). symptoms include sudden wheeziness , difficulty in breathing , dizziness and swelling of the eyelids , face , lips or throat . chest pains may occur and you may be told to take a semi - sitting position . you may also be given nitrates to reduce your chest pain . prolonged and sometimes painful erections ( may occur up to rare to
what viagra contains - the active substance is sildenafil . each tablet contains 25 mg of sildenedafil ( as the citrate salt ). - the other ingredients are : tablet core : microcrystalline cellulose , calcium hydrogen phosphate ( anhydrous ), croscarmellose sodium , magnesium stearate , hypromellose , titanium dioxide ( e171 ), lactose monohydrate , triacetin , indigo carmine aluminium lake ( e132 ). what viagra looks like and contents of the pack viagra film - coated tablets have a rounded - diamond shape and are engraved with the
sifrol contains the active substance pramipexole and belongs to a group of medicines known as dopamine agonists , which stimulate dopamine receptors in the brain . stimulation of the dopamine receptors triggers nerve impulses in thebrain that help to control body movements . sifrol is used to : : treat the symptoms of primary parkinson ' s disease in adults . it can be used alone or in combination with levodopa . treat parkinson's disease in adult patients . the symptoms are moderate to severe primary restless legs syndrome .
do not take sifrol - if you are allergic to pramipexole or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before taking sifol : - if your doctor has told you that you have any medical conditions that could increase your risk of symptoms such as kidney disease . - if the patient experiences hallucinations ( seeing , hearing or feeling things that are not there ). most hallucinations are temporary . - dyskinesia ( e . g . abnormal , uncontrolled movements of the limbs ). in patients with advanced parkinson ' s disease , levodopa has not
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of sifrol for parkinson ' s disease is 3 tablets per day . during the first week , the usual starting dose is 1 tablet of sufrol 0 . 088 mg ( 0 . 264 mg per day ). after 1 week , your doctor may increase your dose to 0 .088 mg ( 1 . 264 mmol / m2 ) once a day . your doctor will adjust your dose if your symptoms return but do not stop taking tablets until your doctor tells you to . the usual
like all medicines , this medicine can cause side effects , although not everybody gets them . evaluation of these side effects is based on the following frequencies : very common : may affect more than 1 in 10 people common : might affect up to 1 in 100 people uncommon : may affects up to1 in 1 , 000 people rare : may effect up to one in 10 , 000 patients with parkinson ' s disease the following side effects have been reported : - dyskinesia ( abnormal , uncontrolled movements of the limbs ), dizziness , nausea ( sickness ), urge to behave in an unusual way - hallucinations ( seeing , hearing or feeling things that
what sifrol contains the active substance is pramipexole . each tablet contains 0 . 088 mg , 0 . 18 mg , or 0 . 35 mg of pramipxole as 0 . 125 mg , either 0 . 25 mg or 0. 5 mg of 1 mg pramimexole dihydrochloride monohydrate . the other ingredients are mannitol , maize starch , anhydrous colloidal silica , povidone k 25 , magnesium stearate . what sifroll looks like and contents of the pack sifol 0 . 01 mg tablets are white to off
emadine is a medicine used for the treatment of seasonal allergic conjunctivitis of the eye . allergic conditions occur in some parts of the body , including the eye , but the allergic reaction can also occur in other parts of your body . allergic conjunctureivitis may occur with some materials ( allergens ) that may cause allergic reactions such as itching , redness and swelling . if this happens on the surface of your eye , you may not feel worse .
do not use emadine - if you are allergic to emedastine or any of the other ingredients of this medicine ( listed in section 6 ). - if your child is more than 3 years old . warnings and precautions talk to your doctor or pharmacist before using benzalkonium chloride . emadin is not recommended for children less than 3 months old . clinical trials have not been conducted in children lessthan 3 years of age . talk to their doctor or nurse before using emadrine if your baby has kidney or liver problems . other medicines and emadmine tell your doctor if you use , have recently used or
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use adults use one drop twice a day ( morning and evening ). use in children and adolescents use in adults 3 months of age and older and adolescents 1 year of age or older and weighing at least 1 kg . use in infants and children weighing at or below 1 kg use in all children . do not swallow the emadine bottle . wash your hands after using the medicine . the bottle can be removed from the bottle and left at room temperature ( below 30 ). remove the cap from the cap
like all medicines , this medicine can cause side effects , although not everybody gets them . the effects are usually mild to moderate . the drops should be used immediately after application . common side effects ( may affect up to 1 in 10 people ) effects in the eye : eye pain , itchy eye and eye redness . uncommon side effects : ( may effect up to1 in 100 people )effects in the back of the eye ( corneal disorder ): abnormal eye sensation , increased tear production , tired eyes , eye irritation , blurred vision , corneel staining and dry eye . general side effects include headache , difficulty sleeping , sin
keep out of the reach and sight of children . do not use emadine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do this to protect from light and moisture . do away with emadadine if you notice it is coloured or there are particles in it . do these to prevent infections ? ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what emadine contains - the active substance is emadastine 0 . 5 mg / ml . - the other ingredients are difumarate , benzalkonium chloride , trometamol , sodium chloride , hypromellose , purified water , hydrochloric acid , sodium hydroxide to maintain acidity levels and ph levels . what emadrine looks like and contents of the pack emadadine is a liquid ( a solution ) supplied in a 5 ml or 10 ml plastic ( drop - bottle ) bottle with a screw cap . not all pack sizes may be marketed .
levetiracetam is an antiepileptic medicine ( a medicine used to treat seizures in epilepsy ). levetiratam actavis is used : on its own in adults and adolescents from 16 years of age with newly diagnosed epilepsy , to treat a certain form of epilepsy . epilepsy is a condition where the patients have repeated fits ( seizures ). levantiracetaman is used for the epilepsy form in which the fits initially affect only one side of the brain , but could thereafter extend to larger areas on both sides of the body ( partial onset seizure with or without secondary generalisation ). leetiracetamm has been
do not take levetiracetam actavis - if you are allergic to levetiraacetam , pyrrolidone derivatives or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking leveturacetamactavis - tell your doctor if you have kidney problems - tell the doctor if any slow down in the growth or unexpected puberty development of your child has been reported . - if your child is taking anti - epileptics ( anti - psychotic medicines ) and you have had thoughts of harming or killing themselves . tell your physician if your
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . levetiracetam actavis is taken twice a day , once in the morning and once inthe evening . monotherapy dose in adults and adolescents from 16 years of age and older : the usual dose is 1 , 000 mg once a day . the dose may later be increased to 3 , 000mg once a daily . your doctor will tell you how many tablets of levetiraacetamactavis to take . the daily dose is 2 tablets of 1 , 500 mg once daily . after therapy dose
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor or the nearest emergency department immediately if you experience : weakness , feel light - headed or dizzy or have difficulty breathing , as these may be signs of a serious allergic ( anaphylactic ) reaction . swelling of the face , lips , tongue and throat ( quincke ' s oedema ), flu - like symptoms , a rash on the face followed by an extended rash with a high temperature , increased levels of liver enzymes seen in blood tests and a decrease in a type of white blood cell 56 ( eosinoph
what levetiracetam actavis contains the active substance is levetviracetam . levetiraacetamactavis 250 mg : each tablet contains 250 mg of levetmiracetam ( as levetaracetam ). levetieracetam actingavis 500 mg : one tablet contains 500 mg of the active ingredient levetirusacetam. leveteracetam actedavis 750 mg : two tablets contain 750 mg of of levevetir acetam (as levetiaracetam ) each tablet of leveriracetamine actavis 1 , 000 mg : the active substances are : tablet core
incruse ellipta contains the active substance umeclidinium bromide which belongs to a group of bronchodilators called bronchiolators . incruse inhala is used to treat adults with chronic obstructive pulmonary disease ( copd ). copd is a long - term condition in which the airways in your lungs become damaged and not able to open properly . this can lead to breathing difficulties . difficulties in breathing can also result in tightening of the muscles around the airway . this medicine works by tightening these muscles in the lungs , helping to control your breathing difficulties and reducing the effects of cop
do not use incruse ellipta 27 if you are allergic to umeclidinium or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using this medicine : if you have asthma . incruruse ellipta should not be used in patients with asthma . if you suffer from heart problems . if your doctor has told you that you have an eye problem called narrow - angle glaucoma ( an enlarged prostate , difficulty passing urine , or a blockage in your bladder ). if you know that you suffer severe liver problems . immediate
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation once a day . you should use this this medicine for 24 hours at the same time each day . do not use more than your doctor tells you to use . you can use incruse ellipta at any time of the day . use incrose elliptka every day for as long as your prescribed dose is to be used . if you have symptoms of using this medicine , such as a sudden attack of breathlessness or wheezing , you should seek medical advice
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions are uncommon ( may affect up to 1 in 100 people ). if you experience any of the following symptoms while taking incruse ellipta , stop taking this medicine and seek medical help immediately : itching skin rash , hives and redness 29 common side effects ( may effect up to1 in 10 people ): faster heart beat painful and frequent urination these may be signs of a urinary tract infection . common cold infection of nose or throat cough feeling of pressure or pain in the cheeks and forehead these may indicate inflammation of the sinuses
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label of the inhaler after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the inhalcer in the sealed tray in order to protect from light . after first opening of the tray , the inhalard should be used within 6 months . once the tray has been opened , the active substance of the medicine should be discarded . once opened , remove the inhaluer from the sealed tray
what incruse ellipta contains - the active substance is umeclidinium bromide . each single inhalation provides a delivered dose of 55 micrograms umecylidinia . each adult should receive a delivered doses of 65 microgramms umechloridinIUM bromides . - the other ingredients are lactose monohydrate ( see section 2 under ' incrusemipta contains lactose '), magnesium stearate . what incrusey ellipta looks like and contents of the pack incruense ellipta is an inhalation powder . the ellipta inhaler consists of a
what nucala is nucal contains the active substance mepolizumab , a monoclonal antibody . monoclabs is a type of protein that recognises and attaches to specific proteins in the body . what nucalan is used for nucalin is used to treat severe asthma in adults , adolescents and children aged 6 years and older . severe asthma affects many eosinophils ( a type a white blood cell that helps the airways to open ) and affects the lungs . in eosinaophilic asthma , the most common form of asthma nucalo is used in adults to prevent
do not use nucala if you are allergic to mepolizumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using this medicine if you have worsening asthma 58 patients have experienced asthma - related side effects when using nucal . if your asthma is not controlled with nucalan , your doctor may decide to reduce the dose or stop nucalo treatment . if you think you may be allergic , ask your doctor for advice . injection site reactions medicines of this type ( monoclonal antibodies ) can cause severe allergic reactions to other
nucala is given under the skin ( subcutaneous injection ). adults and adolescents 12 years of age and older : the recommended dose is 100 mg given once a week . children and adolescents 1 year of age or older : your doctor will decide the dose that is right for you . the pre - filled pen is for single use only . your doctor or nurse will show you how to inject nucala . duration of treatment with nucale your doctor may decide to continue the treatment with a lower dose . your dose of nucal may be increased if your asthma symptoms improve or attacks occur . if your asthma symptoms
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with nucala : allergic reactions allergic or allergic - like reactions may occur very commonly ( may affect more than 1 in 10 people ) after the injection . sometimes symptoms can be severe and need immediate medical attention . symptoms include chest tightness , cough , difficulty breathing fainting dizziness feeling lightheaded ( due to a drop in blood pressure ) swelling of eyelids , face , lips , tongue or mouth hives rash tell your doctor immediately if you experience a reaction similar reaction to nucal . other side effects
keep out of the reach and sight of children . do not use nucala after the expiry date which is stated on the carton and on the pre - filled pen after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the nucale pre -filled pen in the outer carton in order to protect from light . after first opening , the pen may be stored for up to 7 days in the refrigerator ( 4 8 ). discard the pen after 7 days . do away with the pre filled pen if it has been frozen . do throw
what nucala contains - the active substance is mepolizumab . each 1 ml ampoule contains 100 mg of mepolizaumab ( as besilate ). - the other ingredients are sucrose , sodium phosphate dibasic heptahydrate , citric acid monohydrate , polysorbate 80 , edta disodium dihydrate and water for injections . what nucal looks like and contents of the pack nucale 1 mg is supplied as a pack containing 1 ampoules , a multipack containing 3 ampouls , each containing 1 vial .
what ninlaro is and how it works ninlar is a cancer medicine that contains the active substance ixazomib , a ' proteasome inhibitor '. what it is used for ninlara is used to treat a cancer of the bone marrow called multiple myeloma . ixezomib inhibits cell survival by stopping myelomas cells from growing . it also inhibits the growth of a lot of proteins called proteasomes . what it does with ninlao if you have multiple myelo , your doctor will give you other medicines to treat multiple myelin . how it is given to treat myelom
do not take ninlaro if you are allergic to ixazomib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking ninlar if any of these apply to you : if you have been previously treated with ixamib . warnings and symptoms talk to a doctor or nurse before taking this medicine . if any or all of these applies to you , tell your doctor before taking the medicine . stop taking ninlanaro and seek medical help immediately if you experience bleeding , persistent nausea , vomiting , diarrhoea , nerve problems , t
you will be given ninlaro by a doctor who is experienced in the treatment of multiple myeloma . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of ninlar is lenalidomide ( a medicine that dissociates into two substances ), dexamethasone ( an anti - inflammatory medicine ). how much and how often to take your doctor will tell you how many capsules of ninlio to take . you will usually take lenalidomeide and dexamthasone once a day for the
like all medicines , this medicine can cause side effects , although not everybody gets them . very common serious side effects ( may affect more than 1 in 10 people ): low platelet counts ( thrombocytopenia ) nose bleeds that can easily bruise nausea , vomiting , diarrhoea numbness or tingling or burning of the hands or feet ( peripheral neuropathy ) swelling of the legs or feet (> peripheral oedema ) skin rash ( itchy , often on the surface of the body ). rare side effects these may affect up to 1 in 1 , 000 people : severe skin rashes , red to
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the blister tightly closed in order to protect from light . do store below 30 . do this to protect the capsule from moisture . do do not swallow the capsule . do use this product if you notice any damage or signs of tampering to medicine packaging . do throw away any medicines via wastewater or household waste . ask your pharmacist how to
what ninlaro contains the active substance of ninlar is ixazomib . each capsule contains 2 . 3 mg ixezomib and 3 . 3mg ixizomib citrate . the other ingredients are microcrystalline cellulose , magnesium stearate , talc . the capsule shell contains gelatin , titanium dioxide ( e171 ), red iron oxide ( e172 ), shellac , propylene glycol , potassium hydroxide , black iron oxide . the printing ink contains : - the capsule content contains : ix azomib 3 mg / 4 . 3 g ixabom
do not use palforzia if you are allergic to peanuts or arachis hypogaea . warnings and precautions talk to your doctor or pharmacist before using palfORzia . children and adolescents from 4 to 17 years of age should not receive treatment for peanut allergy because peanut ( desensitisation ) is not a natural defence mechanism . palfiorzia is not intended to cause allergic reactions . pforzinia is not used to treat food allergies . talk to a doctor or nurse before using the product . if you have any further questions on the use of palfourzia , ask
do not take palforzia if you are allergic to peanut or soya or any of the other ingredients of palforsia . if your asthma is getting worse or you have a problem swallowing . if you have long term problems with your digestive system . if any of these apply to you , tell your doctor . if the doctor thinks that you have developed a severe mast cell disorder ( severe or life - threatening anaphylaxis ) which may be life - long . if this happens , tell the doctor and take the next dose 60 days after the last dose . if treatment with palfiorzia is not possible
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet once a day . if you have been diagnosed with allergy , allergic reactions ( anaphylaxis ) may occur within 3 months of starting treatment with palforzia . initial doseescalation is recommended . your doctor will explain to you how to start these treatment steps . the initial dose escalation and up - dosing steps are described in section 6 ). if you take more palfourzia than you should if you accidentally take too many tablets , contact your doctor immediately
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with palforzia : severe allergic reactions : tell your doctor immediately if you have any of the following symptoms after taking palfORzia . the reaction may include : - trouble breathing - throat tightness - feeling offulness - trouble swallowing or speaking - changes in voice - dizziness or fainting - severe stomach cramps , pain , vomiting , diarrhoea , severe flushing or itching of the skin palforsia may cause problems with the stomach and digestive system ( eosinoph
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the vial label after exp . the exp date refers to the last day of that month . do store below 25 . do this medicine if you notice any hard lumps of powder or if the liquid is coloured . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what palforzia contains the active substance is palfoforz . each 0 . 5 mg capsule contains 1 , 10 or 20 mg of the active substances . the other ingredients are microcrystalline cellulose , colloidal anhydrous silica and magnesium stearate palfiorzia 100 mg oral powder in capsules with opening microcrycrystallinine celluloses , colloid anhydrated silica , and magnesium starchate paforzias 300 mg oralpowder in sachet microcry crystalline cellulos , collocular anhydric silica ( and magnesiumstearate ) and
zerne belongs to a group of substances called benzodiazepine - related medicinal products . they are used to induce hypnotic actions in adults . they have been shown to help prevent sleeping problems during treatment . if you do not respond to treatment , you may have problems sleeping .
do not take zerene : if you have hypersensitivity ( an allergy ) to zaleplon or any of the other ingredients of zerenea sleep apnoea syndrome ( which may occur for short periods ) if you suffer from severe kidney or liver problems if you are suffering from myasthenia gravis ( which causes very weak and tired muscles , severe breathing and chest problems ) if any of these apply to you , tell your doctor . children and adolescents do not give this medicine to children and adolescent under 18 years of age because it is not known if it is safe to give this product to children . other
always take zerene exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 10 mg once a day . if you have difficulty falling asleep , take your capsule with you . if your doctor tells you to take a lower dose , you should not take more than the recommended dosage . if the dose is 65 mg once daily . if there is mild to moderate liver problems , you may take a dose of 5 mg once every day . in case of mild tomoderate liver problems you should take a higher dose , depending on your response to the medicine . if it is
like all medicines , zerene can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any other changes in your health . the frequency of possible side effects listed below is defined using the following convention : 36 very common ( affects more than 1 user in 10 ) common ( affecting 1 to 10 users in 100 ) uncommon ( affects 1 to10 users in 1 , 000 ) rare ( affects less than 1 users in 10 , 000 ). very rare ( affecting less than1 user in 1, 000 ). not known ( frequency cannot be estimated from the available data ). very common : may affect more than1
what zerene contains - the active substance is zaleplon 5 mg . - the other ingredients are microcrystalline cellulose , pregelatinised starch , silicon dioxide , sodium lauryl sulphate , magnesium stearate , lactose monohydrate , indigo carmine ( e132 ), titanium dioxide ( e171 ), gelatin , titanium dioxide , red iron oxide ( e172 ), yellow iron oxide , black iron oxide (< e172 ) and sodium laurel sulphacy ( e133 ), silicon dioxide ( s - 13050 ). - the printing ink contains shellac , lecithin , simeth
